id	sid	tid	token	lemma	pos
eshr-4669	1	1	microsoft	microsoft	PROPN
eshr-4669	1	2	word	word	PROPN
eshr-4669	1	3	rr_1_4669	rr_1_4669	PROPN
eshr-4669	1	4	-	-	PUNCT
eshr-4669	1	5	article	article	NOUN
eshr-4669	1	6	text-21197-1-18-20220510.docx	text-21197-1-18-20220510.docx	VERB
eshr-4669	1	7	epidemiology	epidemiology	NOUN
eshr-4669	1	8	and	and	CCONJ
eshr-4669	1	9	society	society	NOUN
eshr-4669	1	10	health	health	PROPN
eshr-4669	1	11	review|	review|	PROPN
eshr-4669	1	12	eshr	eshr	PROPN
eshr-4669	1	13	vol	vol	NOUN
eshr-4669	1	14	.	.	PROPN
eshr-4669	2	1	4	4	NUM
eshr-4669	2	2	,	,	PUNCT
eshr-4669	2	3	no	no	INTJ
eshr-4669	2	4	.	.	NOUN
eshr-4669	2	5	2	2	NUM
eshr-4669	2	6	,	,	PUNCT
eshr-4669	2	7	2022	2022	NUM
eshr-4669	2	8	,	,	PUNCT
eshr-4669	2	9	pp	pp	ADJ
eshr-4669	2	10	.	.	PUNCT
eshr-4669	3	1	40	40	NUM
eshr-4669	3	2	-	-	SYM
eshr-4669	3	3	47	47	NUM
eshr-4669	3	4	issn	issn	PROPN
eshr-4669	3	5	2656	2656	NUM
eshr-4669	3	6	-	-	SYM
eshr-4669	3	7	6052	6052	NUM
eshr-4669	3	8	(	(	PUNCT
eshr-4669	3	9	online	online	NOUN
eshr-4669	3	10	)	)	PUNCT
eshr-4669	3	11	|	|	ADV
eshr-4669	3	12	2656	2656	NUM
eshr-4669	3	13	-	-	SYM
eshr-4669	3	14	1107	1107	NUM
eshr-4669	3	15	(	(	PUNCT
eshr-4669	3	16	print	print	NOUN
eshr-4669	3	17	)	)	PUNCT
eshr-4669	3	18	10.26555	10.26555	NUM
eshr-4669	3	19	/	/	SYM
eshr-4669	3	20	eshr.v4i2.4669	eshr.v4i2.4669	NUM
eshr-4669	3	21	40	40	NUM
eshr-4669	3	22	research	research	NOUN
eshr-4669	3	23	article	article	NOUN
eshr-4669	3	24	biofilm	biofilm	NOUN
eshr-4669	3	25	formation	formation	NOUN
eshr-4669	3	26	by	by	ADP
eshr-4669	3	27	uropathogens	uropathogen	NOUN
eshr-4669	3	28	and	and	CCONJ
eshr-4669	3	29	its	its	PRON
eshr-4669	3	30	impact	impact	NOUN
eshr-4669	3	31	on	on	ADP
eshr-4669	3	32	antimicrobial	antimicrobial	ADJ
eshr-4669	3	33	susceptibility	susceptibility	NOUN
eshr-4669	3	34	pattern	pattern	NOUN
eshr-4669	3	35	priyanka	priyanka	PROPN
eshr-4669	3	36	sharma1	sharma1	PROPN
eshr-4669	3	37	,	,	PUNCT
eshr-4669	3	38	sandeep	sandeep	PROPN
eshr-4669	3	39	dogra1	dogra1	PROPN
eshr-4669	3	40	*	*	PROPN
eshr-4669	3	41	,	,	PUNCT
eshr-4669	3	42	bella	bella	PROPN
eshr-4669	3	43	mahajan2	mahajan2	PROPN
eshr-4669	3	44	,	,	PUNCT
eshr-4669	3	45	shashi	shashi	NOUN
eshr-4669	3	46	sudhan	sudhan	PROPN
eshr-4669	3	47	sharma3	sharma3	PROPN
eshr-4669	3	48	1	1	NUM
eshr-4669	3	49	department	department	NOUN
eshr-4669	3	50	of	of	ADP
eshr-4669	3	51	microbiology	microbiology	NOUN
eshr-4669	3	52	,	,	PUNCT
eshr-4669	3	53	govt	govt	NOUN
eshr-4669	3	54	.	.	PUNCT
eshr-4669	4	1	medical	medical	ADJ
eshr-4669	4	2	college	college	PROPN
eshr-4669	4	3	,	,	PUNCT
eshr-4669	4	4	jammu	jammu	PROPN
eshr-4669	4	5	,	,	PUNCT
eshr-4669	4	6	india	india	PROPN
eshr-4669	4	7	2	2	NUM
eshr-4669	4	8	department	department	NOUN
eshr-4669	4	9	of	of	ADP
eshr-4669	4	10	microbiology	microbiology	NOUN
eshr-4669	4	11	,	,	PUNCT
eshr-4669	4	12	ascoms	ascom	NOUN
eshr-4669	4	13	&	&	CCONJ
eshr-4669	4	14	hospital	hospital	PROPN
eshr-4669	4	15	,	,	PUNCT
eshr-4669	4	16	jammu	jammu	PROPN
eshr-4669	4	17	,	,	PUNCT
eshr-4669	4	18	india	india	PROPN
eshr-4669	4	19	3	3	NUM
eshr-4669	4	20	department	department	PROPN
eshr-4669	4	21	of	of	ADP
eshr-4669	4	22	microbiology	microbiology	NOUN
eshr-4669	4	23	,	,	PUNCT
eshr-4669	4	24	govt	govt	NOUN
eshr-4669	4	25	.	.	PUNCT
eshr-4669	5	1	medical	medical	ADJ
eshr-4669	5	2	college	college	PROPN
eshr-4669	5	3	,	,	PUNCT
eshr-4669	5	4	jammu	jammu	PROPN
eshr-4669	5	5	,	,	PUNCT
eshr-4669	5	6	india	india	PROPN
eshr-4669	5	7	*	*	PUNCT
eshr-4669	5	8	correspondence	correspondence	NOUN
eshr-4669	5	9	:	:	PUNCT
eshr-4669	6	1	sandeepdogra@gmail.com	sandeepdogra@gmail.com	X
eshr-4669	6	2	.	.	PUNCT
eshr-4669	6	3	phone	phone	NOUN
eshr-4669	6	4	:	:	PUNCT
eshr-4669	6	5	(	(	PUNCT
eshr-4669	6	6	+91	+91	NOUN
eshr-4669	6	7	)	)	PUNCT
eshr-4669	6	8	9906091412	9906091412	NUM
eshr-4669	6	9	received	receive	VERB
eshr-4669	6	10	14	14	NUM
eshr-4669	6	11	august	august	PROPN
eshr-4669	6	12	2021	2021	NUM
eshr-4669	6	13	;	;	PUNCT
eshr-4669	6	14	accepted	accept	VERB
eshr-4669	6	15	06	06	NUM
eshr-4669	6	16	october	october	PROPN
eshr-4669	6	17	2021	2021	NUM
eshr-4669	6	18	;	;	PUNCT
eshr-4669	6	19	published	publish	VERB
eshr-4669	6	20	2	2	NUM
eshr-4669	6	21	august	august	PROPN
eshr-4669	6	22	2022	2022	NUM
eshr-4669	6	23	abstract	abstract	ADJ
eshr-4669	6	24	background	background	NOUN
eshr-4669	6	25	:	:	PUNCT
eshr-4669	6	26	out	out	ADP
eshr-4669	6	27	of	of	ADP
eshr-4669	6	28	all	all	DET
eshr-4669	6	29	hospital	hospital	NOUN
eshr-4669	6	30	-	-	PUNCT
eshr-4669	6	31	associated	associate	VERB
eshr-4669	6	32	infections	infection	NOUN
eshr-4669	6	33	(	(	PUNCT
eshr-4669	6	34	hais),urinary	hais),urinary	ADJ
eshr-4669	6	35	tract	tract	NOUN
eshr-4669	6	36	infection	infection	NOUN
eshr-4669	6	37	(	(	PUNCT
eshr-4669	6	38	uti	uti	PROPN
eshr-4669	6	39	)	)	PUNCT
eshr-4669	6	40	is	be	AUX
eshr-4669	6	41	the	the	DET
eshr-4669	6	42	second	second	ADJ
eshr-4669	6	43	most	most	ADV
eshr-4669	6	44	common	common	ADJ
eshr-4669	6	45	infection	infection	NOUN
eshr-4669	6	46	that	that	PRON
eshr-4669	6	47	accounts	account	VERB
eshr-4669	6	48	for	for	ADP
eshr-4669	6	49	approximately	approximately	ADV
eshr-4669	6	50	34	34	NUM
eshr-4669	6	51	%	%	NOUN
eshr-4669	6	52	,	,	PUNCT
eshr-4669	6	53	and	and	CCONJ
eshr-4669	6	54	80	80	NUM
eshr-4669	6	55	%	%	NOUN
eshr-4669	6	56	are	be	AUX
eshr-4669	6	57	associated	associate	VERB
eshr-4669	6	58	with	with	ADP
eshr-4669	6	59	indwelling	indwell	VERB
eshr-4669	6	60	catheters	catheter	NOUN
eshr-4669	6	61	and	and	CCONJ
eshr-4669	6	62	hence	hence	ADV
eshr-4669	6	63	with	with	ADP
eshr-4669	6	64	biofilm	biofilm	NOUN
eshr-4669	6	65	formation	formation	NOUN
eshr-4669	6	66	,	,	PUNCT
eshr-4669	6	67	which	which	PRON
eshr-4669	6	68	invites	invite	VERB
eshr-4669	6	69	multi	multi	ADJ
eshr-4669	6	70	-	-	ADJ
eshr-4669	6	71	drug	drug	ADJ
eshr-4669	6	72	resistant	resistant	ADJ
eshr-4669	6	73	microorganisms	microorganism	NOUN
eshr-4669	6	74	.	.	PUNCT
eshr-4669	7	1	the	the	DET
eshr-4669	7	2	present	present	ADJ
eshr-4669	7	3	study	study	NOUN
eshr-4669	7	4	was	be	AUX
eshr-4669	7	5	designed	design	VERB
eshr-4669	7	6	to	to	PART
eshr-4669	7	7	study	study	VERB
eshr-4669	7	8	in	in	ADP
eshr-4669	7	9	-	-	PUNCT
eshr-4669	7	10	vitro	vitro	X
eshr-4669	7	11	biofilm	biofilm	NOUN
eshr-4669	7	12	forming	form	VERB
eshr-4669	7	13	uropathogens	uropathogen	NOUN
eshr-4669	7	14	and	and	CCONJ
eshr-4669	7	15	their	their	PRON
eshr-4669	7	16	antimicrobial	antimicrobial	ADJ
eshr-4669	7	17	susceptibility	susceptibility	NOUN
eshr-4669	7	18	in	in	ADP
eshr-4669	7	19	a	a	DET
eshr-4669	7	20	tertiary	tertiary	ADJ
eshr-4669	7	21	care	care	NOUN
eshr-4669	7	22	hospital	hospital	NOUN
eshr-4669	7	23	in	in	ADP
eshr-4669	7	24	north	north	PROPN
eshr-4669	7	25	india	india	PROPN
eshr-4669	7	26	.	.	PUNCT
eshr-4669	8	1	method	method	PROPN
eshr-4669	8	2	:	:	PUNCT
eshr-4669	8	3	the	the	DET
eshr-4669	8	4	present	present	ADJ
eshr-4669	8	5	cross	cross	ADJ
eshr-4669	8	6	-	-	ADJ
eshr-4669	8	7	sectional	sectional	ADJ
eshr-4669	8	8	study	study	NOUN
eshr-4669	8	9	consisted	consist	VERB
eshr-4669	8	10	of	of	ADP
eshr-4669	8	11	200	200	NUM
eshr-4669	8	12	urine	urine	NOUN
eshr-4669	8	13	specimens	specimen	NOUN
eshr-4669	8	14	collected	collect	VERB
eshr-4669	8	15	over	over	ADP
eshr-4669	8	16	one	one	NUM
eshr-4669	8	17	year	year	NOUN
eshr-4669	8	18	from	from	ADP
eshr-4669	8	19	patients	patient	NOUN
eshr-4669	8	20	with	with	ADP
eshr-4669	8	21	symptoms	symptom	NOUN
eshr-4669	8	22	of	of	ADP
eshr-4669	8	23	urinary	urinary	ADJ
eshr-4669	8	24	tract	tract	NOUN
eshr-4669	8	25	infection	infection	NOUN
eshr-4669	8	26	.	.	PUNCT
eshr-4669	9	1	following	follow	VERB
eshr-4669	9	2	their	their	PRON
eshr-4669	9	3	isolation	isolation	NOUN
eshr-4669	9	4	and	and	CCONJ
eshr-4669	9	5	identification	identification	NOUN
eshr-4669	9	6	,	,	PUNCT
eshr-4669	9	7	all	all	DET
eshr-4669	9	8	the	the	DET
eshr-4669	9	9	isolates	isolate	NOUN
eshr-4669	9	10	were	be	AUX
eshr-4669	9	11	subjected	subject	VERB
eshr-4669	9	12	to	to	ADP
eshr-4669	9	13	screening	screen	VERB
eshr-4669	9	14	for	for	ADP
eshr-4669	9	15	biofilm	biofilm	NOUN
eshr-4669	9	16	formation	formation	NOUN
eshr-4669	9	17	by	by	ADP
eshr-4669	9	18	congo	congo	NOUN
eshr-4669	9	19	red	red	ADJ
eshr-4669	9	20	agar	agar	NOUN
eshr-4669	9	21	(	(	PUNCT
eshr-4669	9	22	cra	cra	PROPN
eshr-4669	9	23	)	)	PUNCT
eshr-4669	9	24	and	and	CCONJ
eshr-4669	9	25	the	the	DET
eshr-4669	9	26	tube	tube	NOUN
eshr-4669	9	27	adherence	adherence	NOUN
eshr-4669	9	28	(	(	PUNCT
eshr-4669	9	29	ta	ta	NOUN
eshr-4669	9	30	)	)	PUNCT
eshr-4669	9	31	methods	method	NOUN
eshr-4669	9	32	.	.	PUNCT
eshr-4669	10	1	subsequently	subsequently	ADV
eshr-4669	10	2	,	,	PUNCT
eshr-4669	10	3	the	the	DET
eshr-4669	10	4	kirby	kirby	PROPN
eshr-4669	10	5	bauer	bauer	PROPN
eshr-4669	10	6	-	-	PUNCT
eshr-4669	10	7	disk	disk	NOUN
eshr-4669	10	8	diffusion	diffusion	NOUN
eshr-4669	10	9	method	method	NOUN
eshr-4669	10	10	performed	perform	VERB
eshr-4669	10	11	the	the	DET
eshr-4669	10	12	antimicrobial	antimicrobial	ADJ
eshr-4669	10	13	susceptibility	susceptibility	NOUN
eshr-4669	10	14	test	test	NOUN
eshr-4669	10	15	.	.	PUNCT
eshr-4669	11	1	results	result	NOUN
eshr-4669	11	2	:	:	PUNCT
eshr-4669	11	3	out	out	ADP
eshr-4669	11	4	of	of	ADP
eshr-4669	11	5	the	the	DET
eshr-4669	11	6	total	total	ADJ
eshr-4669	11	7	samples	sample	NOUN
eshr-4669	11	8	(	(	PUNCT
eshr-4669	11	9	n	n	NOUN
eshr-4669	11	10	=	=	NUM
eshr-4669	11	11	200	200	NUM
eshr-4669	11	12	)	)	PUNCT
eshr-4669	11	13	,	,	PUNCT
eshr-4669	11	14	a	a	DET
eshr-4669	11	15	total	total	NOUN
eshr-4669	11	16	of	of	ADP
eshr-4669	11	17	46	46	NUM
eshr-4669	11	18	(	(	PUNCT
eshr-4669	11	19	23	23	NUM
eshr-4669	11	20	%	%	NOUN
eshr-4669	11	21	)	)	PUNCT
eshr-4669	11	22	were	be	AUX
eshr-4669	11	23	positive	positive	ADJ
eshr-4669	11	24	by	by	ADP
eshr-4669	11	25	the	the	DET
eshr-4669	11	26	cra	cra	PROPN
eshr-4669	11	27	method	method	NOUN
eshr-4669	11	28	,	,	PUNCT
eshr-4669	11	29	while	while	SCONJ
eshr-4669	11	30	33	33	NUM
eshr-4669	11	31	(	(	PUNCT
eshr-4669	11	32	16.5	16.5	NUM
eshr-4669	11	33	%	%	NOUN
eshr-4669	11	34	)	)	PUNCT
eshr-4669	11	35	were	be	AUX
eshr-4669	11	36	positive	positive	ADJ
eshr-4669	11	37	by	by	ADP
eshr-4669	11	38	the	the	DET
eshr-4669	11	39	ta	ta	PROPN
eshr-4669	11	40	method	method	NOUN
eshr-4669	11	41	.	.	PUNCT
eshr-4669	12	1	twenty	twenty	NUM
eshr-4669	12	2	-	-	PUNCT
eshr-4669	12	3	one	one	NUM
eshr-4669	12	4	(	(	PUNCT
eshr-4669	12	5	21	21	NUM
eshr-4669	12	6	%	%	NOUN
eshr-4669	12	7	)	)	PUNCT
eshr-4669	12	8	isolates	isolate	NOUN
eshr-4669	12	9	came	come	VERB
eshr-4669	12	10	positive	positive	ADJ
eshr-4669	12	11	by	by	ADP
eshr-4669	12	12	both	both	DET
eshr-4669	12	13	methods	method	NOUN
eshr-4669	12	14	.	.	PUNCT
eshr-4669	13	1	biofilm	biofilm	NOUN
eshr-4669	13	2	formation	formation	NOUN
eshr-4669	13	3	was	be	AUX
eshr-4669	13	4	seen	see	VERB
eshr-4669	13	5	more	more	ADV
eshr-4669	13	6	commonly	commonly	ADV
eshr-4669	13	7	in	in	ADP
eshr-4669	13	8	females	female	NOUN
eshr-4669	13	9	(	(	PUNCT
eshr-4669	13	10	82	82	NUM
eshr-4669	13	11	%	%	NOUN
eshr-4669	13	12	)	)	PUNCT
eshr-4669	13	13	.	.	PUNCT
eshr-4669	14	1	biofilm	biofilm	NOUN
eshr-4669	14	2	-	-	PUNCT
eshr-4669	14	3	forming	form	VERB
eshr-4669	14	4	uropathogens	uropathogen	NOUN
eshr-4669	14	5	develop	develop	VERB
eshr-4669	14	6	a	a	DET
eshr-4669	14	7	significantly	significantly	ADV
eshr-4669	14	8	higher	high	ADJ
eshr-4669	14	9	resistance	resistance	NOUN
eshr-4669	14	10	to	to	ADP
eshr-4669	14	11	antimicrobial	antimicrobial	ADJ
eshr-4669	14	12	drugs	drug	NOUN
eshr-4669	14	13	than	than	ADP
eshr-4669	14	14	non	non	NOUN
eshr-4669	14	15	-	-	NOUN
eshr-4669	14	16	producers	producer	NOUN
eshr-4669	14	17	.	.	PUNCT
eshr-4669	15	1	conclusion	conclusion	NOUN
eshr-4669	15	2	:	:	PUNCT
eshr-4669	15	3	the	the	DET
eshr-4669	15	4	correlation	correlation	NOUN
eshr-4669	15	5	was	be	AUX
eshr-4669	15	6	significant	significant	ADJ
eshr-4669	15	7	between	between	ADP
eshr-4669	15	8	biofilm	biofilm	NOUN
eshr-4669	15	9	production	production	NOUN
eshr-4669	15	10	and	and	CCONJ
eshr-4669	15	11	multidrug	multidrug	NOUN
eshr-4669	15	12	resistance	resistance	NOUN
eshr-4669	15	13	.	.	PUNCT
eshr-4669	16	1	also	also	ADV
eshr-4669	16	2	,	,	PUNCT
eshr-4669	16	3	it	it	PRON
eshr-4669	16	4	was	be	AUX
eshr-4669	16	5	concluded	conclude	VERB
eshr-4669	16	6	that	that	SCONJ
eshr-4669	16	7	the	the	DET
eshr-4669	16	8	cra	cra	PROPN
eshr-4669	16	9	method	method	NOUN
eshr-4669	16	10	could	could	AUX
eshr-4669	16	11	be	be	AUX
eshr-4669	16	12	employed	employ	VERB
eshr-4669	16	13	to	to	PART
eshr-4669	16	14	detect	detect	VERB
eshr-4669	16	15	biofilm	biofilm	NOUN
eshr-4669	16	16	formation	formation	NOUN
eshr-4669	16	17	in	in	ADP
eshr-4669	16	18	resource	resource	NOUN
eshr-4669	16	19	-	-	PUNCT
eshr-4669	16	20	limited	limit	VERB
eshr-4669	16	21	countries	country	NOUN
eshr-4669	16	22	.	.	PUNCT
eshr-4669	17	1	keywords	keyword	NOUN
eshr-4669	17	2	:	:	PUNCT
eshr-4669	17	3	urinary	urinary	ADJ
eshr-4669	17	4	tract	tract	NOUN
eshr-4669	17	5	infections	infection	NOUN
eshr-4669	17	6	;	;	PUNCT
eshr-4669	17	7	tube	tube	NOUN
eshr-4669	17	8	adherence	adherence	NOUN
eshr-4669	17	9	method	method	NOUN
eshr-4669	17	10	;	;	PUNCT
eshr-4669	17	11	congo	congo	NOUN
eshr-4669	17	12	red	red	ADJ
eshr-4669	17	13	agar	agar	NOUN
eshr-4669	17	14	method	method	NOUN
eshr-4669	17	15	;	;	PUNCT
eshr-4669	17	16	antibacterial	antibacterial	ADJ
eshr-4669	17	17	agents	agent	NOUN
eshr-4669	17	18	introduction	introduction	NOUN
eshr-4669	17	19	talking	talk	VERB
eshr-4669	17	20	of	of	ADP
eshr-4669	17	21	morbidity	morbidity	NOUN
eshr-4669	17	22	worldwide	worldwide	ADV
eshr-4669	17	23	,	,	PUNCT
eshr-4669	17	24	urinary	urinary	ADJ
eshr-4669	17	25	tract	tract	NOUN
eshr-4669	17	26	infections	infection	NOUN
eshr-4669	17	27	(	(	PUNCT
eshr-4669	17	28	utis	utis	NOUN
eshr-4669	17	29	)	)	PUNCT
eshr-4669	17	30	is	be	AUX
eshr-4669	17	31	one	one	NUM
eshr-4669	17	32	of	of	ADP
eshr-4669	17	33	the	the	DET
eshr-4669	17	34	leading	lead	VERB
eshr-4669	17	35	causes	cause	NOUN
eshr-4669	17	36	of	of	ADP
eshr-4669	17	37	which	which	PRON
eshr-4669	17	38	is	be	AUX
eshr-4669	17	39	caused	cause	VERB
eshr-4669	17	40	by	by	ADP
eshr-4669	17	41	different	different	ADJ
eshr-4669	17	42	microorganisms	microorganism	NOUN
eshr-4669	17	43	.	.	PUNCT
eshr-4669	18	1	worldwide	worldwide	ADV
eshr-4669	18	2	,	,	PUNCT
eshr-4669	18	3	uti	uti	PROPN
eshr-4669	18	4	has	have	VERB
eshr-4669	18	5	a	a	DET
eshr-4669	18	6	prevalence	prevalence	NOUN
eshr-4669	18	7	of	of	ADP
eshr-4669	18	8	11%(1	11%(1	NUM
eshr-4669	18	9	)	)	PUNCT
eshr-4669	18	10	,	,	PUNCT
eshr-4669	18	11	sharma	sharma	PROPN
eshr-4669	18	12	(	(	PUNCT
eshr-4669	18	13	biofilm	biofilm	NOUN
eshr-4669	18	14	formation	formation	NOUN
eshr-4669	18	15	by	by	ADP
eshr-4669	18	16	uropathogens	uropathogen	NOUN
eshr-4669	18	17	and	and	CCONJ
eshr-4669	18	18	its	its	PRON
eshr-4669	18	19	impact	impact	NOUN
eshr-4669	18	20	on	on	ADP
eshr-4669	18	21	antimicrobial	antimicrobial	ADJ
eshr-4669	18	22	susceptibility	susceptibility	NOUN
eshr-4669	18	23	pattern	pattern	NOUN
eshr-4669	18	24	)	)	PUNCT
eshr-4669	18	25	vol	vol	NOUN
eshr-4669	18	26	.	.	NOUN
eshr-4669	19	1	4	4	NUM
eshr-4669	19	2	,	,	PUNCT
eshr-4669	19	3	no	no	INTJ
eshr-4669	19	4	.	.	NOUN
eshr-4669	19	5	2	2	NUM
eshr-4669	19	6	,	,	PUNCT
eshr-4669	19	7	2022	2022	NUM
eshr-4669	19	8	,	,	PUNCT
eshr-4669	19	9	pp	pp	ADJ
eshr-4669	19	10	.	.	PUNCT
eshr-4669	20	1	40	40	NUM
eshr-4669	20	2	-	-	SYM
eshr-4669	20	3	47	47	NUM
eshr-4669	20	4	10.26555	10.26555	NUM
eshr-4669	20	5	/	/	SYM
eshr-4669	20	6	eshr.v4i2.4669	eshr.v4i2.4669	NUM
eshr-4669	20	7	41	41	NUM
eshr-4669	20	8	and	and	CCONJ
eshr-4669	20	9	according	accord	VERB
eshr-4669	20	10	to	to	ADP
eshr-4669	20	11	an	an	DET
eshr-4669	20	12	indian	indian	ADJ
eshr-4669	20	13	study	study	NOUN
eshr-4669	20	14	,	,	PUNCT
eshr-4669	20	15	it	it	PRON
eshr-4669	20	16	is	be	AUX
eshr-4669	20	17	36.68	36.68	NUM
eshr-4669	20	18	%	%	NOUN
eshr-4669	20	19	(	(	PUNCT
eshr-4669	20	20	2	2	NUM
eshr-4669	20	21	)	)	PUNCT
eshr-4669	20	22	.	.	PUNCT
eshr-4669	21	1	these	these	DET
eshr-4669	21	2	uropathogens	uropathogen	NOUN
eshr-4669	21	3	tend	tend	VERB
eshr-4669	21	4	to	to	PART
eshr-4669	21	5	colonize	colonize	VERB
eshr-4669	21	6	the	the	DET
eshr-4669	21	7	mucous	mucous	ADJ
eshr-4669	21	8	membrane	membrane	NOUN
eshr-4669	21	9	of	of	ADP
eshr-4669	21	10	the	the	DET
eshr-4669	21	11	bladder	bladder	NOUN
eshr-4669	21	12	and	and	CCONJ
eshr-4669	21	13	form	form	NOUN
eshr-4669	21	14	micro	micro	ADJ
eshr-4669	21	15	bacterial	bacterial	ADJ
eshr-4669	21	16	communities	community	NOUN
eshr-4669	21	17	called	call	VERB
eshr-4669	21	18	biofilms	biofilm	NOUN
eshr-4669	21	19	.	.	PUNCT
eshr-4669	22	1	the	the	DET
eshr-4669	22	2	colonization	colonization	NOUN
eshr-4669	22	3	by	by	ADP
eshr-4669	22	4	these	these	DET
eshr-4669	22	5	microcolonies	microcolonie	NOUN
eshr-4669	22	6	makes	make	VERB
eshr-4669	22	7	them	they	PRON
eshr-4669	22	8	impermeable	impermeable	ADJ
eshr-4669	22	9	to	to	ADP
eshr-4669	22	10	many	many	ADJ
eshr-4669	22	11	antibiotics	antibiotic	NOUN
eshr-4669	22	12	.	.	PUNCT
eshr-4669	23	1	it	it	PRON
eshr-4669	23	2	resultsin	resultsin	VERB
eshr-4669	23	3	the	the	DET
eshr-4669	23	4	evolution	evolution	NOUN
eshr-4669	23	5	of	of	ADP
eshr-4669	23	6	multidrug	multidrug	NOUN
eshr-4669	23	7	-	-	PUNCT
eshr-4669	23	8	resistant	resistant	ADJ
eshr-4669	23	9	strains	strain	NOUN
eshr-4669	23	10	,	,	PUNCT
eshr-4669	23	11	which	which	PRON
eshr-4669	23	12	is	be	AUX
eshr-4669	23	13	the	the	DET
eshr-4669	23	14	leading	leading	ADJ
eshr-4669	23	15	causeof	causeof	ADJ
eshr-4669	23	16	relapses	relapse	NOUN
eshr-4669	23	17	in	in	ADP
eshr-4669	23	18	untreatable	untreatable	ADJ
eshr-4669	23	19	uti	uti	PROPN
eshr-4669	23	20	.	.	PUNCT
eshr-4669	24	1	biofilms	biofilm	NOUN
eshr-4669	24	2	consist	consist	VERB
eshr-4669	24	3	of	of	ADP
eshr-4669	24	4	different	different	ADJ
eshr-4669	24	5	layers	layer	NOUN
eshr-4669	24	6	of	of	ADP
eshr-4669	24	7	cells	cell	NOUN
eshr-4669	24	8	embedded	embed	VERB
eshr-4669	24	9	in	in	ADP
eshr-4669	24	10	a	a	DET
eshr-4669	24	11	matrix	matrix	NOUN
eshr-4669	24	12	of	of	ADP
eshr-4669	24	13	extracellular	extracellular	ADJ
eshr-4669	24	14	exopolysaccharide	exopolysaccharide	NOUN
eshr-4669	24	15	–	–	PUNCT
eshr-4669	24	16	eem	eem	PROPN
eshr-4669	24	17	(	(	PUNCT
eshr-4669	24	18	slime	slime	NOUN
eshr-4669	24	19	)	)	PUNCT
eshr-4669	24	20	,	,	PUNCT
eshr-4669	24	21	which	which	PRON
eshr-4669	24	22	helps	help	VERB
eshr-4669	24	23	adhereto	adhereto	VERB
eshr-4669	24	24	biomedical	biomedical	ADJ
eshr-4669	24	25	surfaces	surface	NOUN
eshr-4669	24	26	and	and	CCONJ
eshr-4669	24	27	protects	protect	VERB
eshr-4669	24	28	them	they	PRON
eshr-4669	24	29	from	from	ADP
eshr-4669	24	30	the	the	DET
eshr-4669	24	31	host	host	NOUN
eshr-4669	24	32	immune	immune	ADJ
eshr-4669	24	33	system	system	NOUN
eshr-4669	24	34	and	and	CCONJ
eshr-4669	24	35	antimicrobial	antimicrobial	ADJ
eshr-4669	24	36	therapy	therapy	NOUN
eshr-4669	24	37	(	(	PUNCT
eshr-4669	24	38	3	3	NUM
eshr-4669	24	39	)	)	PUNCT
eshr-4669	24	40	,	,	PUNCT
eshr-4669	24	41	and	and	CCONJ
eshr-4669	24	42	provides	provide	VERB
eshr-4669	24	43	a	a	DET
eshr-4669	24	44	survival	survival	NOUN
eshr-4669	24	45	strategy	strategy	NOUN
eshr-4669	24	46	to	to	ADP
eshr-4669	24	47	the	the	DET
eshr-4669	24	48	uropathogenic	uropathogenic	NOUN
eshr-4669	24	49	.	.	PUNCT
eshr-4669	25	1	the	the	DET
eshr-4669	25	2	slimeconsists	slimeconsist	NOUN
eshr-4669	25	3	of	of	ADP
eshr-4669	25	4	extracellular	extracellular	ADJ
eshr-4669	25	5	dna	dna	NOUN
eshr-4669	25	6	,	,	PUNCT
eshr-4669	25	7	proteins	protein	NOUN
eshr-4669	25	8	,	,	PUNCT
eshr-4669	25	9	polysaccharides	polysaccharide	NOUN
eshr-4669	25	10	,	,	PUNCT
eshr-4669	25	11	adhesin	adhesin	NOUN
eshr-4669	25	12	,	,	PUNCT
eshr-4669	25	13	and	and	CCONJ
eshr-4669	25	14	autolysin	autolysin	NOUN
eshr-4669	25	15	.	.	PUNCT
eshr-4669	26	1	it	it	PRON
eshr-4669	26	2	starts	start	VERB
eshr-4669	26	3	with	with	ADP
eshr-4669	26	4	the	the	DET
eshr-4669	26	5	attachment	attachment	NOUN
eshr-4669	26	6	of	of	ADP
eshr-4669	26	7	free	free	ADV
eshr-4669	26	8	-	-	PUNCT
eshr-4669	26	9	floating	float	VERB
eshr-4669	26	10	microorganisms	microorganism	NOUN
eshr-4669	26	11	to	to	ADP
eshr-4669	26	12	a	a	DET
eshr-4669	26	13	surface	surface	NOUN
eshr-4669	26	14	.	.	PUNCT
eshr-4669	27	1	initially	initially	ADV
eshr-4669	27	2	,	,	PUNCT
eshr-4669	27	3	these	these	PRON
eshr-4669	27	4	areattached	areattache	VERB
eshr-4669	27	5	through	through	ADP
eshr-4669	27	6	weak	weak	ADJ
eshr-4669	27	7	van	van	PROPN
eshr-4669	27	8	der	der	PROPN
eshr-4669	27	9	waal	waal	PROPN
eshr-4669	27	10	forces	force	NOUN
eshr-4669	27	11	.	.	PUNCT
eshr-4669	28	1	later	later	ADV
eshr-4669	28	2	,	,	PUNCT
eshr-4669	28	3	if	if	SCONJ
eshr-4669	28	4	left	leave	VERB
eshr-4669	28	5	undisturbed	undisturbed	ADJ
eshr-4669	28	6	,	,	PUNCT
eshr-4669	28	7	they	they	PRON
eshr-4669	28	8	anchor	anchor	VERB
eshr-4669	28	9	themselves	themselves	PRON
eshr-4669	28	10	more	more	ADV
eshr-4669	28	11	firmly	firmly	ADV
eshr-4669	28	12	via	via	ADP
eshr-4669	28	13	cell	cell	NOUN
eshr-4669	28	14	adhesion	adhesion	NOUN
eshr-4669	28	15	structures	structure	NOUN
eshr-4669	28	16	such	such	ADJ
eshr-4669	28	17	as	as	ADP
eshr-4669	28	18	pili	pili	NOUN
eshr-4669	28	19	.	.	PUNCT
eshr-4669	29	1	repulsion	repulsion	NOUN
eshr-4669	29	2	to	to	ADP
eshr-4669	29	3	water	water	NOUN
eshr-4669	29	4	plays	play	VERB
eshr-4669	29	5	an	an	DET
eshr-4669	29	6	essential	essential	ADJ
eshr-4669	29	7	role	role	NOUN
eshr-4669	29	8	in	in	ADP
eshr-4669	29	9	determining	determine	VERB
eshr-4669	29	10	the	the	DET
eshr-4669	29	11	ability	ability	NOUN
eshr-4669	29	12	to	to	PART
eshr-4669	29	13	form	form	VERB
eshr-4669	29	14	biofilms(4).using	biofilms(4).use	VERB
eshr-4669	29	15	his	his	PRON
eshr-4669	29	16	simple	simple	ADJ
eshr-4669	29	17	microscopes	microscope	NOUN
eshr-4669	29	18	,	,	PUNCT
eshr-4669	29	19	van	van	PROPN
eshr-4669	29	20	leeuwenhoekobserved	leeuwenhoekobserve	VERB
eshr-4669	29	21	microorganisms	microorganism	NOUN
eshr-4669	29	22	on	on	ADP
eshr-4669	29	23	tooth	tooth	NOUN
eshr-4669	29	24	surfaces	surface	NOUN
eshr-4669	29	25	and	and	CCONJ
eshr-4669	29	26	can	can	AUX
eshr-4669	29	27	be	be	AUX
eshr-4669	29	28	regarded	regard	VERB
eshr-4669	29	29	with	with	ADP
eshr-4669	29	30	the	the	DET
eshr-4669	29	31	discovery	discovery	NOUN
eshr-4669	29	32	of	of	ADP
eshr-4669	29	33	biofilms	biofilm	NOUN
eshr-4669	29	34	.	.	PUNCT
eshr-4669	30	1	costertonet	costertonet	PROPN
eshr-4669	30	2	al	al	PROPN
eshr-4669	30	3	.	.	PROPN
eshr-4669	30	4	,	,	PUNCT
eshr-4669	30	5	in	in	ADP
eshr-4669	30	6	1978	1978	NUM
eshr-4669	30	7	,	,	PUNCT
eshr-4669	30	8	explained	explain	VERB
eshr-4669	30	9	the	the	DET
eshr-4669	30	10	mechanisms	mechanism	NOUN
eshr-4669	30	11	ofmicroorganisms	ofmicroorganism	NOUN
eshr-4669	30	12	'	'	PART
eshr-4669	30	13	adherence	adherence	NOUN
eshr-4669	30	14	to	to	ADP
eshr-4669	30	15	living	living	NOUN
eshr-4669	30	16	and	and	CCONJ
eshr-4669	30	17	nonliving	nonlive	VERB
eshr-4669	30	18	materials	material	NOUN
eshr-4669	30	19	and	and	CCONJ
eshr-4669	30	20	the	the	DET
eshr-4669	30	21	help	help	NOUN
eshr-4669	30	22	provided	provide	VERB
eshr-4669	30	23	by	by	ADP
eshr-4669	30	24	ecologic	ecologic	ADJ
eshr-4669	30	25	niche	niche	NOUN
eshr-4669	30	26	(	(	PUNCT
eshr-4669	30	27	5	5	NUM
eshr-4669	30	28	)	)	PUNCT
eshr-4669	30	29	.	.	PUNCT
eshr-4669	31	1	biofilms	biofilm	NOUN
eshr-4669	31	2	aremainly	aremainly	ADV
eshr-4669	31	3	formed	form	VERB
eshr-4669	31	4	in	in	ADP
eshr-4669	31	5	the	the	DET
eshr-4669	31	6	prostate	prostate	NOUN
eshr-4669	31	7	stones	stone	NOUN
eshr-4669	31	8	,	,	PUNCT
eshr-4669	31	9	urothelium	urothelium	NOUN
eshr-4669	31	10	,	,	PUNCT
eshr-4669	31	11	and	and	CCONJ
eshr-4669	31	12	implanted	implant	VERB
eshr-4669	31	13	foreign	foreign	ADJ
eshr-4669	31	14	bodies	body	NOUN
eshr-4669	31	15	(	(	PUNCT
eshr-4669	31	16	6	6	NUM
eshr-4669	31	17	)	)	PUNCT
eshr-4669	31	18	.	.	PUNCT
eshr-4669	32	1	predisposing	predispose	VERB
eshr-4669	32	2	host	host	NOUN
eshr-4669	32	3	factors	factor	NOUN
eshr-4669	32	4	are	be	AUX
eshr-4669	32	5	age	age	NOUN
eshr-4669	32	6	,	,	PUNCT
eshr-4669	32	7	diabetes	diabetes	NOUN
eshr-4669	32	8	,	,	PUNCT
eshr-4669	32	9	long	long	ADJ
eshr-4669	32	10	-	-	PUNCT
eshr-4669	32	11	term	term	NOUN
eshr-4669	32	12	hospitalization	hospitalization	NOUN
eshr-4669	32	13	,	,	PUNCT
eshr-4669	32	14	and	and	CCONJ
eshr-4669	32	15	catheterization	catheterization	NOUN
eshr-4669	32	16	(	(	PUNCT
eshr-4669	32	17	7	7	NUM
eshr-4669	32	18	)	)	PUNCT
eshr-4669	32	19	.	.	PUNCT
eshr-4669	33	1	national	national	PROPN
eshr-4669	33	2	institute	institute	PROPN
eshr-4669	33	3	health	health	PROPN
eshr-4669	33	4	(	(	PUNCT
eshr-4669	33	5	nih	nih	PROPN
eshr-4669	33	6	)	)	PUNCT
eshr-4669	33	7	says	say	VERB
eshr-4669	33	8	that	that	SCONJ
eshr-4669	33	9	among	among	ADP
eshr-4669	33	10	all	all	DET
eshr-4669	33	11	the	the	DET
eshr-4669	33	12	microbial	microbial	ADJ
eshr-4669	33	13	infections	infection	NOUN
eshr-4669	33	14	,	,	PUNCT
eshr-4669	33	15	80	80	NUM
eshr-4669	33	16	%	%	NOUN
eshr-4669	33	17	are	be	AUX
eshr-4669	33	18	caused	cause	VERB
eshr-4669	33	19	by	by	ADP
eshr-4669	33	20	biofilms	biofilm	NOUN
eshr-4669	33	21	(	(	PUNCT
eshr-4669	33	22	8)	8)	NUM
eshr-4669	33	23	.	.	PUNCT
eshr-4669	34	1	according	accord	VERB
eshr-4669	34	2	to	to	ADP
eshr-4669	34	3	the	the	DET
eshr-4669	34	4	center	center	NOUN
eshr-4669	34	5	for	for	ADP
eshr-4669	34	6	disease	disease	NOUN
eshr-4669	34	7	control	control	NOUN
eshr-4669	34	8	and	and	CCONJ
eshr-4669	34	9	prevention	prevention	NOUN
eshr-4669	34	10	(	(	PUNCT
eshr-4669	34	11	cdc	cdc	PROPN
eshr-4669	34	12	)	)	PUNCT
eshr-4669	34	13	,	,	PUNCT
eshr-4669	34	14	usa	usa	PROPN
eshr-4669	34	15	,	,	PUNCT
eshr-4669	34	16	biofilms	biofilm	NOUN
eshr-4669	34	17	on	on	ADP
eshr-4669	34	18	indwelling	indwell	VERB
eshr-4669	34	19	medical	medical	ADJ
eshr-4669	34	20	devices	device	NOUN
eshr-4669	34	21	consistof	consistof	NOUN
eshr-4669	34	22	gram	gram	PROPN
eshr-4669	34	23	-	-	PUNCT
eshr-4669	34	24	positive	positive	ADJ
eshr-4669	34	25	or	or	CCONJ
eshr-4669	34	26	gram	gram	NOUN
eshr-4669	34	27	-	-	PUNCT
eshr-4669	34	28	negative	negative	ADJ
eshr-4669	34	29	bacteria	bacteria	NOUN
eshr-4669	34	30	or	or	CCONJ
eshr-4669	34	31	yeasts	yeast	NOUN
eshr-4669	34	32	.	.	PUNCT
eshr-4669	35	1	the	the	DET
eshr-4669	35	2	most	most	ADV
eshr-4669	35	3	common	common	ADJ
eshr-4669	35	4	gram	gram	NOUN
eshr-4669	35	5	-	-	PUNCT
eshr-4669	35	6	positivebacteria	positivebacteria	NOUN
eshr-4669	35	7	isolated	isolate	VERB
eshr-4669	35	8	are	be	AUX
eshr-4669	35	9	enterococcus	enterococcus	NOUN
eshr-4669	35	10	faecalis	faecalis	NOUN
eshr-4669	35	11	,	,	PUNCT
eshr-4669	35	12	staphylococcus	staphylococcus	NOUN
eshr-4669	35	13	aureus	aureus	NOUN
eshr-4669	35	14	,	,	PUNCT
eshr-4669	35	15	staphylococcus	staphylococcus	NOUN
eshr-4669	35	16	epidermidis	epidermidi	NOUN
eshr-4669	35	17	,	,	PUNCT
eshr-4669	35	18	streptococcus	streptococcus	NOUN
eshr-4669	35	19	viridans	viridan	NOUN
eshr-4669	35	20	,	,	PUNCT
eshr-4669	35	21	and	and	CCONJ
eshr-4669	35	22	gramnegative	gramnegative	ADJ
eshr-4669	35	23	bacteriaescherichia	bacteriaescherichia	NOUN
eshr-4669	35	24	coli	coli	NOUN
eshr-4669	35	25	,	,	PUNCT
eshr-4669	35	26	klebsiella	klebsiella	NOUN
eshr-4669	35	27	pneumonia	pneumonia	NOUN
eshr-4669	35	28	,	,	PUNCT
eshr-4669	35	29	proteus	proteus	PROPN
eshr-4669	35	30	mirabilis	mirabilis	PROPN
eshr-4669	35	31	,	,	PUNCT
eshr-4669	35	32	and	and	CCONJ
eshr-4669	35	33	pseudomonas	pseudomona	NOUN
eshr-4669	35	34	aeruginosa	aeruginosa	NOUN
eshr-4669	35	35	.	.	PUNCT
eshr-4669	36	1	these	these	DET
eshr-4669	36	2	bacteriacan	bacteriacan	VERB
eshr-4669	36	3	originate	originate	VERB
eshr-4669	36	4	from	from	ADP
eshr-4669	36	5	the	the	DET
eshr-4669	36	6	skin	skin	NOUN
eshr-4669	36	7	of	of	ADP
eshr-4669	36	8	patients	patient	NOUN
eshr-4669	36	9	or	or	CCONJ
eshr-4669	36	10	healthcare	healthcare	NOUN
eshr-4669	36	11	workers	worker	NOUN
eshr-4669	36	12	or	or	CCONJ
eshr-4669	36	13	be	be	AUX
eshr-4669	36	14	some	some	DET
eshr-4669	36	15	other	other	ADJ
eshr-4669	36	16	source	source	NOUN
eshr-4669	36	17	like	like	ADP
eshr-4669	36	18	the	the	DET
eshr-4669	36	19	environment	environment	NOUN
eshr-4669	36	20	(	(	PUNCT
eshr-4669	36	21	9).biofilms	9).biofilm	NOUN
eshr-4669	36	22	are	be	AUX
eshr-4669	36	23	composed	compose	VERB
eshr-4669	36	24	of	of	ADP
eshr-4669	36	25	single	single	ADJ
eshr-4669	36	26	or	or	CCONJ
eshr-4669	36	27	multiple	multiple	ADJ
eshr-4669	36	28	species	specie	NOUN
eshr-4669	36	29	depending	depend	VERB
eshr-4669	36	30	on	on	ADP
eshr-4669	36	31	the	the	DET
eshr-4669	36	32	device	device	NOUN
eshr-4669	36	33	and	and	CCONJ
eshr-4669	36	34	its	its	PRON
eshr-4669	36	35	duration	duration	NOUN
eshr-4669	36	36	of	of	ADP
eshr-4669	36	37	use	use	NOUN
eshr-4669	36	38	in	in	ADP
eshr-4669	36	39	the	the	DET
eshr-4669	36	40	patient.biofilm	patient.biofilm	NOUN
eshr-4669	36	41	on	on	ADP
eshr-4669	36	42	the	the	DET
eshr-4669	36	43	urinary	urinary	ADJ
eshr-4669	36	44	catheter	catheter	NOUN
eshr-4669	36	45	is	be	AUX
eshr-4669	36	46	initially	initially	ADV
eshr-4669	36	47	composed	compose	VERB
eshr-4669	36	48	of	of	ADP
eshr-4669	36	49	single	single	ADJ
eshr-4669	36	50	species	specie	NOUN
eshr-4669	36	51	,	,	PUNCT
eshr-4669	36	52	but	but	CCONJ
eshr-4669	36	53	with	with	ADP
eshr-4669	36	54	time	time	NOUN
eshr-4669	36	55	,	,	PUNCT
eshr-4669	36	56	multispecies	multispecie	NOUN
eshr-4669	36	57	predominates(10	predominates(10	ADJ
eshr-4669	36	58	)	)	PUNCT
eshr-4669	36	59	.	.	PUNCT
eshr-4669	37	1	biofilm	biofilm	NOUN
eshr-4669	37	2	-	-	PUNCT
eshr-4669	37	3	causing	cause	VERB
eshr-4669	37	4	uropathogens	uropathogen	NOUN
eshr-4669	37	5	have	have	VERB
eshr-4669	37	6	an	an	DET
eshr-4669	37	7	inherent	inherent	ADJ
eshr-4669	37	8	resistance	resistance	NOUN
eshr-4669	37	9	to	to	ADP
eshr-4669	37	10	antibiotics	antibiotic	NOUN
eshr-4669	37	11	,	,	PUNCT
eshr-4669	37	12	disinfectants	disinfectant	NOUN
eshr-4669	37	13	,	,	PUNCT
eshr-4669	37	14	and	and	CCONJ
eshr-4669	37	15	antiseptics	antiseptic	NOUN
eshr-4669	37	16	.	.	PUNCT
eshr-4669	38	1	unlike	unlike	ADP
eshr-4669	38	2	planktonic	planktonic	ADJ
eshr-4669	38	3	populations	population	NOUN
eshr-4669	38	4	,	,	PUNCT
eshr-4669	38	5	bacterial	bacterial	ADJ
eshr-4669	38	6	cells	cell	NOUN
eshr-4669	38	7	embedded	embed	VERB
eshr-4669	38	8	in	in	ADP
eshr-4669	38	9	biofilmsshow	biofilmsshow	PROPN
eshr-4669	38	10	intrinsic	intrinsic	ADJ
eshr-4669	38	11	resistance	resistance	NOUN
eshr-4669	38	12	to	to	ADP
eshr-4669	38	13	antibiotics	antibiotic	NOUN
eshr-4669	38	14	which	which	PRON
eshr-4669	38	15	can	can	AUX
eshr-4669	38	16	be	be	AUX
eshr-4669	38	17	due	due	ADJ
eshr-4669	38	18	to	to	ADP
eshr-4669	38	19	the	the	DET
eshr-4669	38	20	inactivation	inactivation	NOUN
eshr-4669	38	21	of	of	ADP
eshr-4669	38	22	antimicrobial	antimicrobial	ADJ
eshr-4669	38	23	agents	agent	NOUN
eshr-4669	38	24	by	by	ADP
eshr-4669	38	25	exopolysaccharide	exopolysaccharide	NOUN
eshr-4669	38	26	(	(	PUNCT
eshr-4669	38	27	eps	eps	PROPN
eshr-4669	38	28	)	)	PUNCT
eshr-4669	38	29	,	,	PUNCT
eshr-4669	38	30	overexpression	overexpression	NOUN
eshr-4669	38	31	of	of	ADP
eshr-4669	38	32	stress	stress	NOUN
eshr-4669	38	33	-	-	PUNCT
eshr-4669	38	34	responsive	responsive	ADJ
eshr-4669	38	35	genes	gene	NOUN
eshr-4669	38	36	,	,	PUNCT
eshr-4669	38	37	presence	presence	NOUN
eshr-4669	38	38	of	of	ADP
eshr-4669	38	39	oxygen	oxygen	NOUN
eshr-4669	38	40	gradients	gradient	NOUN
eshr-4669	38	41	within	within	ADP
eshr-4669	38	42	the	the	DET
eshr-4669	38	43	biofilm	biofilm	NOUN
eshr-4669	38	44	matrix	matrix	NOUN
eshr-4669	38	45	,	,	PUNCT
eshr-4669	38	46	and	and	CCONJ
eshr-4669	38	47	differentiation	differentiation	NOUN
eshr-4669	38	48	of	of	ADP
eshr-4669	38	49	a	a	DET
eshr-4669	38	50	subpopulation	subpopulation	NOUN
eshr-4669	38	51	of	of	ADP
eshr-4669	38	52	biofilm	biofilm	NOUN
eshr-4669	38	53	cells	cell	NOUN
eshr-4669	38	54	into	into	ADP
eshr-4669	38	55	resistant	resistant	ADJ
eshr-4669	38	56	dormant	dormant	ADJ
eshr-4669	38	57	cells(11)(12	cells(11)(12	NOUN
eshr-4669	38	58	)	)	PUNCT
eshr-4669	38	59	.	.	PUNCT
eshr-4669	39	1	in	in	ADP
eshr-4669	39	2	this	this	DET
eshr-4669	39	3	study	study	NOUN
eshr-4669	39	4	,	,	PUNCT
eshr-4669	39	5	our	our	PRON
eshr-4669	39	6	goal	goal	NOUN
eshr-4669	39	7	was	be	AUX
eshr-4669	39	8	to	to	PART
eshr-4669	39	9	detect	detect	VERB
eshr-4669	39	10	the	the	DET
eshr-4669	39	11	biofilm	biofilm	NOUN
eshr-4669	39	12	-	-	PUNCT
eshr-4669	39	13	forming	form	VERB
eshr-4669	39	14	uropathogens	uropathogen	NOUN
eshr-4669	39	15	and	and	CCONJ
eshr-4669	39	16	study	study	VERB
eshr-4669	39	17	their	their	PRON
eshr-4669	39	18	antimicrobial	antimicrobial	ADJ
eshr-4669	39	19	susceptibility	susceptibility	NOUN
eshr-4669	39	20	pattern	pattern	NOUN
eshr-4669	39	21	among	among	ADP
eshr-4669	39	22	patients	patient	NOUN
eshr-4669	39	23	suffering	suffer	VERB
eshr-4669	39	24	from	from	ADP
eshr-4669	39	25	uti	uti	PROPN
eshr-4669	39	26	in	in	ADP
eshr-4669	39	27	a	a	DET
eshr-4669	39	28	tertiary	tertiary	ADJ
eshr-4669	39	29	care	care	NOUN
eshr-4669	39	30	hospital	hospital	NOUN
eshr-4669	39	31	in	in	ADP
eshr-4669	39	32	northern	northern	ADJ
eshr-4669	39	33	india	india	PROPN
eshr-4669	39	34	.	.	PUNCT
eshr-4669	40	1	this	this	DET
eshr-4669	40	2	study	study	NOUN
eshr-4669	40	3	will	will	AUX
eshr-4669	40	4	help	help	VERB
eshr-4669	40	5	the	the	DET
eshr-4669	40	6	clinicians	clinician	NOUN
eshr-4669	40	7	to	to	PART
eshr-4669	40	8	decide	decide	VERB
eshr-4669	40	9	method	method	VERB
eshr-4669	40	10	this	this	DET
eshr-4669	40	11	cross	cross	ADJ
eshr-4669	40	12	-	-	ADJ
eshr-4669	40	13	sectional	sectional	ADJ
eshr-4669	40	14	study	study	NOUN
eshr-4669	40	15	was	be	AUX
eshr-4669	40	16	performed	perform	VERB
eshr-4669	40	17	for	for	ADP
eshr-4669	40	18	one	one	NUM
eshr-4669	40	19	year	year	NOUN
eshr-4669	40	20	on	on	ADP
eshr-4669	40	21	200	200	NUM
eshr-4669	40	22	urine	urine	NOUN
eshr-4669	40	23	specimens	specimen	NOUN
eshr-4669	40	24	from	from	ADP
eshr-4669	40	25	outpatients	outpatient	NOUN
eshr-4669	40	26	(	(	PUNCT
eshr-4669	40	27	n=15	n=15	NUM
eshr-4669	40	28	)	)	PUNCT
eshr-4669	40	29	and	and	CCONJ
eshr-4669	40	30	in	in	ADP
eshr-4669	40	31	-	-	PUNCT
eshr-4669	40	32	patients	patient	NOUN
eshr-4669	40	33	(	(	PUNCT
eshr-4669	40	34	n=185	n=185	NUM
eshr-4669	40	35	)	)	PUNCT
eshr-4669	40	36	who	who	PRON
eshr-4669	40	37	were	be	AUX
eshr-4669	40	38	clinically	clinically	ADV
eshr-4669	40	39	diagnosed	diagnose	VERB
eshr-4669	40	40	with	with	ADP
eshr-4669	40	41	uti	uti	PROPN
eshr-4669	40	42	and	and	CCONJ
eshr-4669	40	43	fell	fall	VERB
eshr-4669	40	44	under	under	ADP
eshr-4669	40	45	the	the	DET
eshr-4669	40	46	inclusion	inclusion	NOUN
eshr-4669	40	47	criteria	criterion	NOUN
eshr-4669	40	48	.	.	PUNCT
eshr-4669	41	1	semi	semi	ADJ
eshr-4669	41	2	-	-	ADJ
eshr-4669	41	3	quantitative	quantitative	ADJ
eshr-4669	41	4	urine	urine	NOUN
eshr-4669	41	5	culture	culture	NOUN
eshr-4669	41	6	was	be	AUX
eshr-4669	41	7	performed	perform	VERB
eshr-4669	41	8	on	on	ADP
eshr-4669	41	9	uti	uti	PROPN
eshr-4669	41	10	agar	agar	NOUN
eshr-4669	41	11	(	(	PUNCT
eshr-4669	41	12	himedia	himedia	NOUN
eshr-4669	41	13	labs	lab	NOUN
eshr-4669	41	14	)	)	PUNCT
eshr-4669	41	15	as	as	ADP
eshr-4669	41	16	per	per	ADP
eshr-4669	41	17	standardized	standardized	ADJ
eshr-4669	41	18	sops	sop	NOUN
eshr-4669	41	19	of	of	ADP
eshr-4669	41	20	the	the	DET
eshr-4669	41	21	department	department	NOUN
eshr-4669	41	22	.	.	PUNCT
eshr-4669	42	1	as	as	SCONJ
eshr-4669	42	2	described	describe	VERB
eshr-4669	42	3	by	by	ADP
eshr-4669	42	4	freeman	freeman	PROPN
eshr-4669	42	5	dj	dj	PROPN
eshr-4669	42	6	et	et	PROPN
eshr-4669	42	7	al	al	PROPN
eshr-4669	42	8	.	.	PROPN
eshr-4669	42	9	,	,	PUNCT
eshr-4669	42	10	1989	1989	NUM
eshr-4669	42	11	(	(	PUNCT
eshr-4669	42	12	13	13	NUM
eshr-4669	42	13	)	)	PUNCT
eshr-4669	42	14	,	,	PUNCT
eshr-4669	42	15	cra	cra	PROPN
eshr-4669	42	16	was	be	AUX
eshr-4669	42	17	performed	perform	VERB
eshr-4669	42	18	.	.	PUNCT
eshr-4669	43	1	cra	cra	PROPN
eshr-4669	43	2	medium	medium	NOUN
eshr-4669	43	3	was	be	AUX
eshr-4669	43	4	prepared	prepare	VERB
eshr-4669	43	5	by	by	ADP
eshr-4669	43	6	mixing	mix	VERB
eshr-4669	43	7	brain	brain	NOUN
eshr-4669	43	8	heart	heart	NOUN
eshr-4669	43	9	infusion	infusion	NOUN
eshr-4669	43	10	broth	broth	NOUN
eshr-4669	43	11	(	(	PUNCT
eshr-4669	43	12	oxoid	oxoid	PROPN
eshr-4669	43	13	,	,	PUNCT
eshr-4669	43	14	uk	uk	PROPN
eshr-4669	43	15	)	)	PUNCT
eshr-4669	43	16	37	37	NUM
eshr-4669	43	17	 	 	SPACE
eshr-4669	43	18	g	g	PROPN
eshr-4669	43	19	/	/	SYM
eshr-4669	43	20	l	l	NOUN
eshr-4669	43	21	,	,	PUNCT
eshr-4669	43	22	sucrose	sucrose	VERB
eshr-4669	43	23	50	50	NUM
eshr-4669	43	24	 	 	SPACE
eshr-4669	43	25	g	g	PROPN
eshr-4669	43	26	/	/	SYM
eshr-4669	43	27	l	l	NOUN
eshr-4669	43	28	,	,	PUNCT
eshr-4669	43	29	agar	agar	VERB
eshr-4669	43	30	no	no	NOUN
eshr-4669	43	31	.	.	PROPN
eshr-4669	43	32	1	1	NUM
eshr-4669	43	33	(	(	PUNCT
eshr-4669	43	34	oxoid	oxoid	PROPN
eshr-4669	43	35	,	,	PUNCT
eshr-4669	43	36	uk	uk	PROPN
eshr-4669	43	37	)	)	PUNCT
eshr-4669	43	38	10	10	NUM
eshr-4669	43	39	 	 	SPACE
eshr-4669	43	40	g	g	PROPN
eshr-4669	43	41	/	/	SYM
eshr-4669	43	42	l	l	NOUN
eshr-4669	43	43	,	,	PUNCT
eshr-4669	43	44	and	and	CCONJ
eshr-4669	43	45	congo	congo	PROPN
eshr-4669	43	46	red	red	ADJ
eshr-4669	43	47	indicator	indicator	NOUN
eshr-4669	43	48	(	(	PUNCT
eshr-4669	43	49	oxoid	oxoid	NOUN
eshr-4669	43	50	,	,	PUNCT
eshr-4669	43	51	uk	uk	PROPN
eshr-4669	43	52	)	)	PUNCT
eshr-4669	43	53	8	8	NUM
eshr-4669	43	54	 	 	SPACE
eshr-4669	43	55	g	g	PROPN
eshr-4669	43	56	/	/	SYM
eshr-4669	43	57	l.	l.	PROPN
eshr-4669	43	58	the	the	DET
eshr-4669	43	59	congo	congo	PROPN
eshr-4669	43	60	red	red	ADJ
eshr-4669	43	61	stain	stain	NOUN
eshr-4669	43	62	(	(	PUNCT
eshr-4669	43	63	himedia	himedia	NOUN
eshr-4669	43	64	labs	lab	NOUN
eshr-4669	43	65	)	)	PUNCT
eshr-4669	43	66	was	be	AUX
eshr-4669	43	67	prepared	prepare	VERB
eshr-4669	43	68	separately	separately	ADV
eshr-4669	43	69	as	as	ADP
eshr-4669	43	70	a	a	DET
eshr-4669	43	71	concentrated	concentrated	ADJ
eshr-4669	43	72	aqueous	aqueous	ADJ
eshr-4669	43	73	solution	solution	NOUN
eshr-4669	43	74	and	and	CCONJ
eshr-4669	43	75	autoclaved	autoclaved	PROPN
eshr-4669	43	76	(	(	PUNCT
eshr-4669	43	77	121	121	NUM
eshr-4669	43	78	°	°	ADP
eshr-4669	43	79	c	c	NOUN
eshr-4669	43	80	for	for	ADP
eshr-4669	43	81	15	15	NUM
eshr-4669	43	82	 	 	SPACE
eshr-4669	43	83	min	min	NOUN
eshr-4669	43	84	)	)	PUNCT
eshr-4669	43	85	from	from	ADP
eshr-4669	43	86	the	the	DET
eshr-4669	43	87	rest	rest	NOUN
eshr-4669	43	88	of	of	ADP
eshr-4669	43	89	the	the	DET
eshr-4669	43	90	other	other	ADJ
eshr-4669	43	91	constituents	constituent	NOUN
eshr-4669	43	92	.	.	PUNCT
eshr-4669	44	1	it	it	PRON
eshr-4669	44	2	was	be	AUX
eshr-4669	44	3	later	later	ADV
eshr-4669	44	4	added	add	VERB
eshr-4669	44	5	to	to	ADP
eshr-4669	44	6	the	the	DET
eshr-4669	44	7	autoclaved	autoclaved	ADJ
eshr-4669	44	8	brain	brain	NOUN
eshr-4669	44	9	heart	heart	NOUN
eshr-4669	44	10	infusion	infusion	NOUN
eshr-4669	44	11	agar	agar	NOUN
eshr-4669	44	12	(	(	PUNCT
eshr-4669	44	13	himedia	himedia	NOUN
eshr-4669	44	14	labs	lab	NOUN
eshr-4669	44	15	)	)	PUNCT
eshr-4669	44	16	with	with	ADP
eshr-4669	44	17	sucrose	sucrose	NOUN
eshr-4669	44	18	at	at	ADP
eshr-4669	44	19	55	55	NUM
eshr-4669	44	20	°	°	NOUN
eshr-4669	44	21	c	c	NOUN
eshr-4669	44	22	.	.	PUNCT
eshr-4669	45	1	cra	cra	PROPN
eshr-4669	45	2	plates	plate	NOUN
eshr-4669	45	3	were	be	AUX
eshr-4669	45	4	then	then	ADV
eshr-4669	45	5	inoculated	inoculate	VERB
eshr-4669	45	6	with	with	ADP
eshr-4669	45	7	test	test	NOUN
eshr-4669	45	8	isolates	isolate	NOUN
eshr-4669	45	9	and	and	CCONJ
eshr-4669	45	10	left	leave	VERB
eshr-4669	45	11	for	for	ADP
eshr-4669	45	12	aerobic	aerobic	ADJ
eshr-4669	45	13	incubation	incubation	NOUN
eshr-4669	45	14	at	at	ADP
eshr-4669	45	15	37	37	NUM
eshr-4669	45	16	°	°	ADP
eshr-4669	45	17	c	c	NOUN
eshr-4669	45	18	for	for	ADP
eshr-4669	45	19	24	24	NUM
eshr-4669	45	20	 	 	SPACE
eshr-4669	45	21	hours	hour	NOUN
eshr-4669	45	22	.	.	PUNCT
eshr-4669	46	1	for	for	ADP
eshr-4669	46	2	all	all	DET
eshr-4669	46	3	positive	positive	ADJ
eshr-4669	46	4	isolates	isolate	NOUN
eshr-4669	46	5	,	,	PUNCT
eshr-4669	46	6	cra	cra	PROPN
eshr-4669	46	7	and	and	CCONJ
eshr-4669	46	8	ta	ta	PROPN
eshr-4669	46	9	methods	method	NOUN
eshr-4669	46	10	detected	detect	VERB
eshr-4669	46	11	biofilm	biofilm	NOUN
eshr-4669	46	12	formation	formation	NOUN
eshr-4669	46	13	.	.	PUNCT
eshr-4669	47	1	black	black	ADJ
eshr-4669	47	2	colonies	colony	NOUN
eshr-4669	47	3	with	with	ADP
eshr-4669	47	4	a	a	DET
eshr-4669	47	5	dry	dry	ADJ
eshr-4669	47	6	crystalline	crystalline	NOUN
eshr-4669	47	7	sharma	sharma	NOUN
eshr-4669	47	8	(	(	PUNCT
eshr-4669	47	9	biofilm	biofilm	NOUN
eshr-4669	47	10	formation	formation	NOUN
eshr-4669	47	11	by	by	ADP
eshr-4669	47	12	uropathogens	uropathogen	NOUN
eshr-4669	47	13	and	and	CCONJ
eshr-4669	47	14	its	its	PRON
eshr-4669	47	15	impact	impact	NOUN
eshr-4669	47	16	on	on	ADP
eshr-4669	47	17	antimicrobial	antimicrobial	ADJ
eshr-4669	47	18	susceptibility	susceptibility	NOUN
eshr-4669	47	19	pattern	pattern	NOUN
eshr-4669	47	20	)	)	PUNCT
eshr-4669	47	21	vol	vol	NOUN
eshr-4669	47	22	.	.	NOUN
eshr-4669	48	1	4	4	NUM
eshr-4669	48	2	,	,	PUNCT
eshr-4669	48	3	no	no	INTJ
eshr-4669	48	4	.	.	NOUN
eshr-4669	48	5	2	2	NUM
eshr-4669	48	6	,	,	PUNCT
eshr-4669	48	7	2022	2022	NUM
eshr-4669	48	8	,	,	PUNCT
eshr-4669	48	9	pp	pp	ADJ
eshr-4669	48	10	.	.	PUNCT
eshr-4669	49	1	40	40	NUM
eshr-4669	49	2	-	-	SYM
eshr-4669	49	3	47	47	NUM
eshr-4669	49	4	10.26555	10.26555	NUM
eshr-4669	49	5	/	/	SYM
eshr-4669	49	6	eshr.v4i2.4669	eshr.v4i2.4669	NUM
eshr-4669	49	7	42	42	NUM
eshr-4669	49	8	consistency	consistency	NOUN
eshr-4669	49	9	indicated	indicate	VERB
eshr-4669	49	10	biofilm	biofilm	NOUN
eshr-4669	49	11	formation	formation	NOUN
eshr-4669	49	12	,	,	PUNCT
eshr-4669	49	13	whereas	whereas	SCONJ
eshr-4669	49	14	no	no	DET
eshr-4669	49	15	-	-	PUNCT
eshr-4669	49	16	biofilm	biofilm	NOUN
eshr-4669	49	17	formation	formation	NOUN
eshr-4669	49	18	was	be	AUX
eshr-4669	49	19	identified	identify	VERB
eshr-4669	49	20	as	as	ADP
eshr-4669	49	21	red	red	ADJ
eshr-4669	49	22	or	or	CCONJ
eshr-4669	49	23	pink	pink	ADJ
eshr-4669	49	24	crystalline	crystalline	NOUN
eshr-4669	49	25	colonies	colony	NOUN
eshr-4669	49	26	(	(	PUNCT
eshr-4669	49	27	figure	figure	NOUN
eshr-4669	49	28	1	1	NUM
eshr-4669	49	29	)	)	PUNCT
eshr-4669	49	30	.	.	PUNCT
eshr-4669	50	1	figure1	figure1	PROPN
eshr-4669	50	2	.	.	PUNCT
eshr-4669	51	1	congo	congo	PROPN
eshr-4669	51	2	red	red	ADJ
eshr-4669	51	3	agar	agar	NOUN
eshr-4669	51	4	method	method	NOUN
eshr-4669	51	5	shows	show	VERB
eshr-4669	51	6	biofilm	biofilm	NOUN
eshr-4669	51	7	producers	producer	NOUN
eshr-4669	51	8	(	(	PUNCT
eshr-4669	51	9	black	black	ADJ
eshr-4669	51	10	crystalline	crystalline	NOUN
eshr-4669	51	11	colonies	colony	NOUN
eshr-4669	51	12	)	)	PUNCT
eshr-4669	51	13	&	&	CCONJ
eshr-4669	51	14	non	non	NOUN
eshr-4669	51	15	-	-	NOUN
eshr-4669	51	16	producers	producer	NOUN
eshr-4669	51	17	(	(	PUNCT
eshr-4669	51	18	pink	pink	ADJ
eshr-4669	51	19	colonies	colony	NOUN
eshr-4669	51	20	)	)	PUNCT
eshr-4669	51	21	tube	tube	NOUN
eshr-4669	51	22	adherencemethod	adherencemethod	NOUN
eshr-4669	51	23	,	,	PUNCT
eshr-4669	51	24	as	as	SCONJ
eshr-4669	51	25	described	describe	VERB
eshr-4669	51	26	by	by	ADP
eshr-4669	51	27	christensen	christensen	PROPN
eshr-4669	51	28	gd	gd	PROPN
eshr-4669	51	29	et	et	PROPN
eshr-4669	51	30	al	al	PROPN
eshr-4669	51	31	.	.	PUNCT
eshr-4669	52	1	(	(	PUNCT
eshr-4669	52	2	14	14	NUM
eshr-4669	52	3	)	)	PUNCT
eshr-4669	52	4	,	,	PUNCT
eshr-4669	52	5	1982	1982	NUM
eshr-4669	52	6	is	be	AUX
eshr-4669	52	7	a	a	DET
eshr-4669	52	8	quantitative	quantitative	ADJ
eshr-4669	52	9	method	method	NOUN
eshr-4669	52	10	for	for	ADP
eshr-4669	52	11	biofilm	biofilm	NOUN
eshr-4669	52	12	detection	detection	NOUN
eshr-4669	52	13	.	.	PUNCT
eshr-4669	53	1	test	test	NOUN
eshr-4669	53	2	organisms	organism	NOUN
eshr-4669	53	3	were	be	AUX
eshr-4669	53	4	inoculated	inoculate	VERB
eshr-4669	53	5	in	in	ADP
eshr-4669	53	6	10	10	NUM
eshr-4669	53	7	ml	ml	NOUN
eshr-4669	53	8	of	of	ADP
eshr-4669	53	9	trypticase	trypticase	NOUN
eshr-4669	53	10	soy	soy	NOUN
eshr-4669	53	11	broth	broth	NOUN
eshr-4669	53	12	with	with	ADP
eshr-4669	53	13	1	1	NUM
eshr-4669	53	14	%	%	NOUN
eshr-4669	53	15	glucose	glucose	NOUN
eshr-4669	53	16	in	in	ADP
eshr-4669	53	17	test	test	NOUN
eshr-4669	53	18	tubes	tube	NOUN
eshr-4669	53	19	and	and	CCONJ
eshr-4669	53	20	incubated	incubate	VERB
eshr-4669	53	21	at	at	ADP
eshr-4669	53	22	37	37	NUM
eshr-4669	53	23	°	°	ADP
eshr-4669	53	24	c	c	NOUN
eshr-4669	53	25	for	for	ADP
eshr-4669	53	26	24	24	NUM
eshr-4669	53	27	hours	hour	NOUN
eshr-4669	53	28	.	.	PUNCT
eshr-4669	54	1	after	after	ADP
eshr-4669	54	2	incubation	incubation	NOUN
eshr-4669	54	3	,	,	PUNCT
eshr-4669	54	4	tubes	tube	NOUN
eshr-4669	54	5	were	be	AUX
eshr-4669	54	6	decanted	decant	VERB
eshr-4669	54	7	,	,	PUNCT
eshr-4669	54	8	washed	wash	VERB
eshr-4669	54	9	with	with	ADP
eshr-4669	54	10	phosphate	phosphate	NOUN
eshr-4669	54	11	-	-	PUNCT
eshr-4669	54	12	buffered	buffer	VERB
eshr-4669	54	13	saline	saline	NOUN
eshr-4669	54	14	(	(	PUNCT
eshr-4669	54	15	ph	ph	NOUN
eshr-4669	54	16	7.3	7.3	NUM
eshr-4669	54	17	)	)	PUNCT
eshr-4669	54	18	,	,	PUNCT
eshr-4669	54	19	and	and	CCONJ
eshr-4669	54	20	dried	dry	VERB
eshr-4669	54	21	.	.	PUNCT
eshr-4669	55	1	tubes	tube	NOUN
eshr-4669	55	2	were	be	AUX
eshr-4669	55	3	then	then	ADV
eshr-4669	55	4	stained	stain	VERB
eshr-4669	55	5	with	with	ADP
eshr-4669	55	6	crystal	crystal	PROPN
eshr-4669	55	7	violet	violet	NOUN
eshr-4669	55	8	(	(	PUNCT
eshr-4669	55	9	0.1	0.1	NUM
eshr-4669	55	10	%	%	NOUN
eshr-4669	55	11	)	)	PUNCT
eshr-4669	55	12	.	.	PUNCT
eshr-4669	56	1	the	the	DET
eshr-4669	56	2	excess	excess	ADJ
eshr-4669	56	3	stain	stain	NOUN
eshr-4669	56	4	was	be	AUX
eshr-4669	56	5	washed	wash	VERB
eshr-4669	56	6	with	with	ADP
eshr-4669	56	7	deionized	deionize	VERB
eshr-4669	56	8	water	water	NOUN
eshr-4669	56	9	and	and	CCONJ
eshr-4669	56	10	dried	dry	VERB
eshr-4669	56	11	.	.	PUNCT
eshr-4669	57	1	the	the	DET
eshr-4669	57	2	scoring	scoring	NOUN
eshr-4669	57	3	for	for	ADP
eshr-4669	57	4	the	the	DET
eshr-4669	57	5	tube	tube	NOUN
eshr-4669	57	6	method	method	NOUN
eshr-4669	57	7	was	be	AUX
eshr-4669	57	8	done	do	VERB
eshr-4669	57	9	according	accord	VERB
eshr-4669	57	10	to	to	ADP
eshr-4669	57	11	the	the	DET
eshr-4669	57	12	results	result	NOUN
eshr-4669	57	13	of	of	ADP
eshr-4669	57	14	the	the	DET
eshr-4669	57	15	control	control	NOUN
eshr-4669	57	16	strains	strain	VERB
eshr-4669	57	17	.	.	PUNCT
eshr-4669	58	1	biofilm	biofilm	NOUN
eshr-4669	58	2	formation	formation	NOUN
eshr-4669	58	3	was	be	AUX
eshr-4669	58	4	considered	consider	VERB
eshr-4669	58	5	positive	positive	ADJ
eshr-4669	58	6	when	when	SCONJ
eshr-4669	58	7	a	a	DET
eshr-4669	58	8	visible	visible	ADJ
eshr-4669	58	9	film	film	NOUN
eshr-4669	58	10	lined	line	VERB
eshr-4669	58	11	the	the	DET
eshr-4669	58	12	wall	wall	NOUN
eshr-4669	58	13	and	and	CCONJ
eshr-4669	58	14	the	the	DET
eshr-4669	58	15	bottom	bottom	NOUN
eshr-4669	58	16	of	of	ADP
eshr-4669	58	17	the	the	DET
eshr-4669	58	18	tube	tube	NOUN
eshr-4669	58	19	(	(	PUNCT
eshr-4669	58	20	figure	figure	NOUN
eshr-4669	58	21	2	2	NUM
eshr-4669	58	22	)	)	PUNCT
eshr-4669	58	23	.	.	PUNCT
eshr-4669	59	1	figure2	figure2	ADJ
eshr-4669	59	2	.	.	PUNCT
eshr-4669	60	1	tube	tube	NOUN
eshr-4669	60	2	adherence	adherence	NOUN
eshr-4669	60	3	method	method	NOUN
eshr-4669	60	4	showing	show	VERB
eshr-4669	60	5	biofilm	biofilm	NOUN
eshr-4669	60	6	producer	producer	NOUN
eshr-4669	60	7	(	(	PUNCT
eshr-4669	60	8	tube	tube	NOUN
eshr-4669	60	9	a	a	X
eshr-4669	60	10	)	)	PUNCT
eshr-4669	60	11	&	&	CCONJ
eshr-4669	60	12	non	non	ADJ
eshr-4669	60	13	-	-	NOUN
eshr-4669	60	14	producer	producer	ADJ
eshr-4669	60	15	(	(	PUNCT
eshr-4669	60	16	tube	tube	NOUN
eshr-4669	60	17	b	b	NOUN
eshr-4669	60	18	)	)	PUNCT
eshr-4669	60	19	antimicrobial	antimicrobial	ADJ
eshr-4669	60	20	susceptibility	susceptibility	NOUN
eshr-4669	60	21	testing	testing	NOUN
eshr-4669	60	22	was	be	AUX
eshr-4669	60	23	performed	perform	VERB
eshr-4669	60	24	using	use	VERB
eshr-4669	60	25	the	the	DET
eshr-4669	60	26	kirby	kirby	PROPN
eshr-4669	60	27	bauer	bauer	PROPN
eshr-4669	60	28	disk	disk	NOUN
eshr-4669	60	29	diffusion	diffusion	NOUN
eshr-4669	60	30	method	method	NOUN
eshr-4669	60	31	on	on	ADP
eshr-4669	60	32	mueller	mueller	PROPN
eshr-4669	60	33	hinton	hinton	PROPN
eshr-4669	60	34	agar	agar	PROPN
eshr-4669	60	35	(	(	PUNCT
eshr-4669	60	36	himedia	himedia	NOUN
eshr-4669	60	37	labs	lab	NOUN
eshr-4669	60	38	)	)	PUNCT
eshr-4669	60	39	according	accord	VERB
eshr-4669	60	40	to	to	ADP
eshr-4669	60	41	the	the	DET
eshr-4669	60	42	clinical	clinical	ADJ
eshr-4669	60	43	laboratory	laboratory	PROPN
eshr-4669	60	44	standard	standard	PROPN
eshr-4669	60	45	institute	institute	PROPN
eshr-4669	60	46	sharma	sharma	PROPN
eshr-4669	60	47	(	(	PUNCT
eshr-4669	60	48	biofilm	biofilm	NOUN
eshr-4669	60	49	formation	formation	NOUN
eshr-4669	60	50	by	by	ADP
eshr-4669	60	51	uropathogens	uropathogen	NOUN
eshr-4669	60	52	and	and	CCONJ
eshr-4669	60	53	its	its	PRON
eshr-4669	60	54	impact	impact	NOUN
eshr-4669	60	55	on	on	ADP
eshr-4669	60	56	antimicrobial	antimicrobial	ADJ
eshr-4669	60	57	susceptibility	susceptibility	NOUN
eshr-4669	60	58	pattern	pattern	NOUN
eshr-4669	60	59	)	)	PUNCT
eshr-4669	60	60	vol	vol	NOUN
eshr-4669	60	61	.	.	NOUN
eshr-4669	61	1	4	4	NUM
eshr-4669	61	2	,	,	PUNCT
eshr-4669	61	3	no	no	INTJ
eshr-4669	61	4	.	.	NOUN
eshr-4669	61	5	2	2	NUM
eshr-4669	61	6	,	,	PUNCT
eshr-4669	61	7	2022	2022	NUM
eshr-4669	61	8	,	,	PUNCT
eshr-4669	61	9	pp	pp	ADJ
eshr-4669	61	10	.	.	PUNCT
eshr-4669	62	1	40	40	NUM
eshr-4669	62	2	-	-	SYM
eshr-4669	62	3	47	47	NUM
eshr-4669	62	4	10.26555	10.26555	NUM
eshr-4669	62	5	/	/	SYM
eshr-4669	62	6	eshr.v4i2.4669	eshr.v4i2.4669	NUM
eshr-4669	62	7	43	43	NUM
eshr-4669	62	8	(	(	PUNCT
eshr-4669	62	9	clsi	clsi	NOUN
eshr-4669	62	10	2019	2019	NUM
eshr-4669	62	11	)	)	PUNCT
eshr-4669	62	12	guidelines	guideline	NOUN
eshr-4669	62	13	(	(	PUNCT
eshr-4669	62	14	15	15	NUM
eshr-4669	62	15	)	)	PUNCT
eshr-4669	62	16	.	.	PUNCT
eshr-4669	63	1	the	the	DET
eshr-4669	63	2	antimicrobial	antimicrobial	ADJ
eshr-4669	63	3	discs	disc	NOUN
eshr-4669	63	4	used	use	VERB
eshr-4669	63	5	for	for	ADP
eshr-4669	63	6	gram	gram	NOUN
eshr-4669	63	7	-	-	PUNCT
eshr-4669	63	8	positive	positive	ADJ
eshr-4669	63	9	isolates	isolate	NOUN
eshr-4669	63	10	were	be	AUX
eshr-4669	63	11	penicillin	penicillin	NOUN
eshr-4669	63	12	g	g	PROPN
eshr-4669	63	13	10	10	NUM
eshr-4669	63	14	units	unit	NOUN
eshr-4669	63	15	,	,	PUNCT
eshr-4669	63	16	gentamicin	gentamicin	NOUN
eshr-4669	63	17	10mcg	10mcg	NOUN
eshr-4669	63	18	,	,	PUNCT
eshr-4669	63	19	ciprofloxacin	ciprofloxacin	PROPN
eshr-4669	63	20	5mcg	5mcg	NUM
eshr-4669	63	21	,	,	PUNCT
eshr-4669	63	22	vancomycin	vancomycin	PROPN
eshr-4669	63	23	30mcg	30mcg	NOUN
eshr-4669	63	24	,	,	PUNCT
eshr-4669	63	25	linezolid	linezolid	NOUN
eshr-4669	63	26	30mcg	30mcg	NOUN
eshr-4669	63	27	,	,	PUNCT
eshr-4669	63	28	nitrofurantoin	nitrofurantoin	NOUN
eshr-4669	63	29	300mcg	300mcg	NUM
eshr-4669	63	30	,	,	PUNCT
eshr-4669	63	31	and	and	CCONJ
eshr-4669	63	32	norfloxacin	norfloxacin	NOUN
eshr-4669	63	33	10mcg	10mcg	NOUN
eshr-4669	63	34	.	.	PUNCT
eshr-4669	64	1	the	the	DET
eshr-4669	64	2	antimicrobial	antimicrobial	ADJ
eshr-4669	64	3	discs	disc	NOUN
eshr-4669	64	4	used	use	VERB
eshr-4669	64	5	for	for	ADP
eshr-4669	64	6	gram	gram	NOUN
eshr-4669	64	7	-	-	PUNCT
eshr-4669	64	8	negative	negative	ADJ
eshr-4669	64	9	isolates	isolate	NOUN
eshr-4669	64	10	were	be	AUX
eshr-4669	64	11	piperacillin	piperacillin	NOUN
eshr-4669	64	12	-	-	PUNCT
eshr-4669	64	13	tazobactam	tazobactam	NOUN
eshr-4669	64	14	100/10mcg	100/10mcg	NUM
eshr-4669	64	15	,	,	PUNCT
eshr-4669	64	16	cefuroxime	cefuroxime	ADJ
eshr-4669	64	17	30mcg	30mcg	NOUN
eshr-4669	64	18	,	,	PUNCT
eshr-4669	64	19	cefepime	cefepime	NOUN
eshr-4669	64	20	30mcg	30mcg	NOUN
eshr-4669	64	21	,	,	PUNCT
eshr-4669	64	22	amikacin	amikacin	PROPN
eshr-4669	64	23	30mcg	30mcg	NOUN
eshr-4669	64	24	,	,	PUNCT
eshr-4669	64	25	imipenem	imipenem	PROPN
eshr-4669	64	26	10mcg	10mcg	NOUN
eshr-4669	64	27	,	,	PUNCT
eshr-4669	64	28	gentamicin	gentamicin	NOUN
eshr-4669	64	29	10mcg	10mcg	NOUN
eshr-4669	64	30	,	,	PUNCT
eshr-4669	64	31	tobramycin	tobramycin	NOUN
eshr-4669	64	32	10mcg	10mcg	NOUN
eshr-4669	64	33	,	,	PUNCT
eshr-4669	64	34	ciprofloxacin	ciprofloxacin	PROPN
eshr-4669	64	35	5mcg	5mcg	NUM
eshr-4669	64	36	,	,	PUNCT
eshr-4669	64	37	cotrimoxazole	cotrimoxazole	NOUN
eshr-4669	64	38	1.25/23.5mcg	1.25/23.5mcg	NUM
eshr-4669	64	39	,	,	PUNCT
eshr-4669	64	40	chloramphenicol	chloramphenicol	NOUN
eshr-4669	64	41	30	30	NUM
eshr-4669	64	42	mcg	mcg	NOUN
eshr-4669	64	43	,	,	PUNCT
eshr-4669	64	44	tetracycline	tetracycline	NOUN
eshr-4669	64	45	30	30	NUM
eshr-4669	64	46	mcg	mcg	NOUN
eshr-4669	64	47	,	,	PUNCT
eshr-4669	64	48	nitrofurantoin	nitrofurantoin	NOUN
eshr-4669	64	49	300mcg	300mcg	PROPN
eshr-4669	64	50	,	,	PUNCT
eshr-4669	64	51	norfloxacin	norfloxacin	PROPN
eshr-4669	64	52	10mcg	10mcg	NOUN
eshr-4669	64	53	,	,	PUNCT
eshr-4669	64	54	amoxicillin	amoxicillin	PROPN
eshr-4669	64	55	/	/	SYM
eshr-4669	64	56	clavulanic	clavulanic	ADJ
eshr-4669	64	57	acid	acid	NOUN
eshr-4669	64	58	20/10mcg	20/10mcg	NUM
eshr-4669	64	59	and	and	CCONJ
eshr-4669	64	60	aztreonam	aztreonam	NOUN
eshr-4669	64	61	30mcg	30mcg	NOUN
eshr-4669	64	62	.	.	PUNCT
eshr-4669	65	1	results	result	VERB
eshr-4669	65	2	a	a	DET
eshr-4669	65	3	total	total	NOUN
eshr-4669	65	4	of	of	ADP
eshr-4669	65	5	185	185	NUM
eshr-4669	65	6	(	(	PUNCT
eshr-4669	65	7	92.5	92.5	NUM
eshr-4669	65	8	%	%	NOUN
eshr-4669	65	9	)	)	PUNCT
eshr-4669	65	10	were	be	AUX
eshr-4669	65	11	indoor	indoor	ADJ
eshr-4669	65	12	patients	patient	NOUN
eshr-4669	65	13	,	,	PUNCT
eshr-4669	65	14	while	while	SCONJ
eshr-4669	65	15	15	15	NUM
eshr-4669	65	16	(	(	PUNCT
eshr-4669	65	17	7.5	7.5	NUM
eshr-4669	65	18	%	%	NOUN
eshr-4669	65	19	)	)	PUNCT
eshr-4669	65	20	were	be	AUX
eshr-4669	65	21	from	from	ADP
eshr-4669	65	22	the	the	DET
eshr-4669	65	23	outdoor	outdoor	ADJ
eshr-4669	65	24	department	department	NOUN
eshr-4669	65	25	.	.	PUNCT
eshr-4669	66	1	out	out	ADP
eshr-4669	66	2	of	of	ADP
eshr-4669	66	3	200	200	NUM
eshr-4669	66	4	urine	urine	NOUN
eshr-4669	66	5	specimens	specimen	NOUN
eshr-4669	66	6	,	,	PUNCT
eshr-4669	66	7	64	64	NUM
eshr-4669	66	8	(	(	PUNCT
eshr-4669	66	9	32	32	NUM
eshr-4669	66	10	%	%	NOUN
eshr-4669	66	11	)	)	PUNCT
eshr-4669	66	12	were	be	AUX
eshr-4669	66	13	females	female	NOUN
eshr-4669	66	14	,	,	PUNCT
eshr-4669	66	15	and	and	CCONJ
eshr-4669	66	16	36	36	NUM
eshr-4669	66	17	(	(	PUNCT
eshr-4669	66	18	18	18	NUM
eshr-4669	66	19	%	%	NOUN
eshr-4669	66	20	)	)	PUNCT
eshr-4669	66	21	were	be	AUX
eshr-4669	66	22	males	male	NOUN
eshr-4669	66	23	.	.	PUNCT
eshr-4669	67	1	most	most	ADJ
eshr-4669	67	2	patients	patient	NOUN
eshr-4669	67	3	belonged	belong	VERB
eshr-4669	67	4	to	to	ADP
eshr-4669	67	5	51	51	NUM
eshr-4669	67	6	to	to	PART
eshr-4669	67	7	70	70	NUM
eshr-4669	67	8	years	year	NOUN
eshr-4669	67	9	(	(	PUNCT
eshr-4669	67	10	36	36	NUM
eshr-4669	67	11	%	%	NOUN
eshr-4669	67	12	)	)	PUNCT
eshr-4669	67	13	,	,	PUNCT
eshr-4669	67	14	followed	follow	VERB
eshr-4669	67	15	by	by	ADP
eshr-4669	67	16	those	those	PRON
eshr-4669	67	17	above	above	ADP
eshr-4669	67	18	70	70	NUM
eshr-4669	67	19	years	year	NOUN
eshr-4669	67	20	(	(	PUNCT
eshr-4669	67	21	29.5	29.5	NUM
eshr-4669	67	22	%	%	NOUN
eshr-4669	67	23	)	)	PUNCT
eshr-4669	67	24	.	.	PUNCT
eshr-4669	68	1	of	of	ADP
eshr-4669	68	2	all	all	PRON
eshr-4669	68	3	,	,	PUNCT
eshr-4669	68	4	102	102	NUM
eshr-4669	68	5	(	(	PUNCT
eshr-4669	68	6	51	51	NUM
eshr-4669	68	7	%	%	NOUN
eshr-4669	68	8	)	)	PUNCT
eshr-4669	68	9	patients	patient	NOUN
eshr-4669	68	10	were	be	AUX
eshr-4669	68	11	catheterized	catheterize	VERB
eshr-4669	68	12	.	.	PUNCT
eshr-4669	69	1	gram	gram	NOUN
eshr-4669	69	2	-	-	PUNCT
eshr-4669	69	3	negative	negative	NOUN
eshr-4669	69	4	dominated	dominate	VERB
eshr-4669	69	5	70	70	NUM
eshr-4669	69	6	%	%	NOUN
eshr-4669	69	7	of	of	ADP
eshr-4669	69	8	the	the	DET
eshr-4669	69	9	positive	positive	ADJ
eshr-4669	69	10	isolates	isolate	NOUN
eshr-4669	69	11	,	,	PUNCT
eshr-4669	69	12	whereas	whereas	SCONJ
eshr-4669	69	13	gram	gram	NOUN
eshr-4669	69	14	-	-	PUNCT
eshr-4669	69	15	positive	positive	ADJ
eshr-4669	69	16	constituted	constitute	VERB
eshr-4669	69	17	30	30	NUM
eshr-4669	69	18	%	%	NOUN
eshr-4669	69	19	.	.	PUNCT
eshr-4669	70	1	out	out	ADP
eshr-4669	70	2	of	of	ADP
eshr-4669	70	3	200	200	NUM
eshr-4669	70	4	uropathogens	uropathogen	NOUN
eshr-4669	70	5	,	,	PUNCT
eshr-4669	70	6	94	94	NUM
eshr-4669	70	7	(	(	PUNCT
eshr-4669	70	8	47	47	NUM
eshr-4669	70	9	%	%	NOUN
eshr-4669	70	10	)	)	PUNCT
eshr-4669	70	11	were	be	AUX
eshr-4669	70	12	escherichia	escherichia	NOUN
eshr-4669	70	13	coli	coli	NOUN
eshr-4669	70	14	,	,	PUNCT
eshr-4669	70	15	followed	follow	VERB
eshr-4669	70	16	by	by	ADP
eshr-4669	70	17	enterococcus	enterococcus	NOUN
eshr-4669	70	18	sp	sp	NOUN
eshr-4669	70	19	.	.	NOUN
eshr-4669	70	20	37(18.5	37(18.5	NUM
eshr-4669	70	21	%	%	NOUN
eshr-4669	70	22	)	)	PUNCT
eshr-4669	70	23	(	(	PUNCT
eshr-4669	70	24	table	table	NOUN
eshr-4669	70	25	1	1	NUM
eshr-4669	70	26	)	)	PUNCT
eshr-4669	70	27	.	.	PUNCT
eshr-4669	71	1	table	table	NOUN
eshr-4669	71	2	1	1	NUM
eshr-4669	71	3	.	.	PUNCT
eshr-4669	72	1	bacterial	bacterial	ADJ
eshr-4669	72	2	uropathogens	uropathogen	NOUN
eshr-4669	72	3	among	among	ADP
eshr-4669	72	4	uti	uti	PROPN
eshr-4669	72	5	patients	patient	NOUN
eshr-4669	72	6	from	from	ADP
eshr-4669	72	7	out	out	ADP
eshr-4669	72	8	patient	patient	NOUN
eshr-4669	72	9	department	department	NOUN
eshr-4669	72	10	(	(	PUNCT
eshr-4669	72	11	opd	opd	PROPN
eshr-4669	72	12	)	)	PUNCT
eshr-4669	72	13	and	and	CCONJ
eshr-4669	72	14	in	in	ADP
eshr-4669	72	15	-	-	PUNCT
eshr-4669	72	16	patient	patient	NOUN
eshr-4669	72	17	department	department	NOUN
eshr-4669	72	18	s.	s.	PROPN
eshr-4669	72	19	no	no	INTJ
eshr-4669	72	20	.	.	PUNCT
eshr-4669	73	1	uropathogens	uropathogens	PROPN
eshr-4669	73	2	opd	opd	PROPN
eshr-4669	73	3	(	(	PUNCT
eshr-4669	73	4	n=15	n=15	PROPN
eshr-4669	73	5	)	)	PUNCT
eshr-4669	73	6	ipd	ipd	PROPN
eshr-4669	73	7	(	(	PUNCT
eshr-4669	73	8	n=185	n=185	PROPN
eshr-4669	73	9	)	)	PUNCT
eshr-4669	73	10	total	total	NOUN
eshr-4669	73	11	(	(	PUNCT
eshr-4669	73	12	n=200	n=200	PROPN
eshr-4669	73	13	)	)	PUNCT
eshr-4669	73	14	1	1	NUM
eshr-4669	73	15	escherichia	escherichia	NOUN
eshr-4669	73	16	coli	coli	NOUN
eshr-4669	73	17	11	11	NUM
eshr-4669	73	18	83	83	NUM
eshr-4669	73	19	94	94	NUM
eshr-4669	73	20	(	(	PUNCT
eshr-4669	73	21	47	47	NUM
eshr-4669	73	22	%	%	NOUN
eshr-4669	73	23	)	)	PUNCT
eshr-4669	73	24	2	2	NUM
eshr-4669	73	25	enterococcus	enterococcus	NOUN
eshr-4669	73	26	spp	spp	NOUN
eshr-4669	73	27	.	.	PROPN
eshr-4669	73	28	0	0	NUM
eshr-4669	74	1	37	37	NUM
eshr-4669	74	2	37	37	NUM
eshr-4669	74	3	(	(	PUNCT
eshr-4669	74	4	18.5	18.5	NUM
eshr-4669	74	5	%	%	NOUN
eshr-4669	74	6	)	)	PUNCT
eshr-4669	74	7	3	3	NUM
eshr-4669	74	8	klebsiella	klebsiella	NOUN
eshr-4669	74	9	pneumoniae	pneumoniae	ADJ
eshr-4669	74	10	0	0	NUM
eshr-4669	74	11	28	28	NUM
eshr-4669	74	12	28	28	NUM
eshr-4669	74	13	(	(	PUNCT
eshr-4669	74	14	14	14	NUM
eshr-4669	74	15	%	%	NOUN
eshr-4669	74	16	)	)	PUNCT
eshr-4669	74	17	4	4	NUM
eshr-4669	74	18	staphylococcus	staphylococcus	NOUN
eshr-4669	74	19	aureus	aureus	NOUN
eshr-4669	74	20	4	4	NUM
eshr-4669	74	21	18	18	NUM
eshr-4669	74	22	22	22	NUM
eshr-4669	74	23	(	(	PUNCT
eshr-4669	74	24	11	11	NUM
eshr-4669	74	25	%	%	NOUN
eshr-4669	74	26	)	)	PUNCT
eshr-4669	74	27	5	5	NUM
eshr-4669	74	28	acinetobacter	acinetobacter	X
eshr-4669	74	29	spp	spp	NOUN
eshr-4669	74	30	.	.	PUNCT
eshr-4669	74	31	0	0	NUM
eshr-4669	75	1	7	7	NUM
eshr-4669	75	2	7	7	NUM
eshr-4669	75	3	(	(	PUNCT
eshr-4669	75	4	3.5	3.5	NUM
eshr-4669	75	5	%	%	NOUN
eshr-4669	75	6	)	)	PUNCT
eshr-4669	75	7	6	6	NUM
eshr-4669	75	8	pseudomonas	pseudomona	NOUN
eshr-4669	75	9	aeruginosa	aeruginosa	NOUN
eshr-4669	75	10	0	0	NUM
eshr-4669	75	11	6	6	NUM
eshr-4669	75	12	6	6	NUM
eshr-4669	75	13	(	(	PUNCT
eshr-4669	75	14	3	3	NUM
eshr-4669	75	15	%	%	NOUN
eshr-4669	75	16	)	)	PUNCT
eshr-4669	75	17	7	7	NUM
eshr-4669	75	18	klebsiella	klebsiella	NOUN
eshr-4669	75	19	oxytoca	oxytoca	NOUN
eshr-4669	75	20	0	0	NUM
eshr-4669	75	21	4	4	NUM
eshr-4669	75	22	4	4	NUM
eshr-4669	75	23	(	(	PUNCT
eshr-4669	75	24	2	2	NUM
eshr-4669	75	25	%	%	NOUN
eshr-4669	75	26	)	)	PUNCT
eshr-4669	75	27	8	8	NUM
eshr-4669	75	28	proteus	proteus	NOUN
eshr-4669	75	29	mirabilis	mirabilis	X
eshr-4669	75	30	0	0	NUM
eshr-4669	75	31	1	1	NUM
eshr-4669	75	32	1	1	NUM
eshr-4669	75	33	(	(	PUNCT
eshr-4669	75	34	0.5	0.5	NUM
eshr-4669	75	35	%	%	NOUN
eshr-4669	75	36	)	)	PUNCT
eshr-4669	75	37	9	9	NUM
eshr-4669	75	38	morganella	morganella	NOUN
eshr-4669	75	39	morganii	morganii	NOUN
eshr-4669	75	40	0	0	NUM
eshr-4669	75	41	1	1	NUM
eshr-4669	75	42	1	1	NUM
eshr-4669	75	43	(	(	PUNCT
eshr-4669	75	44	0.5	0.5	NUM
eshr-4669	75	45	%	%	NOUN
eshr-4669	75	46	)	)	PUNCT
eshr-4669	75	47	out	out	ADP
eshr-4669	75	48	of	of	ADP
eshr-4669	75	49	102	102	NUM
eshr-4669	75	50	catheterized	catheterize	VERB
eshr-4669	75	51	patients	patient	NOUN
eshr-4669	75	52	,	,	PUNCT
eshr-4669	75	53	biofilm	biofilm	NOUN
eshr-4669	75	54	formation	formation	NOUN
eshr-4669	75	55	was	be	AUX
eshr-4669	75	56	observed	observe	VERB
eshr-4669	75	57	in	in	ADP
eshr-4669	75	58	72	72	NUM
eshr-4669	75	59	(	(	PUNCT
eshr-4669	75	60	36	36	NUM
eshr-4669	75	61	%	%	NOUN
eshr-4669	75	62	)	)	PUNCT
eshr-4669	75	63	,	,	PUNCT
eshr-4669	75	64	which	which	PRON
eshr-4669	75	65	was	be	AUX
eshr-4669	75	66	way	way	ADV
eshr-4669	75	67	more	more	ADJ
eshr-4669	75	68	than	than	ADP
eshr-4669	75	69	in	in	ADP
eshr-4669	75	70	community	community	NOUN
eshr-4669	75	71	-	-	PUNCT
eshr-4669	75	72	acquired	acquire	VERB
eshr-4669	75	73	uti	uti	PROPN
eshr-4669	75	74	cases	case	NOUN
eshr-4669	75	75	18	18	NUM
eshr-4669	75	76	(	(	PUNCT
eshr-4669	75	77	9	9	NUM
eshr-4669	75	78	%	%	NOUN
eshr-4669	75	79	)	)	PUNCT
eshr-4669	75	80	.	.	PUNCT
eshr-4669	76	1	table	table	NOUN
eshr-4669	76	2	2	2	NUM
eshr-4669	76	3	shows	show	VERB
eshr-4669	76	4	biofilm	biofilm	NOUN
eshr-4669	76	5	production	production	NOUN
eshr-4669	76	6	by	by	ADP
eshr-4669	76	7	different	different	ADJ
eshr-4669	76	8	methods	method	NOUN
eshr-4669	76	9	.	.	PUNCT
eshr-4669	77	1	cra	cra	PROPN
eshr-4669	77	2	method	method	PROPN
eshr-4669	77	3	detected	detect	VERB
eshr-4669	77	4	83	83	NUM
eshr-4669	77	5	isolates(46	isolates(46	NOUN
eshr-4669	77	6	%	%	NOUN
eshr-4669	77	7	)	)	PUNCT
eshr-4669	77	8	as	as	ADP
eshr-4669	77	9	biofilm	biofilm	NOUN
eshr-4669	77	10	producers	producer	NOUN
eshr-4669	77	11	,	,	PUNCT
eshr-4669	77	12	whereas	whereas	SCONJ
eshr-4669	77	13	ta	ta	PROPN
eshr-4669	77	14	method	method	NOUN
eshr-4669	77	15	detected	detect	VERB
eshr-4669	77	16	only	only	ADV
eshr-4669	77	17	59(33	59(33	NUM
eshr-4669	77	18	%	%	NOUN
eshr-4669	77	19	)	)	PUNCT
eshr-4669	77	20	isolates	isolate	NOUN
eshr-4669	77	21	as	as	ADP
eshr-4669	77	22	biofilm	biofilm	NOUN
eshr-4669	77	23	producers	producer	NOUN
eshr-4669	77	24	.	.	PUNCT
eshr-4669	78	1	table	table	NOUN
eshr-4669	78	2	2	2	NUM
eshr-4669	78	3	.	.	PUNCT
eshr-4669	78	4	biofilm	biofilm	NOUN
eshr-4669	78	5	production	production	NOUN
eshr-4669	78	6	by	by	ADP
eshr-4669	78	7	different	different	ADJ
eshr-4669	78	8	methods	method	NOUN
eshr-4669	78	9	methods	method	NOUN
eshr-4669	78	10	congo	congo	PROPN
eshr-4669	78	11	red	red	ADJ
eshr-4669	78	12	agar	agar	NOUN
eshr-4669	78	13	method	method	NOUN
eshr-4669	78	14	(	(	PUNCT
eshr-4669	78	15	%	%	INTJ
eshr-4669	78	16	)	)	PUNCT
eshr-4669	78	17	tube	tube	NOUN
eshr-4669	78	18	adherence	adherence	NOUN
eshr-4669	78	19	method	method	NOUN
eshr-4669	78	20	(	(	PUNCT
eshr-4669	78	21	%	%	INTJ
eshr-4669	78	22	)	)	PUNCT
eshr-4669	78	23	both	both	DET
eshr-4669	78	24	methods	method	NOUN
eshr-4669	78	25	(	(	PUNCT
eshr-4669	78	26	%	%	INTJ
eshr-4669	78	27	)	)	PUNCT
eshr-4669	78	28	total	total	ADJ
eshr-4669	78	29	number	number	NOUN
eshr-4669	78	30	of	of	ADP
eshr-4669	78	31	isolates	isolate	NOUN
eshr-4669	78	32	83	83	NUM
eshr-4669	78	33	(	(	PUNCT
eshr-4669	78	34	46	46	NUM
eshr-4669	78	35	%	%	NOUN
eshr-4669	78	36	)	)	PUNCT
eshr-4669	78	37	59	59	NUM
eshr-4669	78	38	(	(	PUNCT
eshr-4669	78	39	33	33	NUM
eshr-4669	78	40	%	%	NOUN
eshr-4669	78	41	)	)	PUNCT
eshr-4669	78	42	38	38	NUM
eshr-4669	78	43	(	(	PUNCT
eshr-4669	78	44	21	21	NUM
eshr-4669	78	45	%	%	NOUN
eshr-4669	78	46	)	)	PUNCT
eshr-4669	78	47	sharma	sharma	PROPN
eshr-4669	78	48	(	(	PUNCT
eshr-4669	78	49	biofilm	biofilm	NOUN
eshr-4669	78	50	formation	formation	NOUN
eshr-4669	78	51	by	by	ADP
eshr-4669	78	52	uropathogens	uropathogen	NOUN
eshr-4669	78	53	and	and	CCONJ
eshr-4669	78	54	its	its	PRON
eshr-4669	78	55	impact	impact	NOUN
eshr-4669	78	56	on	on	ADP
eshr-4669	78	57	antimicrobial	antimicrobial	ADJ
eshr-4669	78	58	susceptibility	susceptibility	NOUN
eshr-4669	78	59	pattern	pattern	NOUN
eshr-4669	78	60	)	)	PUNCT
eshr-4669	78	61	vol	vol	NOUN
eshr-4669	78	62	.	.	NOUN
eshr-4669	79	1	4	4	NUM
eshr-4669	79	2	,	,	PUNCT
eshr-4669	79	3	no	no	INTJ
eshr-4669	79	4	.	.	NOUN
eshr-4669	79	5	2	2	NUM
eshr-4669	79	6	,	,	PUNCT
eshr-4669	79	7	2022	2022	NUM
eshr-4669	79	8	,	,	PUNCT
eshr-4669	79	9	pp	pp	ADJ
eshr-4669	79	10	.	.	PUNCT
eshr-4669	80	1	40	40	NUM
eshr-4669	80	2	-	-	SYM
eshr-4669	80	3	47	47	NUM
eshr-4669	80	4	10.26555	10.26555	NUM
eshr-4669	80	5	/	/	SYM
eshr-4669	80	6	eshr.v4i2.4669	eshr.v4i2.4669	NUM
eshr-4669	80	7	44	44	NUM
eshr-4669	80	8	amoxicillin	amoxicillin	NOUN
eshr-4669	80	9	(	(	PUNCT
eshr-4669	80	10	99	99	NUM
eshr-4669	80	11	%	%	NOUN
eshr-4669	80	12	)	)	PUNCT
eshr-4669	80	13	and	and	CCONJ
eshr-4669	80	14	amoxy	amoxy	NOUN
eshr-4669	80	15	-	-	PUNCT
eshr-4669	80	16	clavulanic	clavulanic	NOUN
eshr-4669	80	17	acid	acid	NOUN
eshr-4669	80	18	(	(	PUNCT
eshr-4669	80	19	100	100	NUM
eshr-4669	80	20	%	%	NOUN
eshr-4669	80	21	)	)	PUNCT
eshr-4669	80	22	were	be	AUX
eshr-4669	80	23	resistant	resistant	ADJ
eshr-4669	80	24	in	in	ADP
eshr-4669	80	25	most	most	ADJ
eshr-4669	80	26	biofilmpositiveisolates	biofilmpositiveisolate	NOUN
eshr-4669	80	27	.	.	PUNCT
eshr-4669	81	1	the	the	DET
eshr-4669	81	2	highest	high	ADJ
eshr-4669	81	3	degree	degree	NOUN
eshr-4669	81	4	of	of	ADP
eshr-4669	81	5	drug	drug	NOUN
eshr-4669	81	6	resistance	resistance	NOUN
eshr-4669	81	7	was	be	AUX
eshr-4669	81	8	seen	see	VERB
eshr-4669	81	9	in	in	ADP
eshr-4669	81	10	biofilm	biofilm	NOUN
eshr-4669	81	11	-	-	PUNCT
eshr-4669	81	12	forming	form	VERB
eshr-4669	81	13	acinetobacter	acinetobacter	ADJ
eshr-4669	81	14	spp	spp	NOUN
eshr-4669	81	15	.	.	PUNCT
eshr-4669	81	16	followed	follow	VERB
eshr-4669	81	17	by	by	ADP
eshr-4669	81	18	klebsiella	klebsiella	PROPN
eshr-4669	81	19	sp	sp	PROPN
eshr-4669	81	20	.	.	PROPN
eshr-4669	81	21	and	and	CCONJ
eshr-4669	81	22	pseudomonas	pseudomona	NOUN
eshr-4669	81	23	aeruginosa	aeruginosa	NOUN
eshr-4669	81	24	.	.	PUNCT
eshr-4669	82	1	resistance	resistance	NOUN
eshr-4669	82	2	to	to	ADP
eshr-4669	82	3	antibiotics	antibiotic	NOUN
eshr-4669	82	4	like	like	ADP
eshr-4669	82	5	cefuroxime	cefuroxime	ADJ
eshr-4669	82	6	,	,	PUNCT
eshr-4669	82	7	aztreonam	aztreonam	NOUN
eshr-4669	82	8	,	,	PUNCT
eshr-4669	82	9	imipenem	imipenem	PROPN
eshr-4669	82	10	,	,	PUNCT
eshr-4669	82	11	tobramycin	tobramycin	PROPN
eshr-4669	82	12	,	,	PUNCT
eshr-4669	82	13	norfloxacin	norfloxacin	PROPN
eshr-4669	82	14	,	,	PUNCT
eshr-4669	82	15	cotrimoxazole	cotrimoxazole	NOUN
eshr-4669	82	16	,	,	PUNCT
eshr-4669	82	17	chloramphenicol	chloramphenicol	NOUN
eshr-4669	82	18	,	,	PUNCT
eshr-4669	82	19	gentamicin	gentamicin	NOUN
eshr-4669	82	20	and	and	CCONJ
eshr-4669	82	21	tetracycline	tetracycline	NOUN
eshr-4669	82	22	,	,	PUNCT
eshr-4669	82	23	vancomycin	vancomycin	PROPN
eshr-4669	82	24	was	be	AUX
eshr-4669	82	25	more	more	ADV
eshr-4669	82	26	in	in	ADP
eshr-4669	82	27	biofilm	biofilm	NOUN
eshr-4669	82	28	positive	positive	ADJ
eshr-4669	82	29	isolates	isolate	NOUN
eshr-4669	82	30	(	(	PUNCT
eshr-4669	82	31	table	table	NOUN
eshr-4669	82	32	3	3	NUM
eshr-4669	82	33	)	)	PUNCT
eshr-4669	82	34	.	.	PUNCT
eshr-4669	83	1	biofilm	biofilm	NOUN
eshr-4669	83	2	-	-	PUNCT
eshr-4669	83	3	forming	form	VERB
eshr-4669	83	4	gram	gram	NOUN
eshr-4669	83	5	-	-	PUNCT
eshr-4669	83	6	negative	negative	ADJ
eshr-4669	83	7	bacilli	bacilli	NOUN
eshr-4669	83	8	(	(	PUNCT
eshr-4669	83	9	gnb	gnb	NOUN
eshr-4669	83	10	)	)	PUNCT
eshr-4669	83	11	uropathogenic	uropathogenic	ADJ
eshr-4669	83	12	developed	develop	VERB
eshr-4669	83	13	significantly	significantly	ADV
eshr-4669	83	14	higher	high	ADJ
eshr-4669	83	15	resistance	resistance	NOUN
eshr-4669	83	16	towards	towards	ADP
eshr-4669	83	17	antimicrobial	antimicrobial	ADJ
eshr-4669	83	18	drugs	drug	NOUN
eshr-4669	83	19	.	.	PUNCT
eshr-4669	84	1	discussion	discussion	NOUN
eshr-4669	84	2	urinary	urinary	ADJ
eshr-4669	84	3	tract	tract	NOUN
eshr-4669	84	4	infectionspresenta	infectionspresenta	VERB
eshr-4669	84	5	severe	severe	ADJ
eshr-4669	84	6	health	health	NOUN
eshr-4669	84	7	threat	threat	NOUN
eshr-4669	84	8	concerning	concern	VERB
eshr-4669	84	9	antibiotic	antibiotic	ADJ
eshr-4669	84	10	resistance	resistance	NOUN
eshr-4669	84	11	,	,	PUNCT
eshr-4669	84	12	especially	especially	ADV
eshr-4669	84	13	with	with	ADP
eshr-4669	84	14	biofilm	biofilm	NOUN
eshr-4669	84	15	production	production	NOUN
eshr-4669	84	16	.	.	PUNCT
eshr-4669	85	1	during	during	ADP
eshr-4669	85	2	the	the	DET
eshr-4669	85	3	period	period	NOUN
eshr-4669	85	4	covered	cover	VERB
eshr-4669	85	5	by	by	ADP
eshr-4669	85	6	our	our	PRON
eshr-4669	85	7	study	study	NOUN
eshr-4669	85	8	,	,	PUNCT
eshr-4669	85	9	200	200	NUM
eshr-4669	85	10	samples	sample	NOUN
eshr-4669	85	11	were	be	AUX
eshr-4669	85	12	studied	study	VERB
eshr-4669	85	13	,	,	PUNCT
eshr-4669	85	14	92	92	NUM
eshr-4669	85	15	%	%	NOUN
eshr-4669	85	16	of	of	ADP
eshr-4669	85	17	which	which	PRON
eshr-4669	85	18	were	be	AUX
eshr-4669	85	19	received	receive	VERB
eshr-4669	85	20	from	from	ADP
eshr-4669	85	21	different	different	ADJ
eshr-4669	85	22	wards	ward	NOUN
eshr-4669	85	23	,	,	PUNCT
eshr-4669	85	24	operation	operation	NOUN
eshr-4669	85	25	theatre	theatre	NOUN
eshr-4669	85	26	(	(	PUNCT
eshr-4669	85	27	ot	ot	INTJ
eshr-4669	85	28	)	)	PUNCT
eshr-4669	85	29	,	,	PUNCT
eshr-4669	85	30	cardiac	cardiac	ADJ
eshr-4669	85	31	care	care	NOUN
eshr-4669	85	32	unit	unit	NOUN
eshr-4669	85	33	(	(	PUNCT
eshr-4669	85	34	ccu	ccu	PROPN
eshr-4669	85	35	)	)	PUNCT
eshr-4669	85	36	,	,	PUNCT
eshr-4669	85	37	intensive	intensive	ADJ
eshr-4669	85	38	care	care	NOUN
eshr-4669	85	39	unit	unit	NOUN
eshr-4669	85	40	(	(	PUNCT
eshr-4669	85	41	icu	icu	PROPN
eshr-4669	85	42	)	)	PUNCT
eshr-4669	85	43	,	,	PUNCT
eshr-4669	85	44	while	while	SCONJ
eshr-4669	85	45	opd	opd	PROPN
eshr-4669	85	46	samples	sample	NOUN
eshr-4669	85	47	were	be	AUX
eshr-4669	85	48	only	only	ADV
eshr-4669	85	49	15	15	NUM
eshr-4669	85	50	%	%	NOUN
eshr-4669	85	51	of	of	ADP
eshr-4669	85	52	the	the	DET
eshr-4669	85	53	total	total	ADJ
eshr-4669	85	54	and	and	CCONJ
eshr-4669	85	55	maximum	maximum	ADJ
eshr-4669	85	56	samples	sample	NOUN
eshr-4669	85	57	fell	fall	VERB
eshr-4669	85	58	into	into	ADP
eshr-4669	85	59	the	the	DET
eshr-4669	85	60	age	age	NOUN
eshr-4669	85	61	group	group	NOUN
eshr-4669	85	62	of	of	ADP
eshr-4669	85	63	51	51	NUM
eshr-4669	85	64	–	–	SYM
eshr-4669	85	65	70	70	NUM
eshr-4669	85	66	years	year	NOUN
eshr-4669	85	67	.	.	PUNCT
eshr-4669	86	1	this	this	DET
eshr-4669	86	2	finding	finding	NOUN
eshr-4669	86	3	was	be	AUX
eshr-4669	86	4	also	also	ADV
eshr-4669	86	5	depicted	depict	VERB
eshr-4669	86	6	in	in	ADP
eshr-4669	86	7	madigan	madigan	PROPN
eshr-4669	86	8	e	e	PROPN
eshr-4669	86	9	&	&	CCONJ
eshr-4669	86	10	neff	neff	PROPN
eshr-4669	86	11	d	d	PROPN
eshr-4669	86	12	(	(	PUNCT
eshr-4669	86	13	16	16	NUM
eshr-4669	86	14	)	)	PUNCT
eshr-4669	86	15	.	.	PUNCT
eshr-4669	87	1	our	our	PRON
eshr-4669	87	2	study	study	NOUN
eshr-4669	87	3	observed	observe	VERB
eshr-4669	87	4	that	that	SCONJ
eshr-4669	87	5	the	the	DET
eshr-4669	87	6	infected	infected	ADJ
eshr-4669	87	7	patients	patient	NOUN
eshr-4669	87	8	were	be	AUX
eshr-4669	87	9	primarily	primarily	ADV
eshr-4669	87	10	women	woman	NOUN
eshr-4669	87	11	(	(	PUNCT
eshr-4669	87	12	82	82	NUM
eshr-4669	87	13	%	%	NOUN
eshr-4669	87	14	)	)	PUNCT
eshr-4669	87	15	,	,	PUNCT
eshr-4669	87	16	which	which	PRON
eshr-4669	87	17	can	can	AUX
eshr-4669	87	18	be	be	AUX
eshr-4669	87	19	because	because	SCONJ
eshr-4669	87	20	of	of	ADP
eshr-4669	87	21	anal	anal	ADJ
eshr-4669	87	22	proximity	proximity	NOUN
eshr-4669	87	23	and	and	CCONJ
eshr-4669	87	24	the	the	DET
eshr-4669	87	25	shorter	short	ADJ
eshr-4669	87	26	length	length	NOUN
eshr-4669	87	27	of	of	ADP
eshr-4669	87	28	the	the	DET
eshr-4669	87	29	urethra	urethra	NOUN
eshr-4669	87	30	.	.	PUNCT
eshr-4669	88	1	a	a	DET
eshr-4669	88	2	similar	similar	ADJ
eshr-4669	88	3	finding	finding	NOUN
eshr-4669	88	4	was	be	AUX
eshr-4669	88	5	also	also	ADV
eshr-4669	88	6	reported	report	VERB
eshr-4669	88	7	by	by	ADP
eshr-4669	88	8	kashef	kashef	PROPN
eshr-4669	88	9	n	n	PROPN
eshr-4669	88	10	et	et	PROPN
eshr-4669	88	11	al	al	PROPN
eshr-4669	88	12	.	.	PUNCT
eshr-4669	89	1	(	(	PUNCT
eshr-4669	89	2	17).the	17).the	DET
eshr-4669	89	3	age	age	NOUN
eshr-4669	89	4	group	group	NOUN
eshr-4669	89	5	of	of	ADP
eshr-4669	89	6	61	61	NUM
eshr-4669	89	7	–	–	SYM
eshr-4669	89	8	75	75	NUM
eshr-4669	89	9	years	year	NOUN
eshr-4669	89	10	predominated	predominate	VERB
eshr-4669	89	11	in	in	ADP
eshr-4669	89	12	catheterized	catheterize	VERB
eshr-4669	89	13	patients(n=102	patients(n=102	NOUN
eshr-4669	89	14	)	)	PUNCT
eshr-4669	89	15	.	.	PUNCT
eshr-4669	90	1	the	the	DET
eshr-4669	90	2	maximum	maximum	ADJ
eshr-4669	90	3	number	number	NOUN
eshr-4669	90	4	of	of	ADP
eshr-4669	90	5	patients	patient	NOUN
eshr-4669	90	6	were	be	AUX
eshr-4669	90	7	on	on	ADP
eshr-4669	90	8	catheterization	catheterization	NOUN
eshr-4669	90	9	for	for	ADP
eshr-4669	90	10	>	>	X
eshr-4669	90	11	4	4	NUM
eshr-4669	90	12	days	day	NOUN
eshr-4669	90	13	,	,	PUNCT
eshr-4669	90	14	a	a	DET
eshr-4669	90	15	similar	similar	ADJ
eshr-4669	90	16	finding	finding	NOUN
eshr-4669	90	17	by	by	ADP
eshr-4669	90	18	niveditha	niveditha	PROPN
eshr-4669	90	19	s	s	PROPN
eshr-4669	90	20	et	et	NOUN
eshr-4669	90	21	al	al	PROPN
eshr-4669	90	22	.	.	PUNCT
eshr-4669	91	1	(	(	PUNCT
eshr-4669	91	2	18	18	NUM
eshr-4669	91	3	)	)	PUNCT
eshr-4669	91	4	.	.	PUNCT
eshr-4669	92	1	the	the	DET
eshr-4669	92	2	detection	detection	NOUN
eshr-4669	92	3	of	of	ADP
eshr-4669	92	4	bacteriuria	bacteriuria	NOUN
eshr-4669	92	5	within	within	ADP
eshr-4669	92	6	one	one	NUM
eshr-4669	92	7	week	week	NOUN
eshr-4669	92	8	of	of	ADP
eshr-4669	92	9	the	the	DET
eshr-4669	92	10	catheterization	catheterization	NOUN
eshr-4669	92	11	in	in	ADP
eshr-4669	92	12	this	this	DET
eshr-4669	92	13	study	study	NOUN
eshr-4669	92	14	pertains	pertain	VERB
eshr-4669	92	15	to	to	ADP
eshr-4669	92	16	the	the	DET
eshr-4669	92	17	inadequate	inadequate	ADJ
eshr-4669	92	18	precautions	precaution	NOUN
eshr-4669	92	19	taken	take	VERB
eshr-4669	92	20	while	while	SCONJ
eshr-4669	92	21	handling	handle	VERB
eshr-4669	92	22	catheters	catheter	NOUN
eshr-4669	92	23	.	.	PUNCT
eshr-4669	93	1	escherichia	escherichia	NOUN
eshr-4669	93	2	coli	coli	NOUN
eshr-4669	93	3	was	be	AUX
eshr-4669	93	4	isolated	isolate	VERB
eshr-4669	93	5	from	from	ADP
eshr-4669	93	6	94	94	NUM
eshr-4669	93	7	(	(	PUNCT
eshr-4669	93	8	47	47	NUM
eshr-4669	93	9	%	%	NOUN
eshr-4669	93	10	)	)	PUNCT
eshr-4669	93	11	specimens	specimen	NOUN
eshr-4669	93	12	,	,	PUNCT
eshr-4669	93	13	followed	follow	VERB
eshr-4669	93	14	by	by	ADP
eshr-4669	93	15	klebsiella	klebsiella	NOUN
eshr-4669	93	16	pneumonia	pneumonia	NOUN
eshr-4669	93	17	(	(	PUNCT
eshr-4669	93	18	16	16	NUM
eshr-4669	93	19	%	%	NOUN
eshr-4669	93	20	)	)	PUNCT
eshr-4669	93	21	and	and	CCONJ
eshr-4669	93	22	enterococcus	enterococcus	NOUN
eshr-4669	93	23	spp	spp	NOUN
eshr-4669	93	24	.	.	PUNCT
eshr-4669	94	1	(	(	PUNCT
eshr-4669	94	2	18.5	18.5	NUM
eshr-4669	94	3	%	%	NOUN
eshr-4669	94	4	)	)	PUNCT
eshr-4669	94	5	,	,	PUNCT
eshr-4669	94	6	pseudomonas	pseudomona	VERB
eshr-4669	94	7	aeruginosa	aeruginosa	NOUN
eshr-4669	94	8	(	(	PUNCT
eshr-4669	94	9	3	3	NUM
eshr-4669	94	10	%	%	NOUN
eshr-4669	94	11	)	)	PUNCT
eshr-4669	94	12	,	,	PUNCT
eshr-4669	94	13	staphylococcus	staphylococcus	NOUN
eshr-4669	94	14	aureus	aureus	NOUN
eshr-4669	94	15	(	(	PUNCT
eshr-4669	94	16	11	11	NUM
eshr-4669	94	17	%	%	NOUN
eshr-4669	94	18	)	)	PUNCT
eshr-4669	94	19	,	,	PUNCT
eshr-4669	94	20	acinetobacter	acinetobacter	PROPN
eshr-4669	94	21	spp	spp	NOUN
eshr-4669	94	22	.	.	PUNCT
eshr-4669	95	1	(	(	PUNCT
eshr-4669	95	2	3.5	3.5	NUM
eshr-4669	95	3	%	%	NOUN
eshr-4669	95	4	)	)	PUNCT
eshr-4669	95	5	,	,	PUNCT
eshr-4669	95	6	proteus	proteus	NOUN
eshr-4669	95	7	mirabilis	mirabilis	PROPN
eshr-4669	95	8	and	and	CCONJ
eshr-4669	95	9	morganella	morganella	NOUN
eshr-4669	95	10	morganii	morganii	NOUN
eshr-4669	95	11	(	(	PUNCT
eshr-4669	95	12	0.5	0.5	NUM
eshr-4669	95	13	%	%	NOUN
eshr-4669	95	14	each	each	PRON
eshr-4669	95	15	)	)	PUNCT
eshr-4669	95	16	.	.	PUNCT
eshr-4669	96	1	these	these	DET
eshr-4669	96	2	findings	finding	NOUN
eshr-4669	96	3	were	be	AUX
eshr-4669	96	4	similar	similar	ADJ
eshr-4669	96	5	to	to	ADP
eshr-4669	96	6	the	the	DET
eshr-4669	96	7	studies	study	NOUN
eshr-4669	96	8	conducted	conduct	VERB
eshr-4669	96	9	by	by	ADP
eshr-4669	96	10	noor	noor	PROPN
eshr-4669	96	11	af	af	PROPN
eshr-4669	96	12	et	et	PROPN
eshr-4669	96	13	al	al	PROPN
eshr-4669	96	14	.	.	PUNCT
eshr-4669	97	1	(	(	PUNCT
eshr-4669	97	2	19	19	NUM
eshr-4669	97	3	)	)	PUNCT
eshr-4669	97	4	.	.	PUNCT
eshr-4669	98	1	escherichia	escherichia	NOUN
eshr-4669	98	2	coli	coli	NOUN
eshr-4669	98	3	was	be	AUX
eshr-4669	98	4	responsible	responsible	ADJ
eshr-4669	98	5	for	for	ADP
eshr-4669	98	6	the	the	DET
eshr-4669	98	7	maximum	maximum	ADJ
eshr-4669	98	8	number	number	NOUN
eshr-4669	98	9	of	of	ADP
eshr-4669	98	10	uti	uti	PROPN
eshr-4669	98	11	casesbecause	casesbecause	NOUN
eshr-4669	98	12	of	of	ADP
eshr-4669	98	13	the	the	DET
eshr-4669	98	14	ability	ability	NOUN
eshr-4669	98	15	of	of	ADP
eshr-4669	98	16	uropathogenicescherichia	uropathogenicescherichia	ADJ
eshr-4669	98	17	coli	coli	NOUN
eshr-4669	98	18	(	(	PUNCT
eshr-4669	98	19	upec	upec	NOUN
eshr-4669	98	20	)	)	PUNCT
eshr-4669	98	21	to	to	PART
eshr-4669	98	22	express	express	VERB
eshr-4669	98	23	a	a	DET
eshr-4669	98	24	variety	variety	NOUN
eshr-4669	98	25	of	of	ADP
eshr-4669	98	26	virulence	virulence	NOUN
eshr-4669	98	27	factors	factor	NOUN
eshr-4669	98	28	like	like	ADP
eshr-4669	98	29	adhesins	adhesin	NOUN
eshr-4669	98	30	(	(	PUNCT
eshr-4669	98	31	e.g.	e.g.	ADV
eshr-4669	98	32	,	,	PUNCT
eshr-4669	98	33	type	type	NOUN
eshr-4669	98	34	1	1	NUM
eshr-4669	98	35	and	and	CCONJ
eshr-4669	98	36	p	p	NOUN
eshr-4669	98	37	fimbriae	fimbriae	NOUN
eshr-4669	98	38	)	)	PUNCT
eshr-4669	98	39	and	and	CCONJ
eshr-4669	98	40	toxins	toxin	NOUN
eshr-4669	98	41	like	like	ADP
eshr-4669	98	42	hemolysin	hemolysin	NOUN
eshr-4669	98	43	.	.	PUNCT
eshr-4669	99	1	biofilm	biofilm	NOUN
eshr-4669	99	2	detection	detection	NOUN
eshr-4669	99	3	by	by	ADP
eshr-4669	99	4	cra	cra	PROPN
eshr-4669	99	5	and	and	CCONJ
eshr-4669	99	6	ta	ta	PROPN
eshr-4669	99	7	methods	method	NOUN
eshr-4669	99	8	was	be	AUX
eshr-4669	99	9	(	(	PUNCT
eshr-4669	99	10	46	46	NUM
eshr-4669	99	11	%	%	NOUN
eshr-4669	99	12	)	)	PUNCT
eshr-4669	99	13	and	and	CCONJ
eshr-4669	99	14	(	(	PUNCT
eshr-4669	99	15	33	33	NUM
eshr-4669	99	16	%	%	NOUN
eshr-4669	99	17	)	)	PUNCT
eshr-4669	99	18	respectively	respectively	ADV
eshr-4669	99	19	,	,	PUNCT
eshr-4669	99	20	and	and	CCONJ
eshr-4669	99	21	this	this	PRON
eshr-4669	99	22	correlates	correlate	VERB
eshr-4669	99	23	with	with	ADP
eshr-4669	99	24	the	the	DET
eshr-4669	99	25	study	study	NOUN
eshr-4669	99	26	of	of	ADP
eshr-4669	99	27	hassan	hassan	PROPN
eshr-4669	99	28	a	a	DET
eshr-4669	99	29	et	et	NOUN
eshr-4669	99	30	al.(20	al.(20	NOUN
eshr-4669	99	31	)	)	PUNCT
eshr-4669	99	32	.	.	PUNCT
eshr-4669	100	1	cra	cra	PROPN
eshr-4669	100	2	is	be	AUX
eshr-4669	100	3	a	a	DET
eshr-4669	100	4	rapid	rapid	ADJ
eshr-4669	100	5	,	,	PUNCT
eshr-4669	100	6	sensitive	sensitive	ADJ
eshr-4669	100	7	,	,	PUNCT
eshr-4669	100	8	and	and	CCONJ
eshr-4669	100	9	reproducible	reproducible	VERB
eshr-4669	100	10	method	method	NOUN
eshr-4669	100	11	and	and	CCONJ
eshr-4669	100	12	can	can	AUX
eshr-4669	100	13	be	be	AUX
eshr-4669	100	14	recommended	recommend	VERB
eshr-4669	100	15	in	in	ADP
eshr-4669	100	16	resource	resource	NOUN
eshr-4669	100	17	-	-	PUNCT
eshr-4669	100	18	limited	limit	VERB
eshr-4669	100	19	countries	country	NOUN
eshr-4669	100	20	.	.	PUNCT
eshr-4669	101	1	a	a	DET
eshr-4669	101	2	similar	similar	ADJ
eshr-4669	101	3	finding	finding	NOUN
eshr-4669	101	4	was	be	AUX
eshr-4669	101	5	reported	report	VERB
eshr-4669	101	6	by	by	ADP
eshr-4669	101	7	rewatkar	rewatkar	PROPN
eshr-4669	101	8	ar	ar	PROPN
eshr-4669	101	9	and	and	CCONJ
eshr-4669	101	10	wadher	wadher	NOUN
eshr-4669	101	11	bj	bj	VERB
eshr-4669	101	12	et	et	PROPN
eshr-4669	101	13	al	al	PROPN
eshr-4669	101	14	.	.	PUNCT
eshr-4669	102	1	(	(	PUNCT
eshr-4669	102	2	21	21	NUM
eshr-4669	102	3	)	)	PUNCT
eshr-4669	102	4	.	.	PUNCT
eshr-4669	103	1	quantification	quantification	NOUN
eshr-4669	103	2	of	of	ADP
eshr-4669	103	3	biofilms	biofilm	NOUN
eshr-4669	103	4	done	do	VERB
eshr-4669	103	5	by	by	ADP
eshr-4669	103	6	the	the	DET
eshr-4669	103	7	ta	ta	PROPN
eshr-4669	103	8	method	method	NOUN
eshr-4669	103	9	showed	show	VERB
eshr-4669	103	10	that	that	SCONJ
eshr-4669	103	11	only	only	ADV
eshr-4669	103	12	9	9	NUM
eshr-4669	103	13	%	%	NOUN
eshr-4669	103	14	were	be	AUX
eshr-4669	103	15	strong	strong	ADJ
eshr-4669	103	16	producers	producer	NOUN
eshr-4669	103	17	,	,	PUNCT
eshr-4669	103	18	whereas	whereas	SCONJ
eshr-4669	103	19	20	20	NUM
eshr-4669	103	20	%	%	NOUN
eshr-4669	103	21	were	be	AUX
eshr-4669	103	22	moderate	moderate	ADJ
eshr-4669	103	23	producers	producer	NOUN
eshr-4669	103	24	.	.	PUNCT
eshr-4669	104	1	the	the	DET
eshr-4669	104	2	rest	rest	NOUN
eshr-4669	104	3	of	of	ADP
eshr-4669	104	4	the	the	DET
eshr-4669	104	5	isolates	isolate	NOUN
eshr-4669	104	6	(	(	PUNCT
eshr-4669	104	7	71	71	NUM
eshr-4669	104	8	%	%	NOUN
eshr-4669	104	9	)	)	PUNCT
eshr-4669	104	10	were	be	AUX
eshr-4669	104	11	weak	weak	ADJ
eshr-4669	104	12	producers	producer	NOUN
eshr-4669	104	13	.	.	PUNCT
eshr-4669	105	1	this	this	PRON
eshr-4669	105	2	was	be	AUX
eshr-4669	105	3	also	also	ADV
eshr-4669	105	4	observed	observe	VERB
eshr-4669	105	5	by	by	ADP
eshr-4669	105	6	panda	panda	NOUN
eshr-4669	105	7	ps	ps	PROPN
eshr-4669	105	8	et	et	PROPN
eshr-4669	105	9	al	al	PROPN
eshr-4669	105	10	.	.	PROPN
eshr-4669	106	1	(	(	PUNCT
eshr-4669	106	2	22	22	NUM
eshr-4669	106	3	)	)	PUNCT
eshr-4669	106	4	.	.	PUNCT
eshr-4669	107	1	biofilm	biofilm	NOUN
eshr-4669	107	2	formation	formation	NOUN
eshr-4669	107	3	on	on	ADP
eshr-4669	107	4	cauti	cauti	PROPN
eshr-4669	107	5	was	be	AUX
eshr-4669	107	6	observed	observe	VERB
eshr-4669	107	7	more	more	ADV
eshr-4669	107	8	than	than	ADP
eshr-4669	107	9	community	community	NOUN
eshr-4669	107	10	-	-	PUNCT
eshr-4669	107	11	acquired	acquire	VERB
eshr-4669	107	12	uti	uti	PROPN
eshr-4669	107	13	because	because	SCONJ
eshr-4669	107	14	bacteria	bacteria	NOUN
eshr-4669	107	15	survive	survive	VERB
eshr-4669	107	16	on	on	ADP
eshr-4669	107	17	catheters	catheter	NOUN
eshr-4669	107	18	easily	easily	ADV
eshr-4669	107	19	as	as	SCONJ
eshr-4669	107	20	cauti	cauti	PROPN
eshr-4669	107	21	creates	create	VERB
eshr-4669	107	22	an	an	DET
eshr-4669	107	23	ideal	ideal	ADJ
eshr-4669	107	24	environment	environment	NOUN
eshr-4669	107	25	for	for	ADP
eshr-4669	107	26	bacterial	bacterial	ADJ
eshr-4669	107	27	attachment	attachment	NOUN
eshr-4669	107	28	and	and	CCONJ
eshr-4669	107	29	biofilm	biofilm	NOUN
eshr-4669	107	30	production	production	NOUN
eshr-4669	107	31	.	.	PUNCT
eshr-4669	108	1	antibiotic	antibiotic	ADJ
eshr-4669	108	2	resistance	resistance	NOUN
eshr-4669	108	3	was	be	AUX
eshr-4669	108	4	more	more	ADV
eshr-4669	108	5	among	among	ADP
eshr-4669	108	6	biofilm	biofilm	NOUN
eshr-4669	108	7	producers	producer	NOUN
eshr-4669	108	8	in	in	ADP
eshr-4669	108	9	comparison	comparison	NOUN
eshr-4669	108	10	to	to	ADP
eshr-4669	108	11	non	non	NOUN
eshr-4669	108	12	-	-	NOUN
eshr-4669	108	13	producers	producer	NOUN
eshr-4669	108	14	.	.	PUNCT
eshr-4669	109	1	similar	similar	ADJ
eshr-4669	109	2	results	result	NOUN
eshr-4669	109	3	were	be	AUX
eshr-4669	109	4	obtained	obtain	VERB
eshr-4669	109	5	by	by	ADP
eshr-4669	109	6	rewatkar	rewatkar	PROPN
eshr-4669	109	7	ar	ar	PROPN
eshr-4669	109	8	and	and	CCONJ
eshr-4669	109	9	wadher	wadher	NOUN
eshr-4669	109	10	bj	bj	VERB
eshr-4669	109	11	et	et	PROPN
eshr-4669	109	12	al	al	PROPN
eshr-4669	109	13	.	.	PUNCT
eshr-4669	110	1	(	(	PUNCT
eshr-4669	110	2	21	21	NUM
eshr-4669	110	3	)	)	PUNCT
eshr-4669	110	4	.	.	PUNCT
eshr-4669	111	1	a	a	DET
eshr-4669	111	2	possible	possible	ADJ
eshr-4669	111	3	explanationis	explanationi	NOUN
eshr-4669	111	4	the	the	DET
eshr-4669	111	5	persistence	persistence	NOUN
eshr-4669	111	6	of	of	ADP
eshr-4669	111	7	the	the	DET
eshr-4669	111	8	organism	organism	NOUN
eshr-4669	111	9	,	,	PUNCT
eshr-4669	111	10	decreased	decrease	VERB
eshr-4669	111	11	bacterial	bacterial	ADJ
eshr-4669	111	12	growth	growth	NOUN
eshr-4669	111	13	rate	rate	NOUN
eshr-4669	111	14	in	in	ADP
eshr-4669	111	15	a	a	DET
eshr-4669	111	16	biofilm	biofilm	NOUN
eshr-4669	111	17	,	,	PUNCT
eshr-4669	111	18	and	and	CCONJ
eshr-4669	111	19	increased	increase	VERB
eshr-4669	111	20	expression	expression	NOUN
eshr-4669	111	21	of	of	ADP
eshr-4669	111	22	resistance	resistance	NOUN
eshr-4669	111	23	genes	gene	NOUN
eshr-4669	111	24	.	.	PUNCT
eshr-4669	112	1	restricted	restrict	VERB
eshr-4669	112	2	penetration	penetration	NOUN
eshr-4669	112	3	of	of	ADP
eshr-4669	112	4	antibiotics	antibiotic	NOUN
eshr-4669	112	5	into	into	ADP
eshr-4669	112	6	the	the	DET
eshr-4669	112	7	biofilm	biofilm	NOUN
eshr-4669	112	8	and	and	CCONJ
eshr-4669	112	9	the	the	DET
eshr-4669	112	10	proximity	proximity	NOUN
eshr-4669	112	11	of	of	ADP
eshr-4669	112	12	cells	cell	NOUN
eshr-4669	112	13	within	within	ADP
eshr-4669	112	14	a	a	DET
eshr-4669	112	15	biofilm	biofilm	NOUN
eshr-4669	112	16	results	result	NOUN
eshr-4669	112	17	in	in	ADP
eshr-4669	112	18	plasmid	plasmid	ADJ
eshr-4669	112	19	exchange	exchange	NOUN
eshr-4669	112	20	and	and	CCONJ
eshr-4669	112	21	leads	lead	VERB
eshr-4669	112	22	to	to	ADP
eshr-4669	112	23	the	the	DET
eshr-4669	112	24	spread	spread	NOUN
eshr-4669	112	25	of	of	ADP
eshr-4669	112	26	antimicrobial	antimicrobial	ADJ
eshr-4669	112	27	resistance	resistance	NOUN
eshr-4669	112	28	.	.	PUNCT
eshr-4669	113	1	sharma	sharma	PROPN
eshr-4669	113	2	(	(	PUNCT
eshr-4669	113	3	biofilm	biofilm	NOUN
eshr-4669	113	4	formation	formation	NOUN
eshr-4669	113	5	by	by	ADP
eshr-4669	113	6	uropathogens	uropathogen	NOUN
eshr-4669	113	7	and	and	CCONJ
eshr-4669	113	8	its	its	PRON
eshr-4669	113	9	impact	impact	NOUN
eshr-4669	113	10	on	on	ADP
eshr-4669	113	11	antimicrobial	antimicrobial	ADJ
eshr-4669	113	12	susceptibility	susceptibility	NOUN
eshr-4669	113	13	pattern	pattern	NOUN
eshr-4669	113	14	)	)	PUNCT
eshr-4669	113	15	vol	vol	NOUN
eshr-4669	113	16	.	.	NOUN
eshr-4669	114	1	4	4	NUM
eshr-4669	114	2	,	,	PUNCT
eshr-4669	114	3	no	no	INTJ
eshr-4669	114	4	.	.	NOUN
eshr-4669	114	5	2	2	NUM
eshr-4669	114	6	,	,	PUNCT
eshr-4669	114	7	2022	2022	NUM
eshr-4669	114	8	,	,	PUNCT
eshr-4669	114	9	pp	pp	ADJ
eshr-4669	114	10	.	.	PUNCT
eshr-4669	115	1	40	40	NUM
eshr-4669	115	2	-	-	SYM
eshr-4669	115	3	47	47	NUM
eshr-4669	115	4	10.26555	10.26555	NUM
eshr-4669	115	5	/	/	SYM
eshr-4669	115	6	eshr.v4i2.4669	eshr.v4i2.4669	NUM
eshr-4669	115	7	45	45	NUM
eshr-4669	115	8	table	table	NOUN
eshr-4669	115	9	3	3	NUM
eshr-4669	115	10	.	.	PUNCT
eshr-4669	116	1	antibiogram	antibiogram	NUM
eshr-4669	116	2	of	of	ADP
eshr-4669	116	3	biofilm	biofilm	NOUN
eshr-4669	116	4	and	and	CCONJ
eshr-4669	116	5	non	non	ADJ
eshr-4669	116	6	-	-	ADJ
eshr-4669	116	7	biofilm	biofilm	ADJ
eshr-4669	116	8	producing	produce	VERB
eshr-4669	116	9	isolates	isolate	NOUN
eshr-4669	116	10	antimicrobial	antimicrobial	ADJ
eshr-4669	116	11	agent	agent	NOUN
eshr-4669	116	12	percentage	percentage	NOUN
eshr-4669	116	13	resistance	resistance	NOUN
eshr-4669	116	14	p	p	NOUN
eshr-4669	116	15	-	-	PUNCT
eshr-4669	116	16	value	value	NOUN
eshr-4669	116	17	biofilm	biofilm	NOUN
eshr-4669	116	18	producers	producer	NOUN
eshr-4669	116	19	non	non	ADJ
eshr-4669	116	20	-	-	ADJ
eshr-4669	116	21	biofilm	biofilm	ADJ
eshr-4669	116	22	producers	producer	NOUN
eshr-4669	116	23	amoxicillin	amoxicillin	PROPN
eshr-4669	116	24	72/73	72/73	NUM
eshr-4669	116	25	(	(	PUNCT
eshr-4669	116	26	99	99	NUM
eshr-4669	116	27	%	%	NOUN
eshr-4669	116	28	)	)	PUNCT
eshr-4669	117	1	50/53	50/53	NUM
eshr-4669	117	2	(	(	PUNCT
eshr-4669	117	3	94	94	NUM
eshr-4669	117	4	%	%	NOUN
eshr-4669	117	5	)	)	PUNCT
eshr-4669	117	6	0.019	0.019	NUM
eshr-4669	117	7	amoxy	amoxy	ADJ
eshr-4669	117	8	clavulanic	clavulanic	NOUN
eshr-4669	117	9	acid	acid	NOUN
eshr-4669	117	10	73/73	73/73	NUM
eshr-4669	117	11	(	(	PUNCT
eshr-4669	117	12	100	100	NUM
eshr-4669	117	13	%	%	NOUN
eshr-4669	117	14	)	)	PUNCT
eshr-4669	117	15	51/53	51/53	NUM
eshr-4669	117	16	(	(	PUNCT
eshr-4669	117	17	96	96	NUM
eshr-4669	117	18	%	%	NOUN
eshr-4669	117	19	)	)	PUNCT
eshr-4669	117	20	0.024	0.024	NUM
eshr-4669	117	21	piperacillin	piperacillin	NOUN
eshr-4669	117	22	-	-	PUNCT
eshr-4669	117	23	tazobactam	tazobactam	NOUN
eshr-4669	117	24	40/77	40/77	NUM
eshr-4669	117	25	(	(	PUNCT
eshr-4669	117	26	52	52	NUM
eshr-4669	117	27	%	%	NOUN
eshr-4669	117	28	)	)	PUNCT
eshr-4669	117	29	27/64	27/64	NUM
eshr-4669	117	30	(	(	PUNCT
eshr-4669	117	31	42	42	NUM
eshr-4669	117	32	%	%	NOUN
eshr-4669	117	33	)	)	PUNCT
eshr-4669	117	34	0	0	PUNCT
eshr-4669	117	35	cefuroxime	cefuroxime	NOUN
eshr-4669	117	36	71/73	71/73	NUM
eshr-4669	117	37	(	(	PUNCT
eshr-4669	117	38	98	98	NUM
eshr-4669	117	39	%	%	NOUN
eshr-4669	117	40	)	)	PUNCT
eshr-4669	117	41	44/53	44/53	NOUN
eshr-4669	117	42	(	(	PUNCT
eshr-4669	117	43	83	83	NUM
eshr-4669	117	44	%	%	NOUN
eshr-4669	117	45	)	)	PUNCT
eshr-4669	118	1	0.004	0.004	NUM
eshr-4669	118	2	cefepime	cefepime	NOUN
eshr-4669	118	3	77/97	77/97	NUM
eshr-4669	118	4	(	(	PUNCT
eshr-4669	118	5	80	80	NUM
eshr-4669	118	6	%	%	NOUN
eshr-4669	118	7	)	)	PUNCT
eshr-4669	118	8	56/64	56/64	NUM
eshr-4669	118	9	(	(	PUNCT
eshr-4669	118	10	87	87	NUM
eshr-4669	118	11	%	%	NOUN
eshr-4669	118	12	)	)	PUNCT
eshr-4669	119	1	0.004	0.004	NUM
eshr-4669	119	2	aztreonam	aztreonam	NOUN
eshr-4669	119	3	66/76	66/76	NUM
eshr-4669	119	4	(	(	PUNCT
eshr-4669	119	5	87	87	NUM
eshr-4669	119	6	%	%	NOUN
eshr-4669	119	7	)	)	PUNCT
eshr-4669	119	8	39/56	39/56	NUM
eshr-4669	119	9	(	(	PUNCT
eshr-4669	119	10	70	70	NUM
eshr-4669	119	11	%	%	NOUN
eshr-4669	119	12	)	)	PUNCT
eshr-4669	119	13	0	0	NUM
eshr-4669	120	1	imipenem	imipenem	PROPN
eshr-4669	120	2	67/73	67/73	NUM
eshr-4669	120	3	(	(	PUNCT
eshr-4669	120	4	92	92	NUM
eshr-4669	120	5	%	%	NOUN
eshr-4669	120	6	)	)	PUNCT
eshr-4669	120	7	35/53	35/53	NUM
eshr-4669	120	8	(	(	PUNCT
eshr-4669	120	9	66	66	NUM
eshr-4669	120	10	%	%	NOUN
eshr-4669	120	11	)	)	PUNCT
eshr-4669	120	12	0	0	PUNCT
eshr-4669	121	1	amikacin	amikacin	PROPN
eshr-4669	121	2	64/77	64/77	NUM
eshr-4669	121	3	(	(	PUNCT
eshr-4669	121	4	84	84	NUM
eshr-4669	121	5	%	%	NOUN
eshr-4669	121	6	)	)	PUNCT
eshr-4669	121	7	54/64	54/64	NUM
eshr-4669	121	8	(	(	PUNCT
eshr-4669	121	9	85	85	NUM
eshr-4669	121	10	%	%	NOUN
eshr-4669	121	11	)	)	PUNCT
eshr-4669	121	12	0.022	0.022	NUM
eshr-4669	121	13	tobramycin	tobramycin	NOUN
eshr-4669	121	14	47/77	47/77	NUM
eshr-4669	121	15	(	(	PUNCT
eshr-4669	121	16	61	61	NUM
eshr-4669	121	17	%	%	NOUN
eshr-4669	121	18	)	)	PUNCT
eshr-4669	121	19	17/64	17/64	NUM
eshr-4669	121	20	(	(	PUNCT
eshr-4669	121	21	27	27	NUM
eshr-4669	121	22	%	%	NOUN
eshr-4669	121	23	)	)	PUNCT
eshr-4669	121	24	0	0	NUM
eshr-4669	122	1	norfloxacin	norfloxacin	ADV
eshr-4669	122	2	94/103	94/103	NUM
eshr-4669	122	3	(	(	PUNCT
eshr-4669	122	4	92	92	NUM
eshr-4669	122	5	%	%	NOUN
eshr-4669	122	6	)	)	PUNCT
eshr-4669	123	1	67/88	67/88	NUM
eshr-4669	123	2	(	(	PUNCT
eshr-4669	123	3	77	77	NUM
eshr-4669	123	4	%	%	NOUN
eshr-4669	123	5	)	)	PUNCT
eshr-4669	123	6	0.002	0.002	NUM
eshr-4669	123	7	cotrimoxazole	cotrimoxazole	NOUN
eshr-4669	123	8	62/74	62/74	NUM
eshr-4669	123	9	(	(	PUNCT
eshr-4669	123	10	84	84	NUM
eshr-4669	123	11	%	%	NOUN
eshr-4669	123	12	)	)	PUNCT
eshr-4669	123	13	28/61	28/61	NUM
eshr-4669	123	14	(	(	PUNCT
eshr-4669	123	15	46	46	NUM
eshr-4669	123	16	%	%	NOUN
eshr-4669	123	17	)	)	PUNCT
eshr-4669	123	18	0	0	NUM
eshr-4669	124	1	cefoxitin	cefoxitin	NOUN
eshr-4669	124	2	58/100	58/100	NUM
eshr-4669	124	3	(	(	PUNCT
eshr-4669	124	4	58	58	NUM
eshr-4669	124	5	%	%	NOUN
eshr-4669	124	6	)	)	PUNCT
eshr-4669	124	7	25/85	25/85	NUM
eshr-4669	124	8	(	(	PUNCT
eshr-4669	124	9	30	30	NUM
eshr-4669	124	10	%	%	NOUN
eshr-4669	124	11	)	)	PUNCT
eshr-4669	124	12	0	0	NUM
eshr-4669	124	13	chloramphenicol	chloramphenicol	NOUN
eshr-4669	124	14	46/73	46/73	NUM
eshr-4669	124	15	(	(	PUNCT
eshr-4669	124	16	63	63	NUM
eshr-4669	124	17	%	%	NOUN
eshr-4669	124	18	)	)	PUNCT
eshr-4669	124	19	26/53	26/53	NUM
eshr-4669	124	20	(	(	PUNCT
eshr-4669	124	21	50	50	NUM
eshr-4669	124	22	%	%	NOUN
eshr-4669	124	23	)	)	PUNCT
eshr-4669	124	24	0.022	0.022	NUM
eshr-4669	124	25	gentamicin	gentamicin	VERB
eshr-4669	124	26	98/104	98/104	NOUN
eshr-4669	124	27	(	(	PUNCT
eshr-4669	124	28	94	94	NUM
eshr-4669	124	29	%	%	NOUN
eshr-4669	124	30	)	)	PUNCT
eshr-4669	124	31	77/96	77/96	NUM
eshr-4669	124	32	(	(	PUNCT
eshr-4669	124	33	80	80	NUM
eshr-4669	124	34	%	%	NOUN
eshr-4669	124	35	)	)	PUNCT
eshr-4669	124	36	0.022	0.022	NUM
eshr-4669	124	37	tetracycline	tetracycline	NOUN
eshr-4669	124	38	64/74	64/74	NUM
eshr-4669	124	39	(	(	PUNCT
eshr-4669	124	40	86	86	NUM
eshr-4669	124	41	%	%	NOUN
eshr-4669	124	42	)	)	PUNCT
eshr-4669	124	43	35/61	35/61	NUM
eshr-4669	124	44	(	(	PUNCT
eshr-4669	124	45	57	57	NUM
eshr-4669	124	46	%	%	NOUN
eshr-4669	124	47	)	)	PUNCT
eshr-4669	124	48	0	0	NUM
eshr-4669	125	1	ciprofloxacin	ciprofloxacin	NOUN
eshr-4669	125	2	23/30	23/30	NUM
eshr-4669	125	3	(	(	PUNCT
eshr-4669	125	4	77	77	NUM
eshr-4669	125	5	%	%	NOUN
eshr-4669	125	6	)	)	PUNCT
eshr-4669	125	7	31/35	31/35	NUM
eshr-4669	125	8	(	(	PUNCT
eshr-4669	125	9	88	88	NUM
eshr-4669	125	10	%	%	NOUN
eshr-4669	125	11	)	)	PUNCT
eshr-4669	125	12	0.449	0.449	NUM
eshr-4669	125	13	penicillin	penicillin	NOUN
eshr-4669	125	14	24/27	24/27	NUM
eshr-4669	125	15	(	(	PUNCT
eshr-4669	125	16	89	89	NUM
eshr-4669	125	17	%	%	NOUN
eshr-4669	125	18	)	)	PUNCT
eshr-4669	125	19	27/32	27/32	NUM
eshr-4669	125	20	(	(	PUNCT
eshr-4669	125	21	84	84	NUM
eshr-4669	125	22	%	%	NOUN
eshr-4669	125	23	)	)	PUNCT
eshr-4669	125	24	>	>	SYM
eshr-4669	125	25	0.5	0.5	NUM
eshr-4669	125	26	vancomycin	vancomycin	PROPN
eshr-4669	125	27	10/27	10/27	NUM
eshr-4669	125	28	(	(	PUNCT
eshr-4669	125	29	37	37	NUM
eshr-4669	125	30	%	%	NOUN
eshr-4669	125	31	)	)	PUNCT
eshr-4669	125	32	5/32	5/32	NUM
eshr-4669	125	33	(	(	PUNCT
eshr-4669	125	34	17	17	NUM
eshr-4669	125	35	%	%	NOUN
eshr-4669	125	36	)	)	PUNCT
eshr-4669	125	37	0	0	NUM
eshr-4669	126	1	nitrofurantoin	nitrofurantoin	NOUN
eshr-4669	126	2	14/27	14/27	NUM
eshr-4669	126	3	(	(	PUNCT
eshr-4669	126	4	52	52	NUM
eshr-4669	126	5	%	%	NOUN
eshr-4669	126	6	)	)	PUNCT
eshr-4669	126	7	6/32	6/32	NUM
eshr-4669	126	8	(	(	PUNCT
eshr-4669	126	9	19	19	NUM
eshr-4669	126	10	%	%	NOUN
eshr-4669	126	11	)	)	PUNCT
eshr-4669	126	12	0	0	PUNCT
eshr-4669	126	13	linezolid	linezolid	NOUN
eshr-4669	126	14	0/27	0/27	NUM
eshr-4669	126	15	(	(	PUNCT
eshr-4669	126	16	0	0	NUM
eshr-4669	126	17	%	%	NOUN
eshr-4669	126	18	)	)	PUNCT
eshr-4669	126	19	0/32	0/32	NUM
eshr-4669	126	20	(	(	PUNCT
eshr-4669	126	21	0	0	NUM
eshr-4669	126	22	%	%	NOUN
eshr-4669	126	23	)	)	PUNCT
eshr-4669	126	24	0.001	0.001	NUM
eshr-4669	126	25	in	in	ADP
eshr-4669	126	26	the	the	DET
eshr-4669	126	27	case	case	NOUN
eshr-4669	126	28	of	of	ADP
eshr-4669	126	29	escherichia	escherichia	NOUN
eshr-4669	126	30	coli	coli	NOUN
eshr-4669	126	31	,	,	PUNCT
eshr-4669	126	32	biofilm	biofilm	NOUN
eshr-4669	126	33	producers	producer	NOUN
eshr-4669	126	34	showed	show	VERB
eshr-4669	126	35	maximum	maximum	ADJ
eshr-4669	126	36	resistance	resistance	NOUN
eshr-4669	126	37	toamoxyclavulanic	toamoxyclavulanic	ADJ
eshr-4669	126	38	acid	acid	NOUN
eshr-4669	126	39	followed	follow	VERB
eshr-4669	126	40	by	by	ADP
eshr-4669	126	41	cephalosporins	cephalosporin	NOUN
eshr-4669	126	42	,	,	PUNCT
eshr-4669	126	43	gentamicin	gentamicin	NOUN
eshr-4669	126	44	,	,	PUNCT
eshr-4669	126	45	co	co	NOUN
eshr-4669	126	46	-	-	NOUN
eshr-4669	126	47	trimoxazole	trimoxazole	ADJ
eshr-4669	126	48	amikacin	amikacin	PROPN
eshr-4669	126	49	,	,	PUNCT
eshr-4669	126	50	and	and	CCONJ
eshr-4669	126	51	least	least	ADJ
eshr-4669	126	52	resistance	resistance	NOUN
eshr-4669	126	53	to	to	ADP
eshr-4669	126	54	piperacillin	piperacillin	NOUN
eshr-4669	126	55	-	-	PUNCT
eshr-4669	126	56	tazobactam	tazobactam	NOUN
eshr-4669	126	57	(	(	PUNCT
eshr-4669	126	58	37	37	NUM
eshr-4669	126	59	%	%	NOUN
eshr-4669	126	60	)	)	PUNCT
eshr-4669	126	61	.	.	PUNCT
eshr-4669	127	1	it	it	PRON
eshr-4669	127	2	was	be	AUX
eshr-4669	127	3	similar	similar	ADJ
eshr-4669	127	4	to	to	ADP
eshr-4669	127	5	the	the	DET
eshr-4669	127	6	finding	finding	NOUN
eshr-4669	127	7	observed	observe	VERB
eshr-4669	127	8	by	by	ADP
eshr-4669	127	9	tiwari	tiwari	PROPN
eshr-4669	127	10	aa	aa	PROPN
eshr-4669	127	11	&	&	CCONJ
eshr-4669	127	12	ghnawate	ghnawate	PROPN
eshr-4669	127	13	n	n	INTJ
eshr-4669	127	14	et	et	NOUN
eshr-4669	127	15	al	al	PROPN
eshr-4669	127	16	.	.	PUNCT
eshr-4669	128	1	(	(	PUNCT
eshr-4669	128	2	23	23	NUM
eshr-4669	128	3	)	)	PUNCT
eshr-4669	128	4	.	.	PUNCT
eshr-4669	129	1	in	in	ADP
eshr-4669	129	2	the	the	DET
eshr-4669	129	3	case	case	NOUN
eshr-4669	129	4	of	of	ADP
eshr-4669	129	5	klebsiella	klebsiella	PROPN
eshr-4669	129	6	pneumonia	pneumonia	NOUN
eshr-4669	129	7	,	,	PUNCT
eshr-4669	129	8	resistanceto	resistanceto	VERB
eshr-4669	129	9	multiple	multiple	ADJ
eshr-4669	129	10	antibiotics	antibiotic	NOUN
eshr-4669	129	11	was	be	AUX
eshr-4669	129	12	observed	observe	VERB
eshr-4669	129	13	in	in	ADP
eshr-4669	129	14	biofilm	biofilm	NOUN
eshr-4669	129	15	producers	producer	NOUN
eshr-4669	129	16	,	,	PUNCT
eshr-4669	129	17	which	which	PRON
eshr-4669	129	18	also	also	ADV
eshr-4669	129	19	correlates	correlate	VERB
eshr-4669	129	20	with	with	ADP
eshr-4669	129	21	the	the	DET
eshr-4669	129	22	study	study	NOUN
eshr-4669	129	23	of	of	ADP
eshr-4669	129	24	tiwari	tiwari	PROPN
eshr-4669	129	25	aa	aa	PROPN
eshr-4669	129	26	&	&	CCONJ
eshr-4669	129	27	ghnawate	ghnawate	PROPN
eshr-4669	129	28	n	n	INTJ
eshr-4669	129	29	et	et	NOUN
eshr-4669	129	30	al	al	PROPN
eshr-4669	129	31	.	.	PUNCT
eshr-4669	130	1	(	(	PUNCT
eshr-4669	130	2	23	23	NUM
eshr-4669	130	3	)	)	PUNCT
eshr-4669	130	4	.	.	PUNCT
eshr-4669	131	1	drug	drug	NOUN
eshr-4669	131	2	tobramycin	tobramycin	PROPN
eshr-4669	131	3	was	be	AUX
eshr-4669	131	4	more	more	ADV
eshr-4669	131	5	effective	effective	ADJ
eshr-4669	131	6	in	in	ADP
eshr-4669	131	7	the	the	DET
eshr-4669	131	8	case	case	NOUN
eshr-4669	131	9	of	of	ADP
eshr-4669	131	10	non	non	ADJ
eshr-4669	131	11	-	-	ADJ
eshr-4669	131	12	biofilm	biofilm	ADJ
eshr-4669	131	13	producers	producer	NOUN
eshr-4669	131	14	with	with	ADP
eshr-4669	131	15	83	83	NUM
eshr-4669	131	16	%	%	NOUN
eshr-4669	131	17	sensitivity	sensitivity	NOUN
eshr-4669	131	18	,	,	PUNCT
eshr-4669	131	19	while	while	SCONJ
eshr-4669	131	20	it	it	PRON
eshr-4669	131	21	was	be	AUX
eshr-4669	131	22	25	25	NUM
eshr-4669	131	23	%	%	NOUN
eshr-4669	131	24	sensitive	sensitive	ADJ
eshr-4669	131	25	for	for	ADP
eshr-4669	131	26	biofilm	biofilm	NOUN
eshr-4669	131	27	producers	producer	NOUN
eshr-4669	131	28	.	.	PUNCT
eshr-4669	132	1	our	our	PRON
eshr-4669	132	2	study	study	NOUN
eshr-4669	132	3	concluded	conclude	VERB
eshr-4669	132	4	that	that	SCONJ
eshr-4669	132	5	klebsiella	klebsiella	PROPN
eshr-4669	132	6	sp	sp	PROPN
eshr-4669	132	7	.	.	PROPN
eshr-4669	132	8	was	be	AUX
eshr-4669	132	9	maximum	maximum	ADV
eshr-4669	132	10	resistant	resistant	ADJ
eshr-4669	132	11	to	to	ADP
eshr-4669	132	12	antibiotics	antibiotic	NOUN
eshr-4669	132	13	,	,	PUNCT
eshr-4669	132	14	maybe	maybe	ADV
eshr-4669	132	15	because	because	SCONJ
eshr-4669	132	16	of	of	ADP
eshr-4669	132	17	the	the	DET
eshr-4669	132	18	high	high	ADJ
eshr-4669	132	19	prevalence	prevalence	NOUN
eshr-4669	132	20	of	of	ADP
eshr-4669	132	21	resistant	resistant	ADJ
eshr-4669	132	22	strain	strain	NOUN
eshr-4669	132	23	in	in	ADP
eshr-4669	132	24	our	our	PRON
eshr-4669	132	25	region	region	NOUN
eshr-4669	132	26	or	or	CCONJ
eshr-4669	132	27	the	the	DET
eshr-4669	132	28	exhaustive	exhaustive	ADJ
eshr-4669	132	29	use	use	NOUN
eshr-4669	132	30	of	of	ADP
eshr-4669	132	31	antibiotics	antibiotic	NOUN
eshr-4669	132	32	.	.	PUNCT
eshr-4669	133	1	pseudomonas	pseudomona	NOUN
eshr-4669	133	2	aeruginosa	aeruginosa	PROPN
eshr-4669	133	3	was	be	AUX
eshr-4669	133	4	highly	highly	ADV
eshr-4669	133	5	sensitive	sensitive	ADJ
eshr-4669	133	6	to	to	ADP
eshr-4669	133	7	tobramycin	tobramycin	NOUN
eshr-4669	133	8	in	in	ADP
eshr-4669	133	9	the	the	DET
eshr-4669	133	10	case	case	NOUN
eshr-4669	133	11	of	of	ADP
eshr-4669	133	12	biofilm	biofilm	NOUN
eshr-4669	133	13	producers	producer	NOUN
eshr-4669	133	14	and	and	CCONJ
eshr-4669	133	15	non	non	NOUN
eshr-4669	133	16	-	-	NOUN
eshr-4669	133	17	producers	producer	NOUN
eshr-4669	133	18	.	.	PUNCT
eshr-4669	134	1	so	so	ADV
eshr-4669	134	2	it	it	PRON
eshr-4669	134	3	may	may	AUX
eshr-4669	134	4	be	be	AUX
eshr-4669	134	5	considered	consider	VERB
eshr-4669	134	6	the	the	DET
eshr-4669	134	7	antibiotic	antibiotic	NOUN
eshr-4669	134	8	of	of	ADP
eshr-4669	134	9	choice	choice	NOUN
eshr-4669	134	10	for	for	ADP
eshr-4669	134	11	pseudomonas	pseudomona	NOUN
eshr-4669	134	12	aeruginosa	aeruginosa	NOUN
eshr-4669	134	13	.	.	PUNCT
eshr-4669	135	1	our	our	PRON
eshr-4669	135	2	study	study	NOUN
eshr-4669	135	3	had	have	VERB
eshr-4669	135	4	only	only	ADV
eshr-4669	135	5	one	one	NUM
eshr-4669	135	6	strain	strain	NOUN
eshr-4669	135	7	of	of	ADP
eshr-4669	135	8	acinetobacter	acinetobacter	ADJ
eshr-4669	135	9	baumannii	baumannii	PROPN
eshr-4669	135	10	,	,	PUNCT
eshr-4669	135	11	a	a	DET
eshr-4669	135	12	biofilm	biofilm	NOUN
eshr-4669	135	13	producer	producer	NOUN
eshr-4669	135	14	and	and	CCONJ
eshr-4669	135	15	sharma	sharma	PROPN
eshr-4669	135	16	(	(	PUNCT
eshr-4669	135	17	biofilm	biofilm	NOUN
eshr-4669	135	18	formation	formation	NOUN
eshr-4669	135	19	by	by	ADP
eshr-4669	135	20	uropathogens	uropathogen	NOUN
eshr-4669	135	21	and	and	CCONJ
eshr-4669	135	22	its	its	PRON
eshr-4669	135	23	impact	impact	NOUN
eshr-4669	135	24	on	on	ADP
eshr-4669	135	25	antimicrobial	antimicrobial	ADJ
eshr-4669	135	26	susceptibility	susceptibility	NOUN
eshr-4669	135	27	pattern	pattern	NOUN
eshr-4669	135	28	)	)	PUNCT
eshr-4669	135	29	vol	vol	NOUN
eshr-4669	135	30	.	.	NOUN
eshr-4669	136	1	4	4	NUM
eshr-4669	136	2	,	,	PUNCT
eshr-4669	136	3	no	no	INTJ
eshr-4669	136	4	.	.	NOUN
eshr-4669	136	5	2	2	NUM
eshr-4669	136	6	,	,	PUNCT
eshr-4669	136	7	2022	2022	NUM
eshr-4669	136	8	,	,	PUNCT
eshr-4669	136	9	pp	pp	ADJ
eshr-4669	136	10	.	.	PUNCT
eshr-4669	137	1	40	40	NUM
eshr-4669	137	2	-	-	SYM
eshr-4669	137	3	47	47	NUM
eshr-4669	137	4	10.26555	10.26555	NUM
eshr-4669	137	5	/	/	SYM
eshr-4669	137	6	eshr.v4i2.4669	eshr.v4i2.4669	NUM
eshr-4669	137	7	46	46	NUM
eshr-4669	137	8	resistant	resistant	ADJ
eshr-4669	137	9	to	to	ADP
eshr-4669	137	10	all	all	DET
eshr-4669	137	11	the	the	DET
eshr-4669	137	12	antibiotics	antibiotic	NOUN
eshr-4669	137	13	.	.	PUNCT
eshr-4669	138	1	on	on	ADP
eshr-4669	138	2	the	the	DET
eshr-4669	138	3	other	other	ADJ
eshr-4669	138	4	side	side	NOUN
eshr-4669	138	5	,	,	PUNCT
eshr-4669	138	6	no	no	DET
eshr-4669	138	7	biofilm	biofilm	NOUN
eshr-4669	138	8	-	-	PUNCT
eshr-4669	138	9	producing	produce	VERB
eshr-4669	138	10	strain	strain	NOUN
eshr-4669	138	11	was	be	AUX
eshr-4669	138	12	isolated	isolate	VERB
eshr-4669	138	13	in	in	ADP
eshr-4669	138	14	the	the	DET
eshr-4669	138	15	case	case	NOUN
eshr-4669	138	16	of	of	ADP
eshr-4669	138	17	morganella	morganella	NOUN
eshr-4669	138	18	morganii	morganii	NOUN
eshr-4669	138	19	and	and	CCONJ
eshr-4669	138	20	proteus	proteus	PROPN
eshr-4669	138	21	mirabilis	mirabilis	PROPN
eshr-4669	138	22	.	.	PUNCT
eshr-4669	139	1	however	however	ADV
eshr-4669	139	2	,	,	PUNCT
eshr-4669	139	3	the	the	DET
eshr-4669	139	4	insufficient	insufficient	ADJ
eshr-4669	139	5	sample	sample	NOUN
eshr-4669	139	6	size	size	NOUN
eshr-4669	139	7	makes	make	VERB
eshr-4669	139	8	it	it	PRON
eshr-4669	139	9	impossible	impossible	ADJ
eshr-4669	139	10	to	to	PART
eshr-4669	139	11	draw	draw	VERB
eshr-4669	139	12	practical	practical	ADJ
eshr-4669	139	13	conclusions	conclusion	NOUN
eshr-4669	139	14	from	from	ADP
eshr-4669	139	15	this	this	DET
eshr-4669	139	16	data	data	NOUN
eshr-4669	139	17	.	.	PUNCT
eshr-4669	140	1	in	in	ADP
eshr-4669	140	2	the	the	DET
eshr-4669	140	3	case	case	NOUN
eshr-4669	140	4	of	of	ADP
eshr-4669	140	5	gram	gram	NOUN
eshr-4669	140	6	-	-	PUNCT
eshr-4669	140	7	positive	positive	ADJ
eshr-4669	140	8	cocci	cocci	NOUN
eshr-4669	140	9	,	,	PUNCT
eshr-4669	140	10	linezolid	linezolid	PROPN
eshr-4669	140	11	was	be	AUX
eshr-4669	140	12	100	100	NUM
eshr-4669	140	13	%	%	NOUN
eshr-4669	140	14	sensitive	sensitive	ADJ
eshr-4669	140	15	in	in	ADP
eshr-4669	140	16	both	both	DET
eshr-4669	140	17	biofilm	biofilm	NOUN
eshr-4669	140	18	producers	producer	NOUN
eshr-4669	140	19	and	and	CCONJ
eshr-4669	140	20	non	non	NOUN
eshr-4669	140	21	-	-	NOUN
eshr-4669	140	22	producers	producer	NOUN
eshr-4669	140	23	,	,	PUNCT
eshr-4669	140	24	which	which	PRON
eshr-4669	140	25	shows	show	VERB
eshr-4669	140	26	that	that	SCONJ
eshr-4669	140	27	it	it	PRON
eshr-4669	140	28	can	can	AUX
eshr-4669	140	29	be	be	AUX
eshr-4669	140	30	a	a	DET
eshr-4669	140	31	good	good	ADJ
eshr-4669	140	32	reservoir	reservoir	NOUN
eshr-4669	140	33	.	.	PUNCT
eshr-4669	141	1	this	this	DET
eshr-4669	141	2	finding	finding	NOUN
eshr-4669	141	3	correlates	correlate	VERB
eshr-4669	141	4	well	well	ADV
eshr-4669	141	5	with	with	ADP
eshr-4669	141	6	the	the	DET
eshr-4669	141	7	study	study	NOUN
eshr-4669	141	8	of	of	ADP
eshr-4669	141	9	panda	panda	NOUN
eshr-4669	141	10	ps	ps	PROPN
eshr-4669	141	11	et	et	NOUN
eshr-4669	141	12	al.(22	al.(22	PROPN
eshr-4669	141	13	)	)	PUNCT
eshr-4669	141	14	.	.	PUNCT
eshr-4669	142	1	86	86	NUM
eshr-4669	142	2	%	%	NOUN
eshr-4669	142	3	of	of	ADP
eshr-4669	142	4	staphylococcus	staphylococcus	NOUN
eshr-4669	142	5	aureusismrsa	aureusismrsa	NOUN
eshr-4669	142	6	strains	strain	VERB
eshr-4669	142	7	,	,	PUNCT
eshr-4669	142	8	a	a	DET
eshr-4669	142	9	finding	finding	NOUN
eshr-4669	142	10	similar	similar	ADJ
eshr-4669	142	11	to	to	ADP
eshr-4669	142	12	a	a	DET
eshr-4669	142	13	study	study	NOUN
eshr-4669	142	14	by	by	ADP
eshr-4669	142	15	yousefi	yousefi	PROPN
eshr-4669	142	16	m	m	PROPN
eshr-4669	142	17	et	et	PROPN
eshr-4669	142	18	al	al	PROPN
eshr-4669	142	19	.	.	PUNCT
eshr-4669	143	1	(	(	PUNCT
eshr-4669	143	2	24	24	NUM
eshr-4669	143	3	)	)	PUNCT
eshr-4669	143	4	.	.	PUNCT
eshr-4669	144	1	our	our	PRON
eshr-4669	144	2	study	study	NOUN
eshr-4669	144	3	highlights	highlight	VERB
eshr-4669	144	4	a	a	DET
eshr-4669	144	5	broad	broad	ADJ
eshr-4669	144	6	range	range	NOUN
eshr-4669	144	7	of	of	ADP
eshr-4669	144	8	uropathogens	uropathogen	NOUN
eshr-4669	144	9	and	and	CCONJ
eshr-4669	144	10	multi	multi	ADJ
eshr-4669	144	11	-	-	ADJ
eshr-4669	144	12	drug	drug	ADJ
eshr-4669	144	13	resistant	resistant	ADJ
eshr-4669	144	14	(	(	PUNCT
eshr-4669	144	15	mdr	mdr	NOUN
eshr-4669	144	16	)	)	PUNCT
eshr-4669	144	17	isolates	isolate	NOUN
eshr-4669	144	18	among	among	ADP
eshr-4669	144	19	biofilm	biofilm	NOUN
eshr-4669	144	20	-	-	PUNCT
eshr-4669	144	21	forminguropathogens	forminguropathogens	NOUN
eshr-4669	144	22	.	.	PUNCT
eshr-4669	145	1	this	this	DET
eshr-4669	145	2	study	study	NOUN
eshr-4669	145	3	was	be	AUX
eshr-4669	145	4	concerned	concern	VERB
eshr-4669	145	5	with	with	ADP
eshr-4669	145	6	a	a	DET
eshr-4669	145	7	single	single	ADJ
eshr-4669	145	8	tertiary	tertiary	ADJ
eshr-4669	145	9	setting	setting	NOUN
eshr-4669	145	10	.	.	PUNCT
eshr-4669	146	1	thereforebroader	thereforebroader	NOUN
eshr-4669	146	2	surveillance	surveillance	NOUN
eshr-4669	146	3	is	be	AUX
eshr-4669	146	4	needed	need	VERB
eshr-4669	146	5	to	to	PART
eshr-4669	146	6	determine	determine	VERB
eshr-4669	146	7	the	the	DET
eshr-4669	146	8	local	local	ADJ
eshr-4669	146	9	resistance	resistance	NOUN
eshr-4669	146	10	profiles	profile	NOUN
eshr-4669	146	11	of	of	ADP
eshr-4669	146	12	prevalent	prevalent	ADJ
eshr-4669	146	13	biofilm	biofilm	NOUN
eshr-4669	146	14	-	-	PUNCT
eshr-4669	146	15	forminguropathogens	forminguropathogen	NOUN
eshr-4669	146	16	so	so	SCONJ
eshr-4669	146	17	that	that	SCONJ
eshr-4669	146	18	an	an	DET
eshr-4669	146	19	optimal	optimal	ADJ
eshr-4669	146	20	empirical	empirical	ADJ
eshr-4669	146	21	therapy	therapy	NOUN
eshr-4669	146	22	can	can	AUX
eshr-4669	146	23	be	be	AUX
eshr-4669	146	24	documented	document	VERB
eshr-4669	146	25	.	.	PUNCT
eshr-4669	147	1	conclusion	conclusion	NOUN
eshr-4669	147	2	this	this	DET
eshr-4669	147	3	study	study	NOUN
eshr-4669	147	4	showed	show	VERB
eshr-4669	147	5	a	a	DET
eshr-4669	147	6	considerable	considerable	ADJ
eshr-4669	147	7	opportunity	opportunity	NOUN
eshr-4669	147	8	foruropathogens	foruropathogen	NOUN
eshr-4669	147	9	to	to	PART
eshr-4669	147	10	form	form	VERB
eshr-4669	147	11	biofilms	biofilm	NOUN
eshr-4669	147	12	.	.	PUNCT
eshr-4669	148	1	we	we	PRON
eshr-4669	148	2	observed	observe	VERB
eshr-4669	148	3	asignificant	asignificant	ADJ
eshr-4669	148	4	correlation	correlation	NOUN
eshr-4669	148	5	between	between	ADP
eshr-4669	148	6	biofilm	biofilm	NOUN
eshr-4669	148	7	production	production	NOUN
eshr-4669	148	8	and	and	CCONJ
eshr-4669	148	9	multi	multi	ADJ
eshr-4669	148	10	-	-	ADJ
eshr-4669	148	11	drug	drug	ADJ
eshr-4669	148	12	resistance	resistance	NOUN
eshr-4669	148	13	compared	compare	VERB
eshr-4669	148	14	to	to	ADP
eshr-4669	148	15	non	non	ADJ
eshr-4669	148	16	-	-	ADJ
eshr-4669	148	17	biofilm	biofilm	NOUN
eshr-4669	148	18	-	-	PUNCT
eshr-4669	148	19	forming	form	VERB
eshr-4669	148	20	isolates	isolate	NOUN
eshr-4669	148	21	.	.	PUNCT
eshr-4669	149	1	finally	finally	ADV
eshr-4669	149	2	,	,	PUNCT
eshr-4669	149	3	the	the	DET
eshr-4669	149	4	cra	cra	PROPN
eshr-4669	149	5	method	method	NOUN
eshr-4669	149	6	can	can	AUX
eshr-4669	149	7	be	be	AUX
eshr-4669	149	8	employed	employ	VERB
eshr-4669	149	9	as	as	ADP
eshr-4669	149	10	the	the	DET
eshr-4669	149	11	routine	routine	ADJ
eshr-4669	149	12	laboratory	laboratory	NOUN
eshr-4669	149	13	test	test	NOUN
eshr-4669	149	14	for	for	ADP
eshr-4669	149	15	in	in	ADV
eshr-4669	149	16	-	-	PUNCT
eshr-4669	149	17	vitro	vitro	X
eshr-4669	149	18	biofilm	biofilm	NOUN
eshr-4669	149	19	detection	detection	NOUN
eshr-4669	149	20	as	as	SCONJ
eshr-4669	149	21	it	it	PRON
eshr-4669	149	22	is	be	AUX
eshr-4669	149	23	cost	cost	NOUN
eshr-4669	149	24	-	-	PUNCT
eshr-4669	149	25	effective	effective	ADJ
eshr-4669	149	26	also	also	ADV
eshr-4669	149	27	.	.	PUNCT
eshr-4669	150	1	authors	author	NOUN
eshr-4669	150	2	'	'	PART
eshr-4669	150	3	contribution	contribution	NOUN
eshr-4669	150	4	bm	bm	PROPN
eshr-4669	150	5	and	and	CCONJ
eshr-4669	150	6	sss	sss	PROPN
eshr-4669	150	7	contributed	contribute	VERB
eshr-4669	150	8	to	to	ADP
eshr-4669	150	9	the	the	DET
eshr-4669	150	10	data	datum	NOUN
eshr-4669	150	11	collection	collection	NOUN
eshr-4669	150	12	and	and	CCONJ
eshr-4669	150	13	interpretation	interpretation	NOUN
eshr-4669	150	14	.	.	PUNCT
eshr-4669	151	1	ps	ps	PROPN
eshr-4669	151	2	,	,	PUNCT
eshr-4669	151	3	sd	sd	PROPN
eshr-4669	151	4	contributed	contribute	VERB
eshr-4669	151	5	to	to	ADP
eshr-4669	151	6	the	the	DET
eshr-4669	151	7	data	data	NOUN
eshr-4669	151	8	article	article	NOUN
eshr-4669	151	9	writing	write	VERB
eshr-4669	151	10	and	and	CCONJ
eshr-4669	151	11	its	its	PRON
eshr-4669	151	12	publication	publication	NOUN
eshr-4669	151	13	.	.	PUNCT
eshr-4669	152	1	funding	funding	NOUN
eshr-4669	152	2	statement	statement	NOUN
eshr-4669	152	3	this	this	DET
eshr-4669	152	4	research	research	NOUN
eshr-4669	152	5	has	have	AUX
eshr-4669	152	6	not	not	PART
eshr-4669	152	7	received	receive	VERB
eshr-4669	152	8	external	external	ADJ
eshr-4669	152	9	funding	funding	NOUN
eshr-4669	152	10	.	.	PUNCT
eshr-4669	153	1	conflict	conflict	NOUN
eshr-4669	153	2	of	of	ADP
eshr-4669	153	3	interest	interest	NOUN
eshr-4669	153	4	there	there	PRON
eshr-4669	153	5	is	be	VERB
eshr-4669	153	6	no	no	DET
eshr-4669	153	7	conflict	conflict	NOUN
eshr-4669	153	8	of	of	ADP
eshr-4669	153	9	interest	interest	NOUN
eshr-4669	153	10	in	in	ADP
eshr-4669	153	11	this	this	DET
eshr-4669	153	12	research	research	NOUN
eshr-4669	153	13	.	.	PUNCT
eshr-4669	154	1	references	reference	NOUN
eshr-4669	154	2	1	1	NUM
eshr-4669	154	3	.	.	PUNCT
eshr-4669	154	4	chu	chu	PROPN
eshr-4669	154	5	cm	cm	PROPN
eshr-4669	154	6	,	,	PUNCT
eshr-4669	154	7	lowder	lowder	PROPN
eshr-4669	154	8	jl	jl	PROPN
eshr-4669	154	9	.	.	PUNCT
eshr-4669	154	10	diagnosis	diagnosis	NOUN
eshr-4669	154	11	and	and	CCONJ
eshr-4669	154	12	treatment	treatment	NOUN
eshr-4669	154	13	of	of	ADP
eshr-4669	154	14	urinary	urinary	ADJ
eshr-4669	154	15	tract	tract	NOUN
eshr-4669	154	16	infections	infection	NOUN
eshr-4669	154	17	across	across	ADP
eshr-4669	154	18	age	age	NOUN
eshr-4669	154	19	groups	group	NOUN
eshr-4669	154	20	.	.	PUNCT
eshr-4669	155	1	am	be	AUX
eshr-4669	155	2	j	j	PROPN
eshr-4669	155	3	obstet	obstet	NOUN
eshr-4669	155	4	gynecol	gynecol	PROPN
eshr-4669	156	1	[	[	X
eshr-4669	156	2	internet	internet	NOUN
eshr-4669	156	3	]	]	PUNCT
eshr-4669	156	4	.	.	PUNCT
eshr-4669	157	1	2018;219(1):40–51	2018;219(1):40–51	X
eshr-4669	157	2	.	.	PUNCT
eshr-4669	157	3	available	available	ADJ
eshr-4669	157	4	from	from	ADP
eshr-4669	157	5	:	:	PUNCT
eshr-4669	157	6	https://doi.org/10.1016/j.ajog.2017.12.231	https://doi.org/10.1016/j.ajog.2017.12.231	PROPN
eshr-4669	157	7	2	2	NUM
eshr-4669	157	8	.	.	PUNCT
eshr-4669	157	9	m.	m.	PROPN
eshr-4669	157	10	mehta	mehta	PROPN
eshr-4669	157	11	,	,	PUNCT
eshr-4669	157	12	s.	s.	PROPN
eshr-4669	157	13	bhardwaj	bhardwaj	PROPN
eshr-4669	157	14	and	and	CCONJ
eshr-4669	157	15	js	js	PROPN
eshr-4669	157	16	.	.	PUNCT
eshr-4669	158	1	screening	screen	VERB
eshr-4669	158	2	of	of	ADP
eshr-4669	158	3	urinary	urinary	ADJ
eshr-4669	158	4	isolates	isolate	NOUN
eshr-4669	158	5	for	for	ADP
eshr-4669	158	6	the	the	DET
eshr-4669	158	7	prevalence	prevalence	NOUN
eshr-4669	158	8	and	and	CCONJ
eshr-4669	158	9	antimicrobial	antimicrobial	ADJ
eshr-4669	158	10	susceptibility	susceptibility	NOUN
eshr-4669	158	11	of	of	ADP
eshr-4669	158	12	enterobacteria	enterobacteria	NOUN
eshr-4669	158	13	other	other	ADJ
eshr-4669	158	14	than	than	ADP
eshr-4669	158	15	escherichia	escherichia	NOUN
eshr-4669	158	16	coli	coli	NOUN
eshr-4669	158	17	.	.	PUNCT
eshr-4669	159	1	int	int	NOUN
eshr-4669	159	2	j	j	PROPN
eshr-4669	159	3	life	life	NOUN
eshr-4669	159	4	sci	sci	PROPN
eshr-4669	159	5	pharma	pharma	PROPN
eshr-4669	159	6	res	re	NOUN
eshr-4669	159	7	.	.	PUNCT
eshr-4669	160	1	2013;3(1):100–4	2013;3(1):100–4	NUM
eshr-4669	160	2	.	.	NOUN
eshr-4669	160	3	3	3	X
eshr-4669	160	4	.	.	PUNCT
eshr-4669	161	1	o′gara	o′gara	PROPN
eshr-4669	161	2	jp	jp	PROPN
eshr-4669	161	3	and	and	CCONJ
eshr-4669	161	4	humphreys	humphreys	PROPN
eshr-4669	161	5	h.	h.	PROPN
eshr-4669	161	6	staphylococcus	staphylococcus	PROPN
eshr-4669	161	7	epidermidis	epidermidis	PROPN
eshr-4669	161	8	biofilms	biofilm	NOUN
eshr-4669	161	9	:	:	PUNCT
eshr-4669	161	10	importance	importance	NOUN
eshr-4669	161	11	and	and	CCONJ
eshr-4669	161	12	implications	implication	NOUN
eshr-4669	161	13	.	.	PUNCT
eshr-4669	162	1	j	j	PROPN
eshr-4669	162	2	med	med	PROPN
eshr-4669	162	3	microbiol	microbiol	PROPN
eshr-4669	162	4	.	.	PUNCT
eshr-4669	163	1	2001;50(582):7	2001;50(582):7	NUM
eshr-4669	163	2	.	.	PUNCT
eshr-4669	164	1	4	4	NUM
eshr-4669	164	2	.	.	X
eshr-4669	164	3	v	v	NUM
eshr-4669	164	4	s	s	PROPN
eshr-4669	164	5	,	,	PUNCT
eshr-4669	164	6	ali	ali	PROPN
eshr-4669	164	7	f	f	PROPN
eshr-4669	164	8	,	,	PUNCT
eshr-4669	164	9	lokare	lokare	NOUN
eshr-4669	164	10	n	n	CCONJ
eshr-4669	164	11	,	,	PUNCT
eshr-4669	164	12	matew	matew	ADJ
eshr-4669	164	13	j.	j.	PROPN
eshr-4669	164	14	diabetic	diabetic	ADJ
eshr-4669	164	15	foot	foot	NOUN
eshr-4669	164	16	ulcers	ulcer	NOUN
eshr-4669	164	17	and	and	CCONJ
eshr-4669	164	18	biofilm	biofilm	VERB
eshr-4669	164	19	formationthe	formationthe	DET
eshr-4669	164	20	culprits	culprit	NOUN
eshr-4669	164	21	.	.	PUNCT
eshr-4669	165	1	int	int	PROPN
eshr-4669	166	1	j	j	PROPN
eshr-4669	166	2	biomed	biome	VERB
eshr-4669	166	3	adv	adv	PROPN
eshr-4669	166	4	res	re	NOUN
eshr-4669	166	5	.	.	PUNCT
eshr-4669	167	1	2016;7(9):428	2016;7(9):428	NUM
eshr-4669	167	2	.	.	NOUN
eshr-4669	168	1	5	5	NUM
eshr-4669	168	2	.	.	X
eshr-4669	168	3	heukelekian	heukelekian	PROPN
eshr-4669	168	4	h	h	PROPN
eshr-4669	168	5	ha	ha	INTJ
eshr-4669	168	6	.	.	PROPN
eshr-4669	168	7	relation	relation	NOUN
eshr-4669	168	8	between	between	ADP
eshr-4669	168	9	food	food	NOUN
eshr-4669	168	10	concentration	concentration	NOUN
eshr-4669	168	11	and	and	CCONJ
eshr-4669	168	12	surface	surface	NOUN
eshr-4669	168	13	for	for	ADP
eshr-4669	168	14	bacterial	bacterial	ADJ
eshr-4669	168	15	growth	growth	NOUN
eshr-4669	168	16	.	.	PUNCT
eshr-4669	169	1	j	j	PROPN
eshr-4669	169	2	bacteriol	bacteriol	NOUN
eshr-4669	169	3	.	.	PUNCT
eshr-4669	170	1	1940;40:547–58	1940;40:547–58	X
eshr-4669	170	2	.	.	PUNCT
eshr-4669	171	1	6	6	NUM
eshr-4669	171	2	.	.	X
eshr-4669	171	3	costerton	costerton	PROPN
eshr-4669	171	4	jw	jw	PROPN
eshr-4669	171	5	,	,	PUNCT
eshr-4669	171	6	geesey	geesey	PROPN
eshr-4669	171	7	gg	gg	PROPN
eshr-4669	171	8	ck	ck	PROPN
eshr-4669	171	9	-	-	PUNCT
eshr-4669	171	10	j.	j.	PROPN
eshr-4669	171	11	how	how	SCONJ
eshr-4669	171	12	bacteria	bacteria	NOUN
eshr-4669	171	13	stick	stick	VERB
eshr-4669	171	14	.	.	PUNCT
eshr-4669	172	1	sci	sci	PROPN
eshr-4669	172	2	am	be	AUX
eshr-4669	172	3	.	.	PUNCT
eshr-4669	173	1	1978;238:86–95	1978;238:86–95	NUM
eshr-4669	173	2	.	.	NOUN
eshr-4669	173	3	7	7	NUM
eshr-4669	173	4	.	.	X
eshr-4669	173	5	tenke	tenke	NOUN
eshr-4669	173	6	p	p	X
eshr-4669	173	7	,	,	PUNCT
eshr-4669	173	8	kovacs	kovacs	PROPN
eshr-4669	173	9	b	b	PROPN
eshr-4669	173	10	jm	jm	PROPN
eshr-4669	173	11	and	and	CCONJ
eshr-4669	173	12	ne	ne	PROPN
eshr-4669	173	13	.	.	PUNCT
eshr-4669	174	1	the	the	DET
eshr-4669	174	2	role	role	NOUN
eshr-4669	174	3	of	of	ADP
eshr-4669	174	4	biofilm	biofilm	NOUN
eshr-4669	174	5	infection	infection	NOUN
eshr-4669	174	6	in	in	ADP
eshr-4669	174	7	urology	urology	NOUN
eshr-4669	174	8	.	.	PUNCT
eshr-4669	175	1	world	world	PROPN
eshr-4669	175	2	j	j	PROPN
eshr-4669	175	3	urol	urol	PROPN
eshr-4669	175	4	.	.	PUNCT
eshr-4669	176	1	2006;24(1):13–20	2006;24(1):13–20	NUM
eshr-4669	176	2	.	.	NOUN
eshr-4669	176	3	8	8	NUM
eshr-4669	176	4	.	.	PUNCT
eshr-4669	177	1	joo	joo	PROPN
eshr-4669	177	2	h.s	h.s	PROPN
eshr-4669	177	3	.	.	PROPN
eshr-4669	178	1	om	om	PROPN
eshr-4669	178	2	.	.	PUNCT
eshr-4669	179	1	molecular	molecular	ADJ
eshr-4669	179	2	basis	basis	NOUN
eshr-4669	179	3	of	of	ADP
eshr-4669	179	4	in	in	ADP
eshr-4669	179	5	vivo	vivo	ADJ
eshr-4669	179	6	biofilm	biofilm	NOUN
eshr-4669	179	7	formation	formation	NOUN
eshr-4669	179	8	by	by	ADP
eshr-4669	179	9	bacterial	bacterial	ADJ
eshr-4669	179	10	pathogens	pathogen	NOUN
eshr-4669	179	11	.	.	PUNCT
eshr-4669	180	1	sharma	sharma	PROPN
eshr-4669	180	2	(	(	PUNCT
eshr-4669	180	3	biofilm	biofilm	NOUN
eshr-4669	180	4	formation	formation	NOUN
eshr-4669	180	5	by	by	ADP
eshr-4669	180	6	uropathogens	uropathogen	NOUN
eshr-4669	180	7	and	and	CCONJ
eshr-4669	180	8	its	its	PRON
eshr-4669	180	9	impact	impact	NOUN
eshr-4669	180	10	on	on	ADP
eshr-4669	180	11	antimicrobial	antimicrobial	ADJ
eshr-4669	180	12	susceptibility	susceptibility	NOUN
eshr-4669	180	13	pattern	pattern	NOUN
eshr-4669	180	14	)	)	PUNCT
eshr-4669	180	15	vol	vol	NOUN
eshr-4669	180	16	.	.	NOUN
eshr-4669	181	1	4	4	NUM
eshr-4669	181	2	,	,	PUNCT
eshr-4669	181	3	no	no	INTJ
eshr-4669	181	4	.	.	NOUN
eshr-4669	181	5	2	2	NUM
eshr-4669	181	6	,	,	PUNCT
eshr-4669	181	7	2022	2022	NUM
eshr-4669	181	8	,	,	PUNCT
eshr-4669	181	9	pp	pp	ADJ
eshr-4669	181	10	.	.	PUNCT
eshr-4669	182	1	40	40	NUM
eshr-4669	182	2	-	-	SYM
eshr-4669	182	3	47	47	NUM
eshr-4669	182	4	10.26555	10.26555	NUM
eshr-4669	182	5	/	/	SYM
eshr-4669	182	6	eshr.v4i2.4669	eshr.v4i2.4669	NUM
eshr-4669	182	7	47	47	NUM
eshr-4669	182	8	chem	chem	NOUN
eshr-4669	182	9	biol	biol	NOUN
eshr-4669	182	10	.	.	PUNCT
eshr-4669	183	1	2012;19(12):1503–13	2012;19(12):1503–13	NUM
eshr-4669	183	2	.	.	NOUN
eshr-4669	183	3	9	9	NUM
eshr-4669	183	4	.	.	X
eshr-4669	183	5	l	l	PROPN
eshr-4669	183	6	k.	k.	PROPN
eshr-4669	184	1	riddle	riddle	PROPN
eshr-4669	184	2	of	of	ADP
eshr-4669	184	3	biofilm	biofilm	NOUN
eshr-4669	184	4	resistance	resistance	NOUN
eshr-4669	184	5	.	.	PUNCT
eshr-4669	185	1	antimicrob	antimicrob	PROPN
eshr-4669	185	2	agents	agents	PROPN
eshr-4669	185	3	chemother	chemother	PROPN
eshr-4669	185	4	.	.	PUNCT
eshr-4669	186	1	2001;45:999	2001;45:999	NOUN
eshr-4669	186	2	–	–	PUNCT
eshr-4669	186	3	1007	1007	NUM
eshr-4669	186	4	.	.	PUNCT
eshr-4669	187	1	10	10	NUM
eshr-4669	187	2	.	.	PUNCT
eshr-4669	187	3	donlan	donlan	PROPN
eshr-4669	187	4	rm	rm	PROPN
eshr-4669	187	5	.	.	PROPN
eshr-4669	187	6	biofilms	biofilm	NOUN
eshr-4669	187	7	and	and	CCONJ
eshr-4669	187	8	device	device	NOUN
eshr-4669	187	9	-	-	PUNCT
eshr-4669	187	10	associated	associate	VERB
eshr-4669	187	11	infections	infection	NOUN
eshr-4669	187	12	.	.	PUNCT
eshr-4669	188	1	emerg	emerg	PROPN
eshr-4669	188	2	infect	infect	PROPN
eshr-4669	188	3	dis	dis	PROPN
eshr-4669	188	4	.	.	PUNCT
eshr-4669	189	1	2001;7(2):277–81	2001;7(2):277–81	NUM
eshr-4669	189	2	.	.	PUNCT
eshr-4669	190	1	11	11	NUM
eshr-4669	190	2	.	.	PUNCT
eshr-4669	191	1	stickler	stickler	NOUN
eshr-4669	191	2	dj	dj	PROPN
eshr-4669	191	3	.	.	PUNCT
eshr-4669	192	1	bacterial	bacterial	ADJ
eshr-4669	192	2	biofilms	biofilm	NOUN
eshr-4669	192	3	and	and	CCONJ
eshr-4669	192	4	the	the	DET
eshr-4669	192	5	encrustation	encrustation	NOUN
eshr-4669	192	6	of	of	ADP
eshr-4669	192	7	urethral	urethral	ADJ
eshr-4669	192	8	catheters	catheter	NOUN
eshr-4669	192	9	.	.	PUNCT
eshr-4669	193	1	biofouling	biofoule	VERB
eshr-4669	193	2	.	.	PUNCT
eshr-4669	194	1	1996;94:293–305	1996;94:293–305	X
eshr-4669	194	2	.	.	PUNCT
eshr-4669	194	3	12	12	NUM
eshr-4669	194	4	.	.	PUNCT
eshr-4669	195	1	keren	keren	PROPN
eshr-4669	195	2	i	i	PRON
eshr-4669	195	3	,	,	PUNCT
eshr-4669	195	4	kaldalu	kaldalu	PROPN
eshr-4669	195	5	n	n	CCONJ
eshr-4669	195	6	,	,	PUNCT
eshr-4669	195	7	spoering	spoere	VERB
eshr-4669	195	8	a	a	PRON
eshr-4669	195	9	,	,	PUNCT
eshr-4669	195	10	wang	wang	PROPN
eshr-4669	195	11	y	y	PROPN
eshr-4669	195	12	lk	lk	PROPN
eshr-4669	195	13	.	.	PROPN
eshr-4669	196	1	persister	persister	NOUN
eshr-4669	196	2	cells	cell	NOUN
eshr-4669	196	3	and	and	CCONJ
eshr-4669	196	4	tolerance	tolerance	NOUN
eshr-4669	196	5	to	to	ADP
eshr-4669	196	6	antimicrobials	antimicrobial	NOUN
eshr-4669	196	7	.	.	PUNCT
eshr-4669	197	1	fems	fems	PROPN
eshr-4669	197	2	microbiol	microbiol	PROPN
eshr-4669	197	3	lett	lett	PROPN
eshr-4669	197	4	.	.	PUNCT
eshr-4669	198	1	2004;230:13–8	2004;230:13–8	PROPN
eshr-4669	198	2	.	.	PUNCT
eshr-4669	199	1	13	13	NUM
eshr-4669	199	2	.	.	X
eshr-4669	199	3	freeman	freeman	PROPN
eshr-4669	199	4	dj	dj	PROPN
eshr-4669	199	5	,	,	PUNCT
eshr-4669	199	6	falkiner	falkiner	NOUN
eshr-4669	199	7	fr	fr	PROPN
eshr-4669	199	8	kc	kc	PROPN
eshr-4669	199	9	.	.	PUNCT
eshr-4669	200	1	new	new	ADJ
eshr-4669	200	2	method	method	NOUN
eshr-4669	200	3	for	for	ADP
eshr-4669	200	4	detecting	detect	VERB
eshr-4669	200	5	slime	slime	NOUN
eshr-4669	200	6	production	production	NOUN
eshr-4669	200	7	by	by	ADP
eshr-4669	200	8	coagulase	coagulase	NOUN
eshr-4669	200	9	-	-	PUNCT
eshr-4669	200	10	negative	negative	ADJ
eshr-4669	200	11	staphylococci	staphylococci	NOUN
eshr-4669	200	12	.	.	PUNCT
eshr-4669	201	1	j	j	PROPN
eshr-4669	201	2	clin	clin	PROPN
eshr-4669	201	3	pathol	pathol	PROPN
eshr-4669	201	4	.	.	PUNCT
eshr-4669	202	1	1989;42(8):872–4	1989;42(8):872–4	NUM
eshr-4669	202	2	.	.	PUNCT
eshr-4669	203	1	14	14	NUM
eshr-4669	203	2	.	.	PUNCT
eshr-4669	204	1	christensen	christensen	PROPN
eshr-4669	204	2	gd	gd	PROPN
eshr-4669	204	3	,	,	PUNCT
eshr-4669	204	4	simpson	simpson	PROPN
eshr-4669	204	5	wa	wa	PROPN
eshr-4669	204	6	,	,	PUNCT
eshr-4669	204	7	bisno	bisno	PROPN
eshr-4669	204	8	al	al	PROPN
eshr-4669	204	9	be	be	VERB
eshr-4669	204	10	.	.	PUNCT
eshr-4669	205	1	adherence	adherence	NOUN
eshr-4669	205	2	of	of	ADP
eshr-4669	205	3	slime	slime	NOUN
eshr-4669	205	4	-	-	PUNCT
eshr-4669	205	5	producing	produce	VERB
eshr-4669	205	6	strains	strain	NOUN
eshr-4669	205	7	of	of	ADP
eshr-4669	205	8	staphylococcus	staphylococcus	NOUN
eshr-4669	205	9	epidermidis	epidermidi	NOUN
eshr-4669	205	10	to	to	ADP
eshr-4669	205	11	smooth	smooth	ADJ
eshr-4669	205	12	surfaces	surface	NOUN
eshr-4669	205	13	.	.	PUNCT
eshr-4669	206	1	infect	infect	VERB
eshr-4669	206	2	immun	immun	NOUN
eshr-4669	206	3	.	.	PUNCT
eshr-4669	207	1	1982;37(1):318–26	1982;37(1):318–26	NUM
eshr-4669	207	2	.	.	PUNCT
eshr-4669	207	3	15	15	NUM
eshr-4669	207	4	.	.	PUNCT
eshr-4669	207	5	institute	institute	PROPN
eshr-4669	207	6	cls	cls	PROPN
eshr-4669	207	7	.	.	PUNCT
eshr-4669	208	1	performance	performance	NOUN
eshr-4669	208	2	standard	standard	NOUN
eshr-4669	208	3	for	for	ADP
eshr-4669	208	4	antimicrobial	antimicrobial	ADJ
eshr-4669	208	5	susceptibility	susceptibility	NOUN
eshr-4669	208	6	testing	testing	NOUN
eshr-4669	208	7	.	.	PUNCT
eshr-4669	209	1	24th	24th	ADJ
eshr-4669	209	2	information	information	NOUN
eshr-4669	209	3	supplement	supplement	NOUN
eshr-4669	209	4	.	.	PUNCT
eshr-4669	210	1	nccls	nccls	PROPN
eshr-4669	210	2	document	document	NOUN
eshr-4669	210	3	m100	m100	PROPN
eshr-4669	210	4	-	-	PUNCT
eshr-4669	210	5	s24	s24	NOUN
eshr-4669	210	6	.	.	PUNCT
eshr-4669	211	1	wayne	wayne	PROPN
eshr-4669	211	2	,	,	PUNCT
eshr-4669	211	3	pennsylvania	pennsylvania	PROPN
eshr-4669	211	4	.	.	PUNCT
eshr-4669	212	1	usa	usa	PROPN
eshr-4669	212	2	clin	clin	PROPN
eshr-4669	212	3	lab	lab	PROPN
eshr-4669	212	4	stand	stand	NOUN
eshr-4669	212	5	inst	inst	PROPN
eshr-4669	212	6	.	.	PUNCT
eshr-4669	212	7	2014	2014	NUM
eshr-4669	212	8	.	.	PUNCT
eshr-4669	213	1	16	16	NUM
eshr-4669	213	2	.	.	PUNCT
eshr-4669	214	1	madigan	madigan	PROPN
eshr-4669	214	2	e	e	PROPN
eshr-4669	214	3	and	and	CCONJ
eshr-4669	214	4	neff	neff	PROPN
eshr-4669	214	5	df	df	PROPN
eshr-4669	214	6	.	.	PUNCT
eshr-4669	214	7	care	care	NOUN
eshr-4669	214	8	of	of	ADP
eshr-4669	214	9	the	the	DET
eshr-4669	214	10	patients	patient	NOUN
eshr-4669	214	11	with	with	ADP
eshr-4669	214	12	long	long	ADJ
eshr-4669	214	13	-	-	PUNCT
eshr-4669	214	14	term	term	NOUN
eshr-4669	214	15	indwelling	indwell	VERB
eshr-4669	214	16	urinary	urinary	ADJ
eshr-4669	214	17	catheters	catheter	NOUN
eshr-4669	214	18	.	.	PUNCT
eshr-4669	215	1	online	online	PROPN
eshr-4669	215	2	j	j	PROPN
eshr-4669	215	3	issues	issue	NOUN
eshr-4669	215	4	nurs	nur	VERB
eshr-4669	215	5	.	.	PUNCT
eshr-4669	216	1	2003;8(3):7	2003;8(3):7	NUM
eshr-4669	216	2	.	.	PUNCT
eshr-4669	217	1	17	17	NUM
eshr-4669	217	2	.	.	PUNCT
eshr-4669	218	1	kashef	kashef	PROPN
eshr-4669	218	2	n	n	CCONJ
eshr-4669	218	3	,	,	PUNCT
eshr-4669	218	4	djavid	djavid	VERB
eshr-4669	218	5	ge	ge	PROPN
eshr-4669	218	6	ss	ss	PROPN
eshr-4669	218	7	.	.	PUNCT
eshr-4669	219	1	antimicrobial	antimicrobial	ADJ
eshr-4669	219	2	susceptibility	susceptibility	NOUN
eshr-4669	219	3	patterns	pattern	NOUN
eshr-4669	219	4	of	of	ADP
eshr-4669	219	5	communityacquired	communityacquire	VERB
eshr-4669	219	6	uropathogens	uropathogen	NOUN
eshr-4669	219	7	in	in	ADP
eshr-4669	219	8	tehran	tehran	PROPN
eshr-4669	219	9	.	.	PUNCT
eshr-4669	220	1	iran	iran	PROPN
eshr-4669	220	2	j	j	PROPN
eshr-4669	220	3	infect	infect	VERB
eshr-4669	220	4	dev	dev	PROPN
eshr-4669	220	5	ctries	ctrie	NOUN
eshr-4669	220	6	.	.	PUNCT
eshr-4669	221	1	2010;14(4):202–6	2010;14(4):202–6	NUM
eshr-4669	221	2	.	.	NOUN
eshr-4669	222	1	18	18	NUM
eshr-4669	222	2	.	.	PUNCT
eshr-4669	223	1	niveditha	niveditha	PROPN
eshr-4669	223	2	s	s	PROPN
eshr-4669	223	3	,	,	PUNCT
eshr-4669	223	4	pramodini	pramodini	PROPN
eshr-4669	223	5	s	s	PART
eshr-4669	223	6	,	,	PUNCT
eshr-4669	223	7	umadevi	umadevi	PROPN
eshr-4669	223	8	s	s	PROPN
eshr-4669	223	9	,	,	PUNCT
eshr-4669	223	10	kumar	kumar	PROPN
eshr-4669	223	11	s	s	PROPN
eshr-4669	223	12	ss	ss	PROPN
eshr-4669	223	13	.	.	PUNCT
eshr-4669	224	1	the	the	DET
eshr-4669	224	2	isolation	isolation	NOUN
eshr-4669	224	3	and	and	CCONJ
eshr-4669	224	4	the	the	DET
eshr-4669	224	5	biofilm	biofilm	NOUN
eshr-4669	224	6	formation	formation	NOUN
eshr-4669	224	7	of	of	ADP
eshr-4669	224	8	uropathogens	uropathogen	NOUN
eshr-4669	224	9	in	in	ADP
eshr-4669	224	10	the	the	DET
eshr-4669	224	11	patients	patient	NOUN
eshr-4669	224	12	with	with	ADP
eshr-4669	224	13	catheter	catheter	NOUN
eshr-4669	224	14	-	-	PUNCT
eshr-4669	224	15	associated	associate	VERB
eshr-4669	224	16	urinary	urinary	ADJ
eshr-4669	224	17	tract	tract	NOUN
eshr-4669	224	18	infections	infection	NOUN
eshr-4669	224	19	(	(	PUNCT
eshr-4669	224	20	utis	utis	NOUN
eshr-4669	224	21	)	)	PUNCT
eshr-4669	224	22	.	.	PUNCT
eshr-4669	225	1	j	j	PROPN
eshr-4669	225	2	clin	clin	PROPN
eshr-4669	225	3	boil	boil	PROPN
eshr-4669	225	4	res	re	NOUN
eshr-4669	225	5	.	.	PUNCT
eshr-4669	226	1	2012;6(9):1478–82	2012;6(9):1478–82	NUM
eshr-4669	226	2	.	.	PUNCT
eshr-4669	227	1	19	19	NUM
eshr-4669	227	2	.	.	PUNCT
eshr-4669	227	3	noor	noor	PROPN
eshr-4669	227	4	af	af	PROPN
eshr-4669	227	5	,	,	PUNCT
eshr-4669	227	6	shams	sham	VERB
eshr-4669	227	7	f	f	PROPN
eshr-4669	227	8	,	,	PUNCT
eshr-4669	227	9	munshi	munshi	PROPN
eshr-4669	227	10	sk	sk	PROPN
eshr-4669	227	11	,	,	PUNCT
eshr-4669	227	12	hassan	hassan	PROPN
eshr-4669	227	13	m	m	PROPN
eshr-4669	227	14	nr	nr	PROPN
eshr-4669	227	15	.	.	PUNCT
eshr-4669	228	1	prevalence	prevalence	NOUN
eshr-4669	228	2	and	and	CCONJ
eshr-4669	228	3	antibiogram	antibiogram	PROPN
eshr-4669	228	4	profile	profile	NOUN
eshr-4669	228	5	of	of	ADP
eshr-4669	228	6	uropathogenic	uropathogenic	ADJ
eshr-4669	228	7	isolated	isolate	VERB
eshr-4669	228	8	from	from	ADP
eshr-4669	228	9	hospital	hospital	NOUN
eshr-4669	228	10	and	and	CCONJ
eshr-4669	228	11	community	community	NOUN
eshr-4669	228	12	patients	patient	NOUN
eshr-4669	228	13	with	with	ADP
eshr-4669	228	14	urinary	urinary	ADJ
eshr-4669	228	15	tract	tract	NOUN
eshr-4669	228	16	infections	infection	NOUN
eshr-4669	228	17	in	in	ADP
eshr-4669	228	18	dhaka	dhaka	PROPN
eshr-4669	228	19	city	city	PROPN
eshr-4669	228	20	.	.	PUNCT
eshr-4669	229	1	j	j	PROPN
eshr-4669	229	2	bangladesh	bangladesh	PROPN
eshr-4669	229	3	acad	acad	PROPN
eshr-4669	229	4	sci	sci	PROPN
eshr-4669	229	5	.	.	PUNCT
eshr-4669	230	1	2013;37(1):52	2013;37(1):52	NUM
eshr-4669	230	2	–	–	PUNCT
eshr-4669	230	3	63	63	NUM
eshr-4669	230	4	.	.	NOUN
eshr-4669	230	5	20	20	NUM
eshr-4669	230	6	.	.	PUNCT
eshr-4669	231	1	hassan	hassan	PROPN
eshr-4669	231	2	a	a	PRON
eshr-4669	231	3	,	,	PUNCT
eshr-4669	231	4	usman	usman	PROPN
eshr-4669	231	5	j	j	PROPN
eshr-4669	231	6	,	,	PUNCT
eshr-4669	231	7	kaleem	kaleem	PROPN
eshr-4669	231	8	f	f	PROPN
eshr-4669	231	9	,	,	PUNCT
eshr-4669	231	10	omair	omair	PROPN
eshr-4669	231	11	m	m	PROPN
eshr-4669	231	12	,	,	PUNCT
eshr-4669	231	13	khalid	khalid	PROPN
eshr-4669	231	14	a	a	PROPN
eshr-4669	231	15	i	i	PROPN
eshr-4669	231	16	m.	m.	NOUN
eshr-4669	231	17	evaluation	evaluation	NOUN
eshr-4669	231	18	of	of	ADP
eshr-4669	231	19	different	different	ADJ
eshr-4669	231	20	detection	detection	NOUN
eshr-4669	231	21	methods	method	NOUN
eshr-4669	231	22	of	of	ADP
eshr-4669	231	23	biofilm	biofilm	NOUN
eshr-4669	231	24	formation	formation	NOUN
eshr-4669	231	25	in	in	ADP
eshr-4669	231	26	the	the	DET
eshr-4669	231	27	clinical	clinical	ADJ
eshr-4669	231	28	isolates	isolate	NOUN
eshr-4669	231	29	.	.	PUNCT
eshr-4669	232	1	braz	braz	PROPN
eshr-4669	232	2	j	j	PROPN
eshr-4669	232	3	infect	infect	PROPN
eshr-4669	232	4	dis	dis	PROPN
eshr-4669	232	5	.	.	PUNCT
eshr-4669	233	1	2011;15(4):305–11	2011;15(4):305–11	NUM
eshr-4669	233	2	.	.	NOUN
eshr-4669	233	3	21	21	NUM
eshr-4669	233	4	.	.	PUNCT
eshr-4669	233	5	rewatkar	rewatkar	PROPN
eshr-4669	233	6	ar	ar	PROPN
eshr-4669	233	7	and	and	CCONJ
eshr-4669	233	8	wadher	wadher	NOUN
eshr-4669	233	9	bj	bj	PROPN
eshr-4669	233	10	.	.	PUNCT
eshr-4669	233	11	staphylococcus	staphylococcus	NOUN
eshr-4669	233	12	aureus	aureus	PROPN
eshr-4669	233	13	and	and	CCONJ
eshr-4669	233	14	pseudomonas	pseudomonas	PROPN
eshr-4669	233	15	aeruginosabiofilm	aeruginosabiofilm	NOUN
eshr-4669	233	16	formation	formation	NOUN
eshr-4669	233	17	methods	method	NOUN
eshr-4669	233	18	.	.	PUNCT
eshr-4669	234	1	j	j	PROPN
eshr-4669	234	2	pharm	pharm	PROPN
eshr-4669	234	3	biol	biol	PROPN
eshr-4669	234	4	sci	sci	PROPN
eshr-4669	234	5	.	.	PUNCT
eshr-4669	235	1	2013;8(5):36–40	2013;8(5):36–40	NUM
eshr-4669	235	2	.	.	PUNCT
eshr-4669	236	1	22	22	NUM
eshr-4669	236	2	.	.	PUNCT
eshr-4669	236	3	panda	panda	PROPN
eshr-4669	236	4	ps	ps	PROPN
eshr-4669	236	5	,	,	PUNCT
eshr-4669	236	6	chaudhary	chaudhary	PROPN
eshr-4669	236	7	u	u	NOUN
eshr-4669	236	8	ds	ds	PROPN
eshr-4669	236	9	.	.	PROPN
eshr-4669	236	10	study	study	NOUN
eshr-4669	236	11	of	of	ADP
eshr-4669	236	12	biofilm	biofilm	NOUN
eshr-4669	236	13	production	production	NOUN
eshr-4669	236	14	and	and	CCONJ
eshr-4669	236	15	antimicrobial	antimicrobial	ADJ
eshr-4669	236	16	sensitivity	sensitivity	NOUN
eshr-4669	236	17	pattern	pattern	NOUN
eshr-4669	236	18	of	of	ADP
eshr-4669	236	19	uropathogens	uropathogen	NOUN
eshr-4669	236	20	in	in	ADP
eshr-4669	236	21	a	a	DET
eshr-4669	236	22	tertiary	tertiary	ADJ
eshr-4669	236	23	care	care	NOUN
eshr-4669	236	24	hospital	hospital	NOUN
eshr-4669	236	25	in	in	ADP
eshr-4669	236	26	north	north	PROPN
eshr-4669	236	27	india	india	PROPN
eshr-4669	236	28	.	.	PUNCT
eshr-4669	237	1	int	int	PROPN
eshr-4669	237	2	j	j	PROPN
eshr-4669	237	3	community	community	NOUN
eshr-4669	237	4	med	me	VERB
eshr-4669	237	5	public	public	ADJ
eshr-4669	237	6	heal	heal	NOUN
eshr-4669	237	7	.	.	PUNCT
eshr-4669	238	1	2016;3(9):2421–6	2016;3(9):2421–6	X
eshr-4669	238	2	.	.	NOUN
eshr-4669	238	3	23	23	NUM
eshr-4669	238	4	.	.	PUNCT
eshr-4669	239	1	tiwari	tiwari	ADJ
eshr-4669	239	2	aa	aa	NOUN
eshr-4669	239	3	and	and	CCONJ
eshr-4669	239	4	ghnawate	ghnawate	VERB
eshr-4669	239	5	n.	n.	NOUN
eshr-4669	239	6	detection	detection	NOUN
eshr-4669	239	7	of	of	ADP
eshr-4669	239	8	biofilm	biofilm	NOUN
eshr-4669	239	9	forming	form	VERB
eshr-4669	239	10	bacterial	bacterial	ADJ
eshr-4669	239	11	communities	community	NOUN
eshr-4669	239	12	from	from	ADP
eshr-4669	239	13	urinary	urinary	ADJ
eshr-4669	239	14	catheter	catheter	NOUN
eshr-4669	239	15	of	of	ADP
eshr-4669	239	16	patients	patient	NOUN
eshr-4669	239	17	with	with	ADP
eshr-4669	239	18	change	change	NOUN
eshr-4669	239	19	in	in	ADP
eshr-4669	239	20	its	its	PRON
eshr-4669	239	21	antibiotic	antibiotic	ADJ
eshr-4669	239	22	susceptibility	susceptibility	NOUN
eshr-4669	239	23	pattern	pattern	NOUN
eshr-4669	239	24	and	and	CCONJ
eshr-4669	239	25	triclosan	triclosan	ADJ
eshr-4669	239	26	effect	effect	NOUN
eshr-4669	239	27	from	from	ADP
eshr-4669	239	28	different	different	ADJ
eshr-4669	239	29	hospitals	hospital	NOUN
eshr-4669	239	30	of	of	ADP
eshr-4669	239	31	amravati	amravati	PROPN
eshr-4669	239	32	city	city	PROPN
eshr-4669	239	33	maharashtra	maharashtra	PROPN
eshr-4669	239	34	,	,	PUNCT
eshr-4669	239	35	india	india	PROPN
eshr-4669	239	36	.	.	PUNCT
eshr-4669	240	1	open	open	PROPN
eshr-4669	240	2	j	j	PROPN
eshr-4669	240	3	med	med	PROPN
eshr-4669	240	4	microbio	microbio	NOUN
eshr-4669	240	5	.	.	PUNCT
eshr-4669	241	1	2017;7(3):51–66	2017;7(3):51–66	NUM
eshr-4669	241	2	.	.	X
eshr-4669	242	1	24	24	NUM
eshr-4669	242	2	.	.	PUNCT
eshr-4669	243	1	yousefi	yousefi	PROPN
eshr-4669	243	2	m	m	PROPN
eshr-4669	243	3	,	,	PUNCT
eshr-4669	243	4	pourmand	pourmand	PROPN
eshr-4669	243	5	mr	mr	PROPN
eshr-4669	243	6	,	,	PUNCT
eshr-4669	243	7	fallah	fallah	ADJ
eshr-4669	243	8	f	f	PROPN
eshr-4669	243	9	,	,	PUNCT
eshr-4669	243	10	hashemi	hashemi	X
eshr-4669	243	11	a	a	PRON
eshr-4669	243	12	,	,	PUNCT
eshr-4669	243	13	mashhadi	mashhadi	NOUN
eshr-4669	243	14	r	r	NOUN
eshr-4669	243	15	n	n	CCONJ
eshr-4669	243	16	-	-	PUNCT
eshr-4669	243	17	aa	aa	NOUN
eshr-4669	243	18	.	.	PUNCT
eshr-4669	244	1	characterization	characterization	NOUN
eshr-4669	244	2	of	of	ADP
eshr-4669	244	3	staphylococcus	staphylococcus	NOUN
eshr-4669	244	4	aureus	aureus	NOUN
eshr-4669	244	5	biofilm	biofilm	NOUN
eshr-4669	244	6	formation	formation	NOUN
eshr-4669	244	7	in	in	ADP
eshr-4669	244	8	urinary	urinary	ADJ
eshr-4669	244	9	tract	tract	NOUN
eshr-4669	244	10	infection	infection	NOUN
eshr-4669	244	11	.	.	PUNCT
eshr-4669	245	1	iran	iran	PROPN
eshr-4669	245	2	j	j	PROPN
eshr-4669	245	3	public	public	ADJ
eshr-4669	245	4	heal	heal	NOUN
eshr-4669	245	5	.	.	PUNCT
eshr-4669	246	1	2016;45(4):485–93	2016;45(4):485–93	NUM
eshr-4669	246	2	.	.	PUNCT